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ABSTRACT 
 Focused on the intersection of health, drug use, and poverty, this dissertation 
closely examines the use of discursive registers in the conceptualization of health among 
low-income people who inject drugs in New York City. Using qualitative in-depth 
interviews with 40 people who inject drugs, 13 health care practitioners who provide care 
for drug-using patients, and 4 researchers of drug use, the governmentality of a public 
health risk population—people who inject drugs—is traced. To historicize this population 
a genealogy of the “injection drug user” is conducted through the examination of public 
health research publications from the 1980s and historical literature on the HIV/AIDS 
epidemic. This dissertation sought to answer such questions as: How did the emergence 
in the 1980s of the “injection drug user” function as an act of governmentality? How do 
health care practitioners understand drug use among their patients and what are the 
implications of these understandings for the management of their health and their selves? 
How have risk discourse and particularly harm reduction discourse produced concepts of 
health and governed the bodies of low-income people who inject drugs? And, what can 
be done about health concerns that fall outside of risk discourse? The findings of this 
dissertation interrogate discourses of risk, such as harm reduction, and the discourse of 
addiction as disease by pointing to the narratives of illness offered by people who inject 
drugs. These narratives reveal that these individuals prioritize chronic health conditions 
from which they currently suffer over concerns of risk for infectious disease or the 
disease of addiction. Despite this, people who inject drugs are entangled in a complicated 
web of power through bio-political discourses of risk and disease that renders them 
subjects of disciplinary and pastoral technologies of power. 
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Chapter One 
Introducing the Project: Risk, Disease, Illness and Governance 
 
“They have the risk factors of people not using clean needles. Hepatitis C and HIV.”   
       - Elaine, M.D. 
“Drug use is a chronic disease and like all chronic diseases it needs to be paid attention to. It’s 
not ever going to really completely go away.” 
- Christine, M.D. 
“My main health concerns? Pretty much just my diabetes. It won’t affect me now. It’ll affect me 
later—your legs chopped off and this and that.”  
       - Dan 
 
 This project is an exploration and an analysis of the meaning of health for economically 
marginalized people who inject drugs. By conducting qualitative interviews with low-income 
people who inject drugs, health care practitioners who provide primary care for drug users, and 
public health researchers who study drug use, this project sought to understand how health-
related practices and discourses can govern the bodies of low-income drug users. To historicize 
this research project, a genealogical analysis of the formation of the “injection drug user” risk 
category was conducted. Based on archival research and qualitative interviews with four 
researchers, this historical analysis aimed to understand how acts of public health 
governmentality create and manage populations. 
 The quotes from study participants featured above represent three ways of discussing the 
health of people who inject drugs that emerged during interviews with 40 economically 
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marginalized people who inject drugs and 13 health care practitioners. These interviews, 
conducted between January 2012 and May 2013 in New York City, revealed that the health of 
those who use drugs is understood in at least three ways—1.) through reference to health risks, 
2.) through reference to addiction as a disease, and 3.) through reference to chronic illnesses 
provoked and made worse by economic hardship. My goal in analyzing these conceptualizations 
was to understand how certain discourses function as mechanisms of power with implications for 
material practices. I wanted to track invisible forms of power that work through the desire of 
health care practitioners to provide more access to well-being, and through the desire of people 
who inject drugs to be healthy. Power works through these desires for optimization and 
maximization of health. Foucault’s concept of governmentality provided guidance in 
understanding how various constructs and practices of health could be tied to forms of power 
that manage and regulate people and populations. I applied this Foucauldian analytic to the lay 
knowledge, illness narratives, and doctor-patient relationships depicted by interviewees. 
 Governmentality can be understood as a rationality that constitutes society and in doing 
so makes the governance of society on the population- and individual-level possible (Foucault 
2007a). By introducing the concept in the late 1970s, Foucault was attempting to explain the 
preponderance of internalized self-governance emerging in that decade (Rose, O’Malley and 
Valverde 2006). Neoliberal rationalities of governance that emerged at that time and continue 
today promote personal responsibility, governing-at-a-distance (Petersen and Lupton 1996), and 
regulated autonomy for the individual (Petersen 1997).  
 Understanding the health of people who inject drugs as related to risk, as Elaine, who 
practices medicine at an inpatient drug treatment center, does in the quote above, allows for 
governing-at-a-distance because it means that drug using individuals must tend to their own 
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potential for risk, and thus govern themselves. The interviewees who inject drugs also spoke 
about their health in relation to risk. For example, when asked about her main health concern, 
Karla, a 48-year-old Latina, said: “The only thing I’m worried about now is hepatitis. I want to 
do the test. I want to find out more about that because I really don’t know much about that.” As a 
person who injects drugs, Karla8 was aware of her risk for contracting hepatitis, and wanted to 
monitor this risk by getting tested. Other drug injecting interviewees voiced risks for illnesses 
unrelated to drug use. James, a 34-year-old white homeless man, responded to the question about 
his main health concerns by saying: “Diabetes runs in my family. I don’t eat sweets.” Later in 
our interview he re-stated his concern about this risk and mentioned how he is addressing it: “I 
cut down on sugar in my coffee, which I need to cut down even more because diabetes runs in 
my family, and this is around the same age my mother got it. I have to be careful of that.” Elaine, 
Karla, and James present examples of conceptualizing health through a discourse of risk. 
 Understanding the health of drug users as defined by the disease of addiction, as 
Christine, who provides care in the context of a methadone clinic, does in her introductory quote 
above, means that this group is managed through drug treatment programs that may or may not 
employ pharmaceuticals, but most definitely require abstinence. The discourse of addiction as 
disease calls forth disciplinary technologies of power apparent in drug treatment programs that 
re-build and re-educate selves into drug-abstinent citizens (Gowan and Whetstone 2012; Kaye 
2012b). Though the disease model of addiction has achieved limited acceptance even within 
biomedicine (Campbell 2013; Courtwright 2010; Meurk et al. 2013; Tiger 2013), many of the 
health care practitioners used the language of disease to discuss drug use. Alex, a physician-
researcher, who practices medicine and prescribes buprenorphine, a replacement therapy 
pharmaceutical for opiate users, at a community health care clinic, embraced the disease model, 
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but said: “I think acceptance of the idea that drug dependence is a chronic disease, the same way 
that diabetes and hypertension is, I think acceptance of that idea is still rare in society and the 
medical community.” Christine and Alex provide examples of how drug user health can be 
conceptualized through the lens of addiction as a disease. 
 Conceptualizing health through reference to chronic illness was predominantly enacted 
by drug user interviewees as exemplified by the introductory quote from Dan, a 22-year-old 
white homeless man. These narratives of illness did not reference infectious disease spread 
through drug use or the disease of addiction. Instead, depictions of these experiences usually 
involved chronic conditions, such as diabetes or hypertension, which are associated with social 
disadvantage (Akinbami et al. 2012; Banks et al. [2006] 2013; Gottlieb, O’Connor, and Beiser 
1995; Rabi et al. 2006). When asked about his main health concerns, Russell, a 52-year-old 
white homeless man, answered that he was concerned about hypertension. He said: “Right now, 
it’s high blood pressure. I know I have high blood pressure.” Russell went on to explain that 
during his annual physical at his methadone program a reading of one-ninety over one-fifty was 
observed. Having “a fear or like an anxiety type of thing with doctors,” Russell buys medication 
for his hypertension on the street. Like many of the drug injecting interviewees suffering from 
chronic conditions, Russell took measures to treat his illness despite living in the difficult 
conditions of extreme poverty and being disconnected from health care due to fear of 
stigmatization for his drug use. 
Noting these three problematizations of drug user health: 1.) health as defined through 
risk, 2.) addiction as a disease, and 3.) chronic illnesses provoked or made worse by economic 
hardship, offers the opportunity to re-think the ways constructs of health govern individuals and 
offers nuance to current theorizations of health that hinge largely on risk (e.g., Dumit 2012; 
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Petersen and Lupton 1996). In addition to risk, the construct of disease and the bodily experience 
of illness are significant to the conceptualization and management of health for low-income 
people who inject drugs. The framing of health implies the way it is to be managed and it also 
serves to obscure other ways of understanding health. This occurs when drug users voice health 
concerns, such as chronic illnesses like diabetes, though the predominant frameworks of 
understanding for drug user health have largely to do with risky drug use practices and addiction 
as a disease.  
Discursive formations can be understood as frameworks that form and guide beliefs, 
utterances, and practices. The relationship between discourse and practice is dialectical in that 
practices are formed and guided by pre-existent discourses, and pre-existent practices engender 
discursive supports. In the Foucauldian understanding of discourse, practices are made 
intelligible and possible through discourse. Foucault (1990) saw discourse as both an instrument 
and an effect of power. It is an instrument in that it governs material practices. It is an effect of 
power because its utterance is the result of technologies of power, or practices, which produce 
and discipline subjects. This means that my analysis of discourse is intimately tied up with 
practices. The discourses that my interviewees spoke were evidence of prior brushes with 
powerful practices, as well as intimations of practices to come. Furthermore, the act of speaking 
a discourse is a practice. This speaking act produces subjectivity at the same time as it 
materializes and reproduces vectors of social power. 
The primary risk discourse that addresses the health of people who inject drugs is harm 
reduction. As a social movement and a public health project realized by researchers, health 
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promoters, social workers, activists, and drug users themselves, harm reduction1 is largely 
concerned with protecting and improving the health of people who use drugs. Through offering 
education, material resources, and other behavioral interventions, harm reduction aims to reduce 
the harms associated with drug use. Needle exchange was a foundational manifestation of harm 
reduction in the United States, but harm reduction is also actualized through health promotion 
materials, peer-to-peer (or drug user-to-drug user) educational efforts, and the provision of 
Naloxone, a drug that reverses opiate overdose, among other things. The prevention of HIV 
transmission through safer and more sterile injection practices was the impetus for the 
consolidation of harm reduction research and practice in the United States in the 1990s (Heller 
and Paone 2011). Since then, hepatitis C and overdose have become central concerns of the 
movement, along with an on-going concern over the stigmatization of drug use and drug users. 
Upon beginning this research project, I had assumed that the rationality of harm 
reduction, with its focus on disease transmission, would be the predominant medium through 
which notions of drug user health were expressed. However, I quickly learned that this was not 
completely the case. The drug users voiced myriad other health concerns that did not align with 
the infection prevention interventions offered by harm reduction, and the health care 
practitioners spent much time talking about the disease of addiction. Harm reduction was not the 
singular paradigm through which health was understood. 
 This project addresses the following broad questions: 
• How and why did the category of people who inject drugs emerge in the 1980s and 
1990s? How did this function as an act of governmentality along bio-political and 
neoliberal lines, and what were the specificities of this act of governing power? In other 
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  The term “harm reduction” can signify a variety of things from drug using techniques that 
reduce harm to a collectivity of people concerned with drug user rights. Unless  otherwise 
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words, what were the particular acts of governmentality that produced and managed 
certain bodies through this drug user categorization?  
• How do health care practitioners understand drug use among their patients who inject 
drugs? In what ways do health care practitioners deploy harm reduction discourse and 
practice? How do they discuss addiction as disease? How might differing concepts of 
health imply differing forms of power that manage and regulate drug using bodies? 
• How have risk discourse and particularly harm reduction discourse produced concepts of 
health and governed the bodies of low-income people who inject drugs? How does the 
neoliberal logic of personal responsibility function within individual health maintenance? 
What can be done about health concerns that fall outside of risk discourse? 
In exploring conceptualizations of health and disease, I often used the analytic frame 
formed by Foucault’s theorization of governmentality, but this dissertation should function as 
more than an example of the governance of drug users. By featuring the thoughts and ideas of 
people who inject drugs, health care practitioners, and public health researchers, this work 
contests the narrow parameters of health set down by harm reduction and addiction-as-disease 
renderings of drug user health. The sociological analysis presented here offers to biomedical and 
public health research and practice an interrogation of health that goes beyond disease 
prevalence, risk factors, and health beliefs. By simply asking drug users and health care 
practitioners how they define and understand health and drug use, I was able to see the vectors of 
power put in motion by practices of governance. However, I also saw the effects of poverty and 
the domination of disease ideology. In this way, the work featured in the following chapters 
functions to broaden analyses of health, as well as governance. 
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Prior to beginning this project, I was employed as a research assistant for a public health 
study of hepatitis C among people who inject drugs. In this study, risk for hepatitis C was a main 
focus. I administered lengthy surveys that asked questions about drug use history and practices, 
among other things. Through this work, I began to realize that there was much more going on 
health-wise for the interviewees than just the possibility of risky drug use. The surveys were 
incredibly detailed, yet they did not cover many aspects of the interviewees’ lives that could 
affect health, such as social and economic marginalization, which could block access to health 
care and put particular strains on the body. I also noticed that my attempts to provide information 
in a harm reduction mode, by discussing the transmission of disease and less risky drug use 
practices, only seemed to apply to a small corner of the drug users’ lives. These individuals 
voiced other concerns, such as lack of housing or compassionate health care, with more urgency. 
These concerns played a formative role in the creation of this project, which was broadly 
conceived as a way to sociologically understand the self-described health concerns of 
economically marginalized people who inject drugs and to critically analyze the ways health care 
providers managed their drug using patients through discourses of health. Through immersing 
myself in the literature on health, drug use, and harm reduction, as well as following my interest 
in Foucauldian-style analysis, an image emerged of “injection drug users” as a group that had 
been governed and disciplined through the use of a variety of rationalities with harm reduction 
and addiction being key in this governance. Thus, I embarked on an exploration that would result 
in the work presented here. 
 
THE ANALYTIC SUBSTANCE 
Lay Knowledge 
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 In deciding to conduct qualitative interviews with economically marginalized people who 
inject drugs I was building off a foundation set by decades of work in medical sociology. My 
initial concern for how drug users define health can be situated within a broad swath of literature 
that uses qualitative methods to examine “health beliefs” (e.g., Blaxter 1990; Pierret 1993; 
Radley and Billig 1996), or what is now called “lay knowledge” (Lawton 2003; Williams 2013). 
Lay knowledge as defined by Williams (2013) refers to, “… the ideas and perspectives employed 
by social actors to interpret their experiences of health and illness in everyday life” (p. 119). 
Initially referred to as “lay beliefs,” a recent transition in terminology to “lay knowledge” places 
more value on the perspectives offered by those outside of the medical field (Williams and 
Popay [1994] 2006). There is much to be analyzed within presentations of lay knowledge, from 
contestations of scientific expertise to reflections of current cultural values and ideological 
interests (Williams 2013) to declarations of normativity (Radley and Billig 1996). When people 
talk about health and illness they are reflecting not only their individual perspectives but also the 
way that society constructs these issues (Radley and Billig 1996; Werner, Widding Isaksen and 
Malterud 2004; Williams 2013). In asking drug users questions that might offer an outline of 
their conception of health, I was able to access perspectives on various socially-generated 
constructions of drug user health, such as that which is primarily interested in the prevention of 
infectious disease. Analyzing lay knowledge offers the opportunity to access different 
frameworks for interpreting health and illness (Williams 2013). The drug injecting interviewees 
offered this analytic opportunity by interpreting their health through frameworks of risk and 
frameworks of illness.  
Qualitative research that examines the lay knowledge of people who use drugs finds that 
many actively seek out ways to maintain and improve their health (Drumm et al. 2005; Duterte et 
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al. 2001; Olsen et al. 2012). Drumm et al. (2005) found that "...street drug users do not passively 
accept the health consequences of use, but rather actively engage in behaviors that attempt to 
ameliorate damage to their health as well as behaviors specifically designed to improve their 
health" (p. 608). Illicit drug users' health attitudes and concerns tended to mirror those of the 
general population and many employ a variety of health practices, including exercising, taking 
vitamins and healthy eating (Duterte et al. 2001; Olsen et al. 2012). This research into attitudes 
about health among drug users and their participation in healthy behaviors documents the ways 
drug users adopt normative standards of health maintenance separate from and despite their drug 
use. 
Illness Narratives 
 In asking low-income people who inject drugs to talk about their health, I was offered 
narratives of experiences of illness, which forms another broad field of inquiry in medical 
sociology. In contrast to Parsons’ (1951) foundational theorization of the sick role, which takes 
an outsider’s perspective toward the experience of the patient, research that examines illness 
experiences takes an insider’s perspective and seeks to understand the subjective meanings 
patients give to their illness (Conrad 2009). Examining narratives of illness “… draws scholarly 
attention away from medical settings and medical perspectives on disease and toward the 
nonmedical settings and nonmedical perspectives of everyday life” (Bell 2000: 184). The 
meaning of the construct of “illness” is made clearer when the distinction between disease and 
illness is delineated. Disease is understood as the physiological manifestation of a condition, 
while illness is the experience a person has with a disease (Eisenberg 1977). Investigations of 
experiences of illness reveal how illness is socially constructed and more specifically that “… 
people enact their illness and endow it with meaning” (Conrad and Barker 2010: S71). Some 
	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   	   	  
	   	   	   	  
11 
prominent works in this subfield of study have examined how people make discoveries about the 
self in illness (Charmaz 1999), how illness can function as a biographical disruption (Bury 
1982), how social movements and disease regimes impact the illness experience (Klawiter 2004), 
and how sufferers might evoke the trope of heroically fighting their chronic illness (Kelly and 
Dickinson 1997). The study of illness experience is linked to the “narrative turn,” whereby 
knowledge is constructed through the telling of stories. The telling of illness narratives reveals 
that there are multiple truths constructed by knowers who are socially and historically located 
(Bell 2000). In relating narratives of illness, patients are often making efforts to “integrate or 
reintegrate [themselves] into their social worlds” (Bury and Monaghan 2013).  
 As mentioned, I encountered illness narratives when I spoke to drug users about their 
health, which served to show that their sense of health was not immediately related to the 
concerns of the harm reduction movement (such as risk for HIV/AIDS and hepatitis C). Rather, 
they were struggling with illness in settings of poverty that worsened their conditions and made 
efforts to address their health difficult. There has been some concern that sociologists’ depictions 
of illness narratives do not examine the ways social structure impacts the experience of illness 
(Pierret 2003). My analysis of illness narratives in chapter five addresses this concern by opening 
up a discussion of the potential for structures of inequality to provoke and worsen illness. 
Research into the illness narratives of drug users who are positive for hepatitis C has 
found that they can express a sense of unconcern about their hepatitis infection, which may be 
related to desensitization to the health problems it poses due to the high prevalence of this 
infection among injectors (Harris 2009; Olsen et al. 2012). Some individuals may feel they have 
bigger and more immediate problems than their hepatitis C infection (Olsen et al. 2012). 
Whether hepatitis C presents a biographical disruption in the lives of drug users is contextual and 
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may depend on previous experiences of illness, marginalization, and hardship (Harris 2009). 
Similarly, it has been found that, in relation to other traumatic life events, HIV infection may not 
be as devastating a biographical disruption as might be expected (Ciambrone 2001). Illness 
experiences are, indeed, embedded within particular local contexts, broader social structures of 
inequality, and individual life course trajectories that mediate the meanings and level of 
importance individuals assign to their illness. 
Social Inequality and Health Disparities 
More than impacting the meanings assigned to health and illness, social inequality has 
been linked to disparities in health. It has long been known that lower socioeconomic status is 
associated with ill health (Adler and Ostrove 1999; Link and Phelan 1995) and that poverty is 
associated with higher mortality rates (Menchik 1993; Haan, Kaplan and Camacho 1987). 
Warren and Herandez (2007) report that researchers have recognized links between 
socioeconomic status and aggregate morbidity and mortality rates for nearly 200 years. In their 
fundamental causes theory, Link and Phelan (1995) argue that social factors such as 
socioeconomic status and social support are fundamentally linked to health because they allow 
access to important resources, and that this fundamental link will stay intact despite interventions 
to reduce proximate risks for disease. Warren and Hernandez (2007) tested the temporal 
endurance of this fundamental link across the 20th century, and found that socioeconomic 
gradients in morbidity and mortality declined only modestly. In their exposition of Link and 
Phelan’s (1995) theory, Freese and Lutfey (2011) affirm that any study of disease risk factors 
must be placed in a larger context of history and inequality. Link’s (2008) “social shaping of 
population health” approach proposes that the success of advances in medical technology and 
knowledge is unevenly distributed, such that those with more resources of knowledge, money, 
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power, prestige, and beneficial social connections benefit more from these advances. He 
emphasizes the importance of social processes in determining “whether health-relevant 
information and technology is effectively deployed and how long it takes to spread through 
populations” (Link 2008: 379). Link (2008) cites health disparities based on race, level of 
education, and family income and avers that health-enhancing discoveries will result in a 
“powerful social shaping of health disparities” (p. 374). Clarke et al. (2010) refer to a similar 
concept--“stratified biomedicalization”--where the benefits of biomedicalization, a process that 
refers to the co-construction of biomedicine by advances in technoscience, commodification, risk 
surveillance, and medical enhancement, are unequally distributed and “may exacerbate rather 
than ameliorate social inequalities along many different dimensions” (p. 29). 
Trying to figure out the social factors that may lead to population-level health disparities 
is a major preoccupation of medical sociologists. The stress paradigm (Pearlin, Aneshensel and 
Leblanc 1997; Thoits 2006; Umberson, Liu, and Reczek 2008) has aided in explaining how 
upstream social and psychological factors, namely those related to stress and stress proliferation, 
may be associated with negative outcomes in mental and physical health. Those living in 
situations of economic and social marginalization may experience levels of stress that ultimately 
impact their physical health and leave them vulnerable to illness. 
Cumulative disadvantage over the life course can help to explain disparities in well-being 
and health at the population level, as well. First emerging as a way to understand heterogeneity 
among cohorts (Dannefer 1987), cumulative disadvantage theory posits that disadvantages (or 
conversely, advantages) may compound over the life course and lead to worse (or better) 
outcomes in various areas, including health (Ferraro and Kelley-Moore 2003). The chain of 
compounding disadvantages may be difficult to disrupt with evidence showing that even early 
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life military participation, an activity that could plausibly improve one’s life chances and health 
outcomes, may not provide benefits concerning mortality later in life (London and Wilmoth 
2006). Depictions of processes of cumulative disadvantage were present in my interviews with 
low-income people who inject drugs, as they often started out economically disadvantaged in life 
and through a compounding series of hardships and barriers to resources ended up living in 
destitute situations that made caring for their health difficult. 
The Doctor-Patient Relationship 
Another way health may be impacted by social inequality is through the doctor-patient 
relationship. This relationship can be experienced as difficult for both low-income drug injectors 
and their health care providers due to mutual mistrust (Merrill et al. 2002), practitioner ignorance 
and prejudice (Brener et al. 2010; Ding et al. 2005; Edlin et al. 2005; Paterson et al. 2007, Weiss 
et al. 2004), and patient fear and anxiety in anticipation of poor treatment (McCoy 2005; Merrill 
et al. 2002). Removing drug use from the picture, incongruities in class background can hinder 
communication between patient and doctor, with economically marginalized patients tending to 
be more passive in their interactions with doctors (Cockerham 2004). Though the professional 
authority of physicians may have been tempered by payment structures such as managed care 
organizations (Heritage and Maynard 2006; Waitzkin 2000), hospital physicians still develop 
methods to “get rid of patients,” especially undesirable or difficult ones (Mizrahi 1985), and may 
discharge low-income drug users before they are fully healed (Bourgois 2010). These efforts are 
not completely explained by the attitudes and prejudice of physicians, as there exist institutional 
financial pressures to limit the care patients receive (Bourgois 2010; Mizrahi 1985). However, 
careful examination of doctor-patient relationships has found that physicians may communicate 
normative standards of healthy living when treating drug-using patients and ignore the social 
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contexts of drugs use, choosing instead to direct the conversation on a technical track. In this 
way, physicians exercise an almost hidden form of social control by implicitly encouraging 
patients to adapt to the social contexts that may be the cause of their trouble (Waitzkin 1991).  
Health care practitioner ignorance and prejudice regarding people who use drugs may 
provide underlying reasons for drug user avoidance of health care (Weiss et al. 2004). Some 
physicians hold negative attitudes toward people who inject drugs (Ding et al. 2005) and may 
feel that they should be able to control their drug use (Brener et al. 2010). While it has been 
found that doctors with more experience caring for people who inject tend to express more 
favorable attitudes toward these patients (Brener et al. 2007; Ding et al. 2005), it has been 
hypothesized that more contact might cause physicians to expect negative behavior, such as lack 
of adherence (Edlin et al. 2005; Paterson et al. 2007). 
Ethnographic research has revealed hospital staff disparagingly referring to patients who 
inject drugs as “frequent fliers” and using them as teaching tools, since the surgical removal of 
abscesses provide a good teaching opportunity for interns (Bourgois 2010: 242-7). Other 
qualitative research found that doctors expressed discomfort and uncertainty in caring for these 
patients. They were fearful of deception by drug using patients, and thus avoided conversations 
about pain in order to preclude any patient requests for opiate-based pain medication (Merrill et 
al. 2002). A lack of standardized medical approaches to providing care for patients who inject 
drugs may be responsible for some of their discomfort (Merrill et al. 2002). On the other side of 
the doctor-patient relationship, it has been found that drug users experience fear and anxiety in 
anticipation of the interpersonal and medical treatment they will receive (McCoy 2005; Merrill et 
al. 2002). As I discuss in chapter four, the health care practitioners I interviewed expressed 
concern for the compassionate treatment of their drug using patients and used the disease model 
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of addiction to de-stigmatize drug use when speaking to their patients, as well as other medical 
professionals. Though I was not able to directly observe the doctor-patient relationship in my 
fieldwork, I asked questions of both low-income drug using interviewees and health care 
practitioner interviewees that revealed aspects of this relationship and how drug user health was 
constructed through doctor-patient interactions. 
Through analyses of lay knowledge, illness narratives, the social structural dimensions of 
health, and the doctor-patient relationship, I was able to begin seeing an outline of the diffuse 
technologies of power at work in discourses of health mobilized by economically marginalized 
people who inject drugs and health care practitioners. Accounts of what health means given by 
both groups of interviewees revealed when and how harm reduction discourse governs thoughts 
and practices. Narratives of illness offered by people who inject drugs revealed times when harm 
reduction discourse did not provide a vocabulary for discussing health. Through these 
articulations of experiences of illness, I was able to see direct links between poverty and ill 
health, and how a variety of cumulative hardships could render care of one’s health nearly 
impossible. Asking health care practitioners to describe how they understand their drug-using 
patients’ actions and how they related to them during medical visits, showed that discourses of 
harm reduction and addiction as disease and the practices associated with these approaches were 
present in these interactions. This accumulation of observations led to the use of governmentality 
as a theoretical lens for understanding how power flowed through definitions and enactments of 
health by way of the pre-packaged discourses of harm reduction and addiction as disease. Of 
course, these discourses did not appear out of thin air. They were created by activists, scientists, 
scholars, health care practitioners, people who use drugs, and many others who work in a variety 
of contexts from bureaucratic institutions to the streets of New York City. And, they were 
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certainly not created as mechanisms specifically for the deployment of power over people who 
use drugs and health care practitioners. However, as discourses with certain vocabularies of 
reason and ideology, they have come to produce and modify the thoughts and actions of drug 
users and doctors as they construct their own notions of what health means and how it might be 
medically addressed. 
HISTORICAL CONTEXTS 
Health as Risk 
People who use drugs by injection came into sharp focus as a particular type of drug user 
in the 1980s when they were identified as a risk group for AIDS, though at the time the illness 
did not have a formal name yet. As epidemiologists and other public health workers tracked the 
dynamics of the disease’s transmission, they divided its sufferers into risk categories that were to 
take on a preponderance of cultural meaning, mostly negative. The act of risk categorization 
enabled a proliferation of research studies that in seeking to understand the cultural 
characteristics of people who inject drugs also proposed ways to govern these individuals to 
abate disease transmission. These governing activities, which produced the “injection drug user,” 
took place within a social context that was beginning to define notions of health with reference to 
risk and evoke morality in the maintenance of health through the securing of risk.  
While the imperative of health has been present in U.S. society since at least the 1700s, 
when Protestant culture began to focus on concerns of the material (rather than spiritual) world, 
its urgency and range has gradually increased, such that health is now a “super-value” connected 
to personal responsibility and an expansive moralization (Crawford 2006: 410). How did we 
arrive at such a frenetic state? Clarke et al. (2010) describe a process of biomedicalization 
wherein the concept and practice of health is multiply-constructed by the life sciences, 
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biotechnology, pharmaceutical development, and capital. In an atmosphere of “market 
medicine,” patients are refashioned as consumers who demand the right to consume health 
(Patton 2010:xiii). Just as consumption within advanced capitalist economies becomes intimately 
tied to identity (Reith 2004), health as a perpetually out-of-reach status also becomes intertwined 
with identity (Crawford 2006). In fact, so much so that social groups are formed based on health 
status and biological characteristics (Rabinow 1996) and claims of citizenship are made (Petryna 
2004).  
Health’s connection to morality and identity was underscored by the swing towards 
personal responsibility instantiated by the neoliberal turn of the 1970s, which effectively 
dismantled a burgeoning political impetus toward universal health care (Crawford 2006). This 
individualizing trend made it possible to blame those whose health status had been negatively 
impacted by socially structured inequality. Berlant (2007) couches the act of blame within 
networks of power: “Biopower operates when a hegemonic bloc organizes the reproduction of 
life in ways that allow political crises to be cast as conditions of specific bodies and their 
competence at maintaining health or other conditions of social belonging; thus this bloc gets to 
judge the problematic body's subjects, whose agency is deemed to be fundamentally destructive" 
(p. 765). In discussing the “crises” of obesity, Berlant (2007) points to a politicized practice of 
mischaracterizing morality and agency with respect to populations of workers caught up in the 
demands of economic speed-up in late capitalism.  In summarizing the implications of current 
conceptualizations of health, Metzl (2010) writes, "... 'health' is a term replete with value 
judgments, hierarchies, and blind assumptions that speak as much about power and privilege as 
they do about well-being. Health is a desired state, but it is also a prescribed state and an 
ideological position" (pp. 1-2).  
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 It is clear from previous research, which documents the pro-health activities of drug users 
(Drumm et al. 2005; Duterte et al. 2001; Olsen et al. 2012), as well as that presented here, that 
people who inject drugs are affected by and participate in this moral economy. Those living in 
conditions of social and economic marginality still take responsibility for maintaining a healthy 
lifestyle and still manifest personal responsibility when dealing with ill-health produced in many 
instances by structured vulnerability. Many of the interviewees made efforts to highlight their 
personal ethics by discussing their careful attempts to maintain their health and minimize health 
risks. For instance, most interviewees made it clear that they had taken very few risks when 
injecting drugs and that they made attempts to seek medical care, though these attempts were not 
always successful.  
 Angela, a 29-year-old white woman who injects methadone, provides an example of how 
she works to protect her health while injecting. Her statement also provides an example of how 
lay knowledge may reveal perceptions of social values. Angela felt there was irony in her efforts 
to inject methadone safely. In describing the caution she takes in selecting the formulation of 
methadone she will inject, she said: “Every [methadone] program besides the one I'm on, which 
is great that I'm on this one, actually puts water in [the methadone they distribute]. I wouldn't do 
it if it had water in it because water has minerals and all this other stuff. It sounds stupid, I know, 
coming from someone like me.”  
 The moralized personal maintenance of health also has roots in a contemporary notion of 
health as being composed of a conglomeration and calculation of risk factors that necessitate 
personal monitoring. A calculus of risk factors has come to stand in for health in biomedical and 
epidemiologic contexts and subsequently the interpersonal relationship between patient and 
doctor has transformed into matrices of risk (Castel 1991; Dumit 2012). On the individual level 
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this means that health is determined by quantitative and qualitative measures of risk for future ill 
health. On the population level health is ascertained through surveillance, which works to 
conceptualize and standardize risks that in turn rationalize more surveillance (Clarke et al. 2003). 
The constant proliferation of risks generates a sense of insecurity that becomes normalized—“To 
be normal, therefore, is to be insecure. . .” (Dumit 2012: 1). Originally conceived as a category 
of individuals at risk for HIV/AIDS, people who inject drugs are therefore inherently located 
within a risky and insecure state. Harm reduction places their risk for disease transmission at the 
center of its mission though the drug users themselves may voice health concerns other than the 
risk for HIV/AIDS.  
 A focus on risk factors as indicative of health also bears connection to the neoliberal 
rhetoric of personal responsibility. A focus on risk factors compels individuals and populations 
to participate in self-care practices, which moderate the burden of individuals on society 
(Petersen 1997). Risk plays a crucial role in neoliberal societies by employing the agency of 
subjects in their own self-regulation (Petersen 1997).  This is precisely the task of what Petersen 
and Lupton (1996) identify as the new public health, which focuses on the environment (in its 
broadest sense) and lifestyle as sources of risk. Thus, people whose lifestyle includes the use of 
drugs by injection are enjoined to self-regulate based on the presence of risks. While risk 
ostensibly gives people a choice, “ . . . the rhetoric in which the choice is couched leaves no 
room for maneuver” (Lupton [1993] 2013: 492). Given this “duties discourse” and the presence 
of scientifically-generated risk factors, “ . . . ‘health’ has come to be used as a kind of shorthand 
for signifying the capacity of the modern self to be transformed through the deployment of 
various ‘rational’ practices of the self” (Petersen and Lupton 1996: xiv). Indeed, harm reduction 
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has offered drug users the ability to transform one’s self into an ethical drug user through 
practices that address health by lowering risk. 
 In the context of risk proliferation and its meaningful hold over “health,” a drug user who 
chooses to inject, and is thus considered “at-risk” for infectious disease, could be perceived as 
inherently unhealthy. The creation of the “injection drug user” risk category is certainly 
indicative of reformulations of the meaning of health to include risk factors. However, as my 
research will reveal, the health of this group was complicated by concerns beyond their status as 
a group at risk for contracting HIV/AIDS. By asking low-income drug users, as well as health 
care practitioners who care for them, to put forth their own understandings of health, this 
dissertation interrogates and in some ways contests a reliance on risk factors as signifiers of 
health status.  
The Emergence of a Risk Category 
 It is within this context of the reconceptualization of health as connected to risk that the 
“injection drug user” came into view in the early 1980s as a risk group for AIDS. When the 
Centers for Disease Control (CDC) released its first report on AIDS in 1981, drug use 
researchers had been suspecting for several years that some type of ailment was impacting 
people who inject drugs as they were seeing a rising number of pneumonia-related deaths (Des 
Jarlais 2009). Prior to AIDS, it was clear to public health workers and injectors alike that 
hepatitis B was spread through the sharing of needles. This knowledge was applied to the new 
condition, referred to as “walking pneumonia,” and injectors began to adjust their drug use 
practices (Des Jarlais 2009; Des Jarlais, Friedman, and Hopkins 1985). Beyond their association 
with hepatitis B, people who used drugs by injection had not received much attention as a 
coherent group by researchers. Most of the prominent social science literature on drug use before 
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HIV/AIDS focused on the type of drug used or simply on “addicts” (e.g., Agar 1973; Becker 
1963; Feldman 1976; Preble and Casey 1976).  
 Using an epidemiological approach, the CDC developed a risk group schematic to 
organize the sufferers of AIDS and in doing so created the category of people who inject drugs. 
By creating such a schematic the CDC contributed to an understanding of the disease that placed 
the onus of infection and transmission onto certain groups of people (homosexual men, drug 
injectors, Haitians, among others) regardless of whether they participated in practices that could 
lead to infection (Glick Schiller, Crystal and Lewellen 1994; Oppenheimer 1988). Although the 
language of the risk group label has shifted over the last three decades, the categorization of 
people based on injection has persisted. 
 Beginning in 1984, this group began to have a salient presence in the public health 
research literature, initially being referred to as “intravenous drug abusers,” which reveals the 
moral shading of the risk group by use of the word “abuser.” Through examining the popular 
research literature, a process of construction and governance is revealed, as the person who 
injects drugs is surveilled, described, and subjected to behavioral interventions. Early literature 
puts forth a concern that people who inject drugs will spread AIDS to their non-injecting sexual 
partners and children (Des Jarlais, Friedman, and Hopkins 1985; Ginzberg 1984; Marmor et al. 
1984), thereby setting up a boundary around this group and placing them in opposition to two 
socially-sanctioned groups—non-injectors and children. Also, in these early articles, researchers 
hesitantly propose that AIDS is spread between injectors through sharing needles and other 
injection related materials (Ginzberg 1984; Marmor et al. 1984). These nascent ideas present 
pathways of intervention that demonstrate the early stirrings of governmentality by highlighting 
individual-level, malleable behaviors. 
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 In 1986, literature began to appear that outlined the cultural traits of the “subculture” of 
people who inject drugs. An air of hopelessness was present as researchers described the social 
bonding that needle sharing enabled among injectors (Des Jarlais, Friedman, and Strug 1986; 
Friedman, Des Jarlais and Sotheran 1986). The act of describing these cultural traits functioned 
as a way to further delineate this group, and thus allow for more relevant governing. In fact, 
simply focusing on injection drug using culture and lifestyle opened a surface upon which 
interventions could spread. 
 The literature that followed in 1987 and 1988 focused more precisely on behavior 
change, both that initiated by public health workers and that initiated by people who inject drugs. 
People who inject drugs were now thought to be fully malleable, and thus were subjected to 
behavioral interventions aimed at preventing the transmission of HIV/AIDS. In one proposed 
behavioral change framework, an aim was to attach new cognitive and emotional meanings to 
sharing needles (Des Jarlais and Friedman 1988), thus revealing that behavior change went 
below the surface of the body to modify people’s thoughts and emotions. Behavioral 
interventions were also becoming more widespread as the federal government provided wide 
scale funding to support a research endeavor, the National AIDS Demonstration Research 
project, which assigned research participants to risk reduction interventions (Page and Singer 
2010).  
 Around this time, people who inject drugs were beginning to advocate for themselves and 
push to legalize syringe exchange. Though public health researchers had supported and in some 
instances worked to initiate these efforts (Friedman et al. 1987), people who inject drugs were 
now fashioning themselves as self-advocating and self-governing subjects. Linking their identity 
to civic responsibility, these activist injectors exemplify a neoliberal cultural rationality that 
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connects personal goals to “the public good” (Petersen 1997: 203). By supporting and 
collaborating with current and former drug users, researchers realized they could spur self-
governance among this group. Through the interplay of research activities and grassroots actions, 
the image of the person who injects drugs as an activist began to form. 
 The loosening in some localities of restrictions on syringe possession also worked to 
fashion the person who injects drugs as self-governing. With fewer legal restrictions to hamper 
injection drug use, injectors were offered more autonomy, though this was buttressed with 
expectations of self-regulation. Key research in the early 1990s that critiqued earlier fixations on 
pathological drug user culture by noting that people share needles because the legal system 
impedes access to new syringes, as well as the ability to carry syringes (Koester 1994), implies 
the reduction of regulations over injection drug use. Despite their socially marginal status, the 
person who injects drugs was being swept into the current political and economic impulse to 
make individuals responsible for maintaining their health by identifying risks and securing them. 
 Later research of the 1990s and early 2000s acted to expand bio-political and governing 
power over this subject position by focusing on a new concern—hepatitis C—and re-organizing 
the risk category. The high prevalence of hepatitis C among people who inject drugs caused 
concern for the economic burden this might pose to our health care system (Edlin et al. 2005) 
and brought forth new types of surveillance and behavioral intervention. Concurrently, findings 
from public health research revealed that the HIV prevalence of people who use heroin and 
cocaine but do not inject is similar to that of those who do inject (Des Jarlais, Arasteh and 
Friedman 2011). With this in mind, researchers began to focus on the non-injection drug user, 
NIDU, and, going further, suggested that people who inject drugs and people who use drugs by 
other means be combined into one risk category. This serves to consolidate certain types of bio-
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political power over drug users as a whole and thus, refashions the early risk group schematic put 
in place by the CDC.  
It is at this precarious moment for the “injection drug user” risk category that my research 
project began. Noting the potential insufficiency or irrelevance of the grouping of drug users I 
had chosen to study, I asked the health care practitioners if this categorization was relevant to 
their work. Most said that it was meaningful to the care they provided patients because this type 
of drug user had heightened risk for HIV/AIDS and hepatitis C. However, one health care 
practitioner, Christine, felt that this categorization was not necessary. When asked about the 
services her facility provides for people who inject drugs, she replied: “I am sort of curious why 
this separation of people who inject drugs? I see this as a very academically derived group 
because from the bottom I don't see that as a very distinct group.” She went on to explain that 
she screens all of her drug-using patients for HIV and hepatitis figuring that it’s likely they 
injected at some point. Taking into account Christine’s viewpoint, along with current findings on 
HIV prevalence and drug use, it must be noted that a degree of ambivalence has emerged with 
regard to the salience of this risk category. The research and interventions that once focused on 
people who inject drugs may now be expanding to touch all drug users and thus, continue the 
perpetual formation and re-formation of categories for governance. 
Harm Reduction 
Following alongside the emergence of the “injection drug user” in public health research 
were gradual efforts by activists to implement harm reduction’s foundational intervention—
syringe exchange. The first, albeit illegal, syringe exchange in the United States emerged in 1983 
in New Haven, Connecticut when Jon Stuen Parker, a medical student and former heroin user, 
began to distribute syringes (McLean 2013). This coincides with early appearances of the 
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“intravenous drug abuser” in public health research literature. However, harm reduction’s roots 
are often traced to the 1970s formation of the Junkiebond, or Junkie League, of Rotterdam, 
which functioned as a type of trade union with an orientation toward drug user rights (Marlatt 
1996). Though input from the Junkiebond stimulated the Dutch movement toward a “pragmatic” 
and “humane” approach to stemming the AIDS epidemic among injectors, the initial goals of the 
Junkiebond were much broader. As stated in Marlatt (1996), Wijngaart (1991) explains: 
The starting point of the “Junkiebond” is to look after the interests of the drug 
users. The most important thing is to combat the deterioration of the user or, to 
put it another way, to improve the housing and general situation of the addict. 
Their philosophy is that drug users themselves know best what their problems 
are. The work of the “Junkiebond” involves consultations with government 
officials about matters like the distribution of methadone, the availability of free 
sterile syringes, the policy of the lawmakers and police, and housing problems (p. 39). 
The inclusion of housing and the “general situation of the addict” in the concerns and mission of 
the Junkiebond is instructive for understanding the roots of harm reduction and how the 
movement differs in its purpose in the United States. The initial approach of the Junkiebond was 
political and service oriented, interested in drug user rights and basic needs. 
 The term “harm reduction” was subsequently coined in Liverpool, Merseyside, England 
in the early 1980s as health officials responded to a moral panic over heroin use and HIV/AIDS. 
In this setting and as applied by health authorities, harm reduction became more institutionalized 
and public health-oriented. McLean (2013) explains: “Where the Rotterdam union framed its 
mandate in terms of users’ rights, Merseyside health officials emphasized the public health and 
public order benefits of harm reduction…” (p. 22). Positioning harm reduction securely under 
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the auspices of public health authorities has shaped its practices and politics ever since, and 
further cemented a disconnection from the movement’s anarchist roots (Smith 2012; Stoller 
1998). The institutionalization of particular components of the harm reduction approach, mainly 
those having to do with interventions into the techniques of drug injection, steered the movement 
away from its earlier mission of mutual aid and an expansive approach to bettering the general 
situation of the drug user. 
Harm reduction’s importation to the United States occurred soon after its christening in 
Liverpool with Jon Stuen Parker’s illegal needle exchange in New Haven (McLean 2013). In 
New York the powerful presence of the AIDS Coalition To Unleash Power (ACT-UP) aided 
drug user activists in their attempts to establish legitimate syringe exchanges through public and 
controversial direct action techniques (Lune 2007). This connection to ACT-UP is perhaps 
partially responsible for the harm reduction movement’s emphasis on HIV/AIDS prevention to 
the detriment of the earlier mission to improve the general situation of drug users. Further, as 
Heller and Paone (2011) note, “… ‘winning’ arguments for the expansion of syringe access have 
been rooted in the crisis of HIV/AIDS, rather than the need for a continuum of care and 
treatment services addressing problems of drug use” (p. 140). Preventing the spread of 
HIV/AIDS was and continues to be the catalyzing force behind harm reduction activities in the 
United States, which limits the possibilities for this movement to address other causes of ill 
health among drug users, such as structured inequality.  
The first legal syringe exchange in New York City was piloted in 1988 by the 
Department of Health and did not involve people who inject drugs or their advocates in its 
planning or implementation, though it had come about in part due to pressure exerted by activists 
involved with the Association for Drug Abuse Prevention and Treatment (ADAPT), the first 
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HIV/AIDS community-based organization in New York City committed to harm reduction 
(Anderson 1991; Heller and Paone 2011; Lune 2007). Two years were spent planning and 
redesigning what was initially conceived as a clinical trial to test the efficacy of syringe 
exchange in the prevention of HIV transmission (Anderson 1991). The supposed objectivity of 
medical research was mobilized as a means to sidestep contentious policy debate over syringe 
exchange (Anderson 1991). Unable to secure a more suitable location, the clinical trial pilot 
syringe exchange program was located at the Department of Health headquarters across the street 
from One Police Plaza (Anderson 1991). A myriad of restrictions were placed on the practices of 
this syringe exchange by city officials concerned about the possibility that access to syringes 
might spur increased injection drug use (Anderson 1991). Potential participants were accepted on 
referral from drug treatment programs to ensure that participants were not new users. Further, 
participants had to carry photo ID cards identifying them as injection drug users and submit to 
medical exams that included blood testing. The blood within returned syringes was tested to 
ensure that no participants had shared their syringes with others (Anderson 1991; Lune 2007). 
Attendance was low at this syringe exchange and after a year it was closed when a new mayor, 
David Dinkins, was elected and brought with him a health commissioner “ideologically 
opposed” to syringe exchange (Anderson 1991).  
After the closure, three channels of organizational activity—ACT UP, ADAPT, and John 
Stuen Parker along with Rod Sorge—forged the way toward legitimating syringe exchange by 
operating illegal, underground syringe exchanges. In 1990 eight activists, who became known as 
the “needle eight,” arranged for their arrest by taking out an ad announcing their intent to 
distribute clean needles for free in the Lower East Side of Manhattan. Their arrest initiated a 
major court challenge to the State law criminalizing needle possession (Heller and Paone 2011). 
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The eight defendants were acquitted on the basis that their syringe exchange activities 
constituted a “public health necessity.” This ruling along with findings from a New Haven study 
on the effectiveness of needle exchange in the prevention of HIV, eventually led to the 
establishment of the syringe exchange waiver system whereby programs gain exemption from 
the legal requirement for prescriptions in the dispensing of sterile injection equipment (Heller 
and Paone 2011; Lune 2007). The waiver system is still in use today though syringe exchange 
remains illegal at the federal level. There are currently fourteen syringe exchange programs 
operating in New York City. 
Syringe exchange focuses on a singular concern of injection drug use—injection 
practices that can lead to illness and injury. While harm reduction centers typically offer social 
services, meals and basic supplies such as soap and socks in addition to syringes by exchange, 
the harm reduction movement in the U.S. has largely maintained a focus on narrow public health 
interventions which do little (if anything) to address the structural inequality that leads to risk 
vulnerability and poor health among economically and socially marginalized drug users. In part 
SEP administrators hesitate to pursue more progressive or radical approaches to improving the 
general situation of the drug user because syringe exchange is politically unfavorable and 
administrators fear losing the minimal resources they do have, if they were to push the envelope 
(Lune 2007: 99).   
The continued framing of harm reduction as a public health approach has disconnected it 
from its more radical roots. Smith (2012) writes “ …the resultant disconnect between 
contemporary public health policy and the oppositional roots of harm reduction practice has 
sanitized the latter, actively drawing attention away from the role of structural factors 
underpinning the phenomena of drug dependence” (pp. 209-210). Describing the founding 
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philosophy of harm reduction as reflecting anarchist values and practice, Smith (2012) states, 
“… harm reduction discourse might therefore be seen as a disguised language developed to 
describe an emergent anarchist model of care for capitalism’s most oppressed, yet symptomatic 
victims” (p. 213). Smith’s commentary and analysis of the current state of harm reduction in 
North America exhorts us to look back to the roots of harm reduction for guidance in re-shaping 
the movement into one that addresses the holistic concerns of drug users and the structural roots 
of their oppression. 
Through its efforts to improve and recast the health of drug users, harm reduction is a 
manifestation of governmentality that regulates and normalizes bodies and creates subjectivities 
by implicating people who inject drugs in technologies of the self. Through harm reduction 
health promotion campaigns, people who inject drugs are instructed to take care of themselves 
by refusing to share needles and following sterile techniques of injection that involve alcohol 
swabs and new tourniquets among other items (Fraser 2004). In many ways, those laboring under 
the banner of harm reduction, researchers and activists alike, helped to produce the “injection 
drug user” subject who enacts an ethical identity through self-governance. In particular, 
ethnographers participating in federally-funded HIV prevention research helped to create this 
subject position by isolating behavioral factors of HIV risk and offering instruction on safer 
injection techniques as they conducted research (Campbell and Shaw 2008: 696).  
 The governance of drug users through harm reduction policies and practices works in part 
through a reformulation of the discourse around drug use. Drug use is recast as a normal activity, 
but with a preferred range of behaviors and actions (O’Malley 1999). Through this 
normalization, illicit drug users are enjoined to self-govern so that their drug using practices fall 
within the range of acceptability. In this way, the will of each individual drug user is aligned to 
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the project of harm reduction (McLean 2011; O’Malley 1999). Since much of the knowledge 
produced through harm reduction research efforts relies on risk calculations, drug users are 
enticed to accept harm reduction educational interventions through their appeal to truth by way 
of probabilistic statistics (O’Malley 1999: 196). The production of statistics indicates that harm 
reduction is a bio-political project with an interest in health and vitality on the population level, 
as well as on the level of the individual (McLean 2011).  
 Harm reduction interventions interpellate certain types of drug using subjects. As 
technologies of the self, rituals of needle exchange and safe injection may positively influence 
drug user subjectivities (Fraser 2004; McLean 2011). Situated in a neoliberal context of 
individual responsibility, harm reduction practices allow drug users to assume a subject position 
that aligns with the prevailing culture of regulated self-care (Fraser 2004). For example, needle 
exchange programs shape drug users’ subjectivities by labeling them as “clients” and positioning 
them as rational subjects interested in preserving their health (McLean 2011: 76).  Harm 
reduction fashions the illicit drug user into both a “biomedicalized drug user” and a “public 
health citizen” (Vitellone 2010: 872). Drug users are also positioned as ethical subjects who are 
interested in “doing the right thing” in terms of their own drug use practices, as well as through 
those of others, through proscriptions of needle sharing (Campbell and Shaw 2008; Vitellone 
2010). Drug users may perform their ethical subjecthood through answering questions about 
their drug use practices by resort to standard harm reduction mantras (of never sharing needles or 
always cleaning needles with bleach, for instance) despite not always being able to follow 
prescribed harm reduction behaviors (Campbell and Shaw 2008).  
 Much of the governmentality exhibited by harm reduction occurs through the paradigm 
of the biomedical. As Roe (2005) sees it, harm reduction is now defined by medical programs, 
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professionals, and policies, which puts it at odds with those who see harm reduction as a 
platform for broader and more structural social change. There are in fact two camps within harm 
reduction—the medical, which focuses on the individual and the promotion of health, and the 
activist, which decries the medicalization of social problems (Roe 2005). However, it appears 
that “medical” harm reduction is winning the battle to define harm reduction, in part, perhaps, 
because the medical approach aligns nicely with neoliberal efforts to reduce societal costs by 
enjoining individuals to self-regulate (Roe 2005; Smith 2012). There has been a call from the 
activist formulation of harm reduction to refocus the movement’s efforts on the structural causes 
of harm (Smith 2012) and the effects of damaging policies, such as drug prohibition (Roe 2005). 
McLean (2011) makes the case for an inclusive effort by both harm reduction camps: “An 
investment in the health of IDUs—and drug users at large—is not incompatible with a broader 
concern for social justice, the macro-level determinants of drug use and addiction, and the larger 
context of risk” (p. 78). These calls function to counter the individualizing effects of the 
governing rationality of harm reduction by drawing attention to the systematic and structured 
inequalities that produce vulnerability, risk, and harm. In chapter five, I echo these calls with 
regard to inequitable access to resources that support health. 
The Disease Model of Addiction 
 While harm reduction may have offered an alternative way to think about drug use, the 
disease model of addiction is still very much present in explanations of drug use. By referring to 
certain practices of illicit drug use as diseased, this model is pertinent to conceptions of drug user 
health. Most of the health care practitioners I interviewed referred to addiction as a disease or at 
least discussed the neurological qualities of drug use. Thus, it was revealed to me as I conducted 
my interviews that harm reduction, along with its focus on infectious disease, was not the only 
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way health care practitioners understood the health of their drug-injecting patients. Many of them 
were concerned with the disease of addiction and the way it disallowed their patients from 
resisting drug use. The absence of agency that this disease entails runs counter to the creation 
and bolstering of autonomy evident in harm reduction education and interventions. Despite this 
apparent contradiction, the health care practitioners expressed no dissonance in their support of 
both harm reduction and the disease model of addiction. 
 Dating back to at least the early 19th century, the notion that addiction is a disease or 
disease-like was initially put forth by the temperance movement, which located the source of 
addiction in the drug or substance itself (Levine 1978). Toward the end of the 19th century, 
through a convergence of interests between the industrial state and the medical profession, the 
notion of addiction as a disease of the will appeared. This was a “moral-medical” model rooted 
in the need for productivity, labor discipline, and self-regulation during industrialization. At this 
time, the loss of control evident in excessive consumption was seen as “anathema to reason” and 
understood as a “clear threat to the moral and political order of industrial society” (Reith 2004: 
288). Evidence of the effort to locate addiction in the individual body (Levine 1978) is provided 
by prohibition-era, federally-funded research that pointed to psychopathology and personality 
disorders as the root causes of addiction (Courtwright 2010: 139). The disease concept of 
addiction gained further traction through the Addiction Research Center, a congressionally 
mandated narcotics rehabilitation and research farm that opened in 1935 and supported research 
into the physiological components of addiction (Campbell 2007). Methadone maintenance 
treatment, which was developed in the 1960s through a system of clinics, also served to support 
the disease model of addiction by using a so-called medication to aid addicts in stabilizing their 
lives and their relationship to opiates. The idea behind methadone treatment was partially based 
	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   	   	  
	   	   	   	  
34 
on the belief that opiate addicts created a permanent biochemical change in their physiology 
(Conrad and Schneider 1992: 135). 
 Current understandings of the disease of addiction center on the brain and construct 
narratives of brain activity that involve chronic relapse and permanent or semi-permanent neuro-
chemical changes. This iteration of the disease model is referred to as Chronic Relapsing Brain 
Disease (CRBD) and considered the “NIDA paradigm,” NIDA being the National Institute on 
Drug Abuse (Dingel, Karkazis, and Koenig 2011). Strongly tied to elaborations in technoscience 
and institutional structures, the application of neuroscience to the study of addiction (Campbell 
2010; Hammer et al. 2013; Vrecko 2010) produced an “expansion of the biological” that 
displaced previous distinctions between physical and psychological drug dependence (Keane and 
Hamill 2010: 55-6). 
 Despite addiction’s firm grounding in medical and biological discourse, social and 
cultural critics point out that it remains, at least in part, a social and cultural construct. Keane 
(2002) reminds us that a medical framing of addiction still has social normalization and 
improvement as its goal. A disease rendering of addiction relies upon culturally constructed 
parameters of addictive desire and behavioral practice that reinforce norms and allow addiction 
to be seen in the body (Keane 2002; Kaye 2012a). Violations of norms of consumption are 
linked to an ambivalent notion of freedom apparent in the neoliberal, cultural construction of the 
subject, wherein the individual is enjoined to act freely, but within certain limits. Addiction, or a 
culturally constructed notion of addiction, is one of these limits (Reith 2004). Keane (2002) 
affirms that our notion of addiction is tied to “a particular notion of the unique and autonomous 
individual” (p. 6). While it is important to recognize the potential usefulness of biological 
information or even biological intervention in responding to addiction, we must “. . . re-situate 
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these material possibilities in relation to cultural and political realms that socially materialize the 
biological and bring it ‘to matter’” (Kaye 2012a: 43). 
 While addiction was discussed primarily as a disease by the health care practitioner 
interviewees in this project, it must be pointed out that the complete medicalization of addiction 
has not yet occurred (Campbell 2013; Courtwright 2010; Tiger 2013). Many people who use 
drugs are punished by the criminal justice system and/or become involved in 12-step addiction 
treatment regimes (Tiger 2013). Furthermore, the adoption of the disease model has been resisted 
by some social scientists, police, and political actors (Courtwright 2010). None of the people 
who inject drugs that I interviewed described their drug use as a disease. I did not ask them direct 
questions about this association, nor did I directly ask the health care practitioners if they thought 
addiction was a disease. It is likely their professional position and medical training disposed 
them to this way of understanding addiction. Exploring the way drug use is understood as a 
disease by health care practitioners and what this implies for technologies of power that address 
people who inject drugs is a goal of the exploration of “health” in this project. 
THEORETICAL CONTEXTS 
 
Much of the work in this dissertation is informed and supported by a general theory of 
governmentality, a concept that emerged as a way to analyze the rationalities, practices, 
mentalities, and art of governance. I see low-income people who inject drugs as governed in 
particular ways by particular discourses of health. Some of the specificities of their governance 
engage other forms of power identified by Foucault, such as bio-politics and anatamo-politics. 
The current logic guiding the acts of governance observed in this dissertation can partially be 
explained by the neo-liberal turn in the 1970s, which instilled the rationalities of personal-
responsibility and self-governance in individuals. However, there are times and places where the 
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governance of drug users falls outside of this logic and edges toward top-down disciplinary 
power. In this section, I contextualize and explain the theories that grounded my analyses. 
Governmentality 
 Akin to Foucault’s quest to outline the technologies of power that manifested in the 
practices of psychiatry and penology and the identification of sexuality, the concept of 
governmentality allowed Foucault (2007) to conduct an analysis that sought to move “outside of 
the state” in order to envisage “an encompassing point of view with regard to the state as there 
was with regard to local and definite institutions” (p. 118). In some ways, the broad and general 
technology of power that materializes in the state and its population underwrites the technologies 
of power that have their manifestation in various societal institutions of domination, such as the 
prison and mental hospital (Foucault 2007a: 118). In its original theorization, governmentality 
denotes a broad swath of power or “an encompassing point of view” (Foucault 2007a: 118) that 
emanates from the state and in doing so constitutes the state. For the purposes of the analyses of 
this project, it is best to focus on the quality of power that Foucault theorizes rather than its 
mediator, the state, because, as I will discuss, the political-economic context of neoliberalism has 
meant that forms of direct state power have given way to less direct, governing-at-a-distance 
(Harvey 2007; Petersen 1997; Rose 2001). Despite this, governmentality, as a theoretical lens, 
remains useful because it details a particular type of power regardless of its proposed origin. In 
order to explain and contextualize the formation of this theory some description of its 
relationship to the state must be discussed. 
 Examining the early modern state, Foucault (2007) discerned that the emergence of the 
concept of a population enabled a new, fledgling rationality of governance. Population becomes 
the ultimate end of government, which places its attention on, “. . . the welfare of the population, 
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the improvement of its condition, the increase of its wealth, longevity, health and so on. . .” 
(Foucault 1994: 216-7). Population forms the “scene of a newly ‘real’ social body” that can be 
submitted to calculations and statistical analyses and is a surface for the application of social 
policy (Orr 2010: 549). It is through the concept of population that a governing sort of power can 
get to the individual.  
 In tracing the roots of this type of governing power, Foucault introduces pastoral power, a 
power interested in the “conduct of each and of all” (Rose, O’Malley, and Valverde 2006: 83). 
With its roots in the pre-Christian East and then in the Christian East, pastoral power appears in 
two forms: first, in the idea of a beneficent shepherd guiding a flock, and second, in the practice 
of spiritual direction, “the direction of souls” (Foucault 2007a: 123). Pastoral power is an 
individualizing power in that the shepherd directs the whole flock, but he can only do so through 
accountability to each individual sheep (Foucault 2007a: 128). In its second form, pastoral power 
“. . . demands a knowledge of the ‘truth’ of one’s self in exchange for the spiritual guidance and 
protection of a pastoral figure” (Orr 2010: 549). Foucault (1988) traces this to a historical 
monastic ritual of contemplation and constant scrutiny of the consciousness, which transmutes 
into “technologies of the self,” those practices that permit individuals to effect by their own 
means or with the help of others a certain number of operations on their own bodies and souls, 
thoughts, conduct, and way of being (p. 18). 
 While governmentality of the mid-18th century produced the concept of population, this 
does not prevent it from focusing on the individual as well. Rather, it is through governance 
aimed at the population that power can be had over the individual. Governmental technologies 
take shape at the intersection of a science of administering society in its totality and in caring for 
the flock through individualizing knowledge of each member (Orr 2010: 549). Pastoral power 
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exhibits simultaneous concern for the flock and its individual members. Foucault (2007) writes: 
“It looks after the flock, it looks after the individuals of the flock, it sees to it that the sheep do 
not suffer, it goes in search of those that have strayed off course, and it treats those that are 
injured” (p. 127). In practices of governance, there is a convergence of this type of power with 
what is referred to as police power, or a science of administration at the population level (Dean 
1999: 92). It is these two types of power—policing and pastoral—that constitute the social and 
allow power to “move between managing social relations and governing individual conduct” 
(Orr 2010: 549). 
 Though much of Foucault’s work on governmentality was concerned with the 
rationalities of the state in constituting itself in conjunction with a concept of population, his 
focus on the individualizing and productive capacity of power provides useful analytics for my 
work here. Using governmentality as a type of analytic approach provides “. . . a language and a 
framework for thinking about the linkages between questions of government, authority and 
politics, and questions of identity, self and person” (Dean 1999: 13). As a productive force 
governmentality sees its subjects as “resources to be fostered, to be used and to be optimized” 
(Dean 1999: 20). With these goals in mind, practices of governance work to enjoin individuals to 
produce certain socially and politically desirable identities and identifications. In this way, 
governance takes place “without the full awareness of the people” (Foucault 1994: 217). Dean 
(1999) explains further: 
  Regimes of government do not determine forms of subjectivity. They elicit, promote, 
facilitate, foster and attribute various capacities, qualities and statuses to particular 
agents. They are successful to the extent that these agents come to experience themselves 
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through such capacities (e.g. of rational decision-making), qualities (e.g. as having a 
sexuality) and statuses (e.g. as being an active citizen, p. 32). 
 One of the clearest ways to see governmentality of the individual among drug users is to 
examine harm reduction discourse, which makes appeals on the individual level and facilitates 
personal responsibility for health among drug users (Fraser 2004). In an act of ethopolitics (Rose 
2001), harm reduction enjoins needle users to fashion themselves as ethically responsible 
citizens by way of participating in certain sterile or otherwise pro-health practices (Campbell and 
Shaw 2008; Vitellone 2010). Through interviewing economically marginalized people who 
inject drugs, I saw evidence of the governing effects of harm reduction in the ways some 
discussed their health. They did this by articulating health concerns that aligned with the 
prioritized health concerns of harm reduction interventions—HIV/AIDS and hepatitis C—and by 
describing ethical behavior that aligns with harm reduction teachings.  
The creation of the “injection drug user” risk category in the 1980s enabled the 
governance of a certain group of individuals such that they could be regulated as a population 
and governed-at-a-distance as individuals to diminish the spread of HIV/AIDS. One of the first 
steps in this governing process was to describe this group by conducting ethnographic 
observation that aimed to discern why individuals were at increased risk for HIV transmission. 
This research endeavor sought to get at the “‘truth’ of one’s self” (Orr 2010: 549), or for 
example, the “truth” of why one might share needles, in order to provide pastoral guidance 
toward a less risky drug using lifestyle. 
Neoliberalism 
 While the concept of governmentality elucidates a form of power that registers at both the 
population and individual level, the concept of neoliberalism brings into view a particular 
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rationality of governance. The rationality behind current modes of governance is tied to beliefs 
about the necessity of a liberal economic market, where individuals are offered certain types of 
freedom as a cost-saving measure and as a way to compel entrepreneurialism and instill personal 
responsibility. Part of neoliberalism's work is to produce citizen-subjects who think of 
themselves as individual entrepreneurial actors who are responsible for their own survival 
(Brown 2003; Ong 2007). This subject has no claims on the state and must fend for his or herself 
through enterprise, which neoliberal governance nurtures through certain optimizing 
technologies aimed at producing subjects who are self-animating and self-governing (Ong 2007).   
 Low-income drug users may not be envisioned as potential entrepreneurial subjects, but 
they can at least participate in practices that reduce their economic burden to society. The risk 
discourse of harm reduction offers this possibility by engaging people who inject drugs in self-
monitoring and self-care. By appealing to drug users to protect their health and by providing 
them with low-cost ways of doing so, harm reduction interventions enjoin drug users to take 
responsibility for their health. The self-animating discourse of neoliberalism played a role in self-
organizing among drug users in the 1990s that helped usher in legal syringe exchange programs. 
This had implications for the subjectivity of the “injection drug user,” which included a 
connection to activism and self-governance. 
However, harm reduction strategies of needle exchange and overdose prevention 
education, for example, are not inclusive forms of care, but are rather the bare minimum (Garcia 
2010). They are neoliberal tools that facilitate self-governance among low-income drug users 
who may have limited means to access quality, compassionate health care. While they may 
extend the capacity of drug users to take care of themselves, many economically marginalized 
drug users are still lacking access to basic health care and, furthermore, the basic essentials 
	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   	   	  
	   	   	   	  
41 
needed to survive, such as housing. Some interviewees told of illness experiences that were 
initiated and exacerbated by a lack of stable housing. Even in these desperate times, the 
interviewees described concerns over their limited capacity to be personally responsible for their 
health. This is indicative of the hold neoliberal rhetoric has over every day rationalities. 
Neoliberal governance has spawned a hegemonic belief system that, "...  has pervasive effects on 
ways of thought to the point where it has become incorporated into the common-sense way many 
of us interpret, live in, and understand the world” (Harvey 2005: 3).   
Neoliberalism as a “marketized” governmentality is both an indirect, in that it regulates 
through individual freedom, and highly cost-effective form of normalization of the population 
(Gowan 2012/2013). However, it must be noted that this practice of governmentality may be 
mainly directed at the broad middle classes of more industrialized countries, leaving socially and 
economically marginalized populations to be normalized through “old-fashioned disciplinary 
institutions,” such as the criminal justice system (Gowan 2012/2013). Foucault (1994) himself 
points out that an interest in discipline was never fully displaced by the new focus on governing 
the population. Discipline is a technology of power situated within a particular governing context 
that utilizes its techniques, rationalities, and institutions (Dean 1999: 19-20). As I will discuss 
further, economically marginalized people who inject drugs are recipients of both neoliberal 
governance and disciplinary power. As individuals with a disease, the disease of addiction, drug 
users can be made subject to the disciplinary power of abstinence-only drug treatment programs. 
Bio-power 
Bio-power, which signifies a particular type of governing power, affects the experiences 
of people who inject drugs in specific ways as they are managed and disciplined through 
reference to their health and drug use. The proliferation of public health research on people who 
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inject drugs in the 1980s and 1990s, which monitored drug users as a population and re-
fashioned their subjectivity, exemplifies an act of bio-power that both regularized a population 
and harnessed individual capacities. Bio-power consists of two types of power--anatamo-politics, 
which focuses on the individual body and works to form and shape it through discipline and 
surveillance (Foucault 1979), and bio-politics, which focuses on the species-body and looks to 
regularize the variability of human vitality at the population level (Foucault 1984). Foucault 
(2003) does not see these two types of power as necessarily distinct from one another, but rather 
that bio-politics uses anatamo-politics by, "... infiltrating it, embedding itself in existing 
disciplinary techniques” (p. 242). 
As with governmentality, bio-politics emerged with the constitution of the population as 
a field of knowledge, regulation, and action (Dean 1999). Bio-politics takes the population as its 
primary focus and views it through the lens of biological processes. Thus, normalizing and 
regularizing power is directed at the “species body.” This is the body “. . . imbued with the 
mechanics of life and serving as the basis of the biological processes: propagation, births and 
mortality, the level of health, life expectancy and longevity, with all the conditions that can cause 
these to vary” (Foucault 1984: 262). The type of power Foucault (1984) describes through the 
concept of bio-politics is a positive power that seeks to optimize and multiply life. In this way, 
bio-politics is interested in health and expresses this through its goal of affecting collective 
human existence (Rabinow and Rose 2006: 197). People who inject drugs were and continue to 
be the subjects of large-scale bio-political projects aimed at reducing the spread of HIV/AIDS. 
These projects, often funded by the federal government, report on factors relevant to the vitality 
of people who inject drugs and in doing so construct the subjectivity of this particular type of 
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drug user. This type of monitoring feeds into the creation of localized interventions that aim to 
impact the health of the species-body.  
Constituted by the disciplining of bodies through institutional practices, anatamo-politics 
focuses on how bodies are rendered docile and then optimized to strategic ends through training, 
surveillance, and examinations. Foucault's (1979) theorization of anatamo-politics examines how 
these disciplining tactics take place in the institutions of education, military, hospital, and 
factory. In explaining the disciplinary use of surveillance Foucault (1979) writes: “In discipline, 
it is the subjects who have to be seen. Their visibility assures the hold of the power that is 
exercised over them” (p. 187). Another tactic, normalizing judgment “. . . compares, 
differentiates, hierarchizes, homogenizes, excludes. . .” bodies in processes that work to establish 
“normal” levels by marking gaps and creating hierarchies (1979: 183). Through these 
disciplinary practices of anatamo-politics bodies are molded, such that their forces and capacities 
can be put to use in various institutional projects. Public health and harm reduction programs that 
involve drug users in educational interventions can be understood as disciplinary projects that 
produce certain types of subjects whose forces and capacities are put to work in the maintenance 
of individual health (McLean 2013). In the context of drug treatment programs, drug users may 
be subject to anatamo-politics through disciplinary practices of normalizing judgment and 
surveillance that function to mold subjectivity and refashion subjects into a particular, often 
racially-coded, image of a productive citizen (Gowan and Whetstone 2012; Kaye 2012b). The 
use of the disease model of addiction by health care practitioners implies the need for 
disciplinary power in its linkage to abstinence-based addiction treatment programs.  
Sorting through the types of power that form the subjectivities of economically 
marginalized people who inject drugs and impact their understanding of health and the practices 
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of health care providers, it is clear that differing technologies of power are not always so 
different and thus do not function in mutual exclusivity. Governmentality offers an image of 
power that functions on the population and individual level and aids with understanding how the 
“injection drug user” subject position was formed and how individuals were implicated in their 
own self-governance through this formation. Bio-politics as a technology of power shows how 
health is involved in the governance of populations and works to explain how power manifests in 
state and local projects that aim to promote the health of people who use drugs. Anatamo-politics 
explains how people who inject drugs are shaped by institutional practices that discipline drug 
consumption. These technologies of power are infused with the rationalities of neoliberalism that 
emphasize personal responsibility and self-governance. This can be seen when drug user health 
is managed through a discourse of risk that enjoins individuals to participate in technologies of 
the self to affect changes on their selves and the health practices, such as safer injection, that 
accompany this new identification. People who inject drugs are caught up in various webs of 
power that shape their identity and practices. Looking at how their health is conceptualized is 
one way to begin understanding the power that produces their subjectivity and informs their 
actions. 
CHAPTER OVERVIEWS 
Chapter Two 
 Before analyzing the data I collected, I begin in chapter two by discussing how I collected 
it. I chose to conduct my research through the use of in-depth interviews because I was hoping to 
gain access to the meanings research participants gave to health and the discourses they 
mobilized to discuss their perspectives. The power of discourses is what I sought to understand 
in this research project and conducting in-depth interviews allowed access to the space of 
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discourse. In this chapter, I discuss power asymmetries between the researcher and participants, 
and reflexivity, using a post-structural approach toward understanding power. While there were 
certainly status and power differentials between myself and the individuals I interviewed, I 
experienced power as flexibly practiced during the interviews and thus not fixed by preconceived 
ideas of who held the most power. I took the perspective that power was expressed relationally 
and interactionally, and depended on the particularities of the person I was interviewing and the 
discussion that took place. With that in mind, reflexivity became more of a practice to be carried 
out during fieldwork and less of a way to write myself into the research post-hoc. This chapter 
critiques any stable or fixed representations of research participants and self, but also seeks to 
note the variety of power relations present in my interviews with both a socially marginalized 
group (low-income people who inject drugs) and two socially elite groups (health care 
practitioners and public health researchers).  
Chapter Three 
 Chapter three offers background on and analysis of the emergence of the HIV/AIDS risk 
category “injection drug user” or as it is now known “people who inject drugs” by understanding 
it as a practice of governmentality.  I deploy Foucault’s concept of governmentality to analyze 
the intersection of power that is interested in populations and power that impacts on the 
individual level. Using archival research, which entailed the review of public health journal 
articles from the early 1980s to the present, and interviews with public health researchers, I piece 
together a history of governmentality that begins in the early 1980s and follows the category of 
person who injects up to the present. This chapter notes early efforts to describe this population, 
the development of behavioral interventions based on these descriptions, sociological critiques 
that dispelled the early descriptions, efforts by researchers to promote personal responsibility 
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among drug users, and the continued governance-at-a-distance of this population. The category 
was created and animated by public health and social science researchers as part of a 
humanitarian effort to prevent the spread of HIV/AIDS. In this endeavor, the category functioned 
both as a way to govern and as evidence of the governance of a bounded group of socially 
marginal people. This chapter traces the specificities and nuances of this particular act of 
governmentality. Through early efforts to describe the culture of people who inject drugs, the 
subjectivity of this type of drug user was made pliable to bio-political concerns. Later research, 
which noted the legal obstacles to health maintenance through the use of new syringes, played 
into contemporary trends of neoliberal governance-at-a-distance by offering people who inject 
drugs a sphere of regulated freedom. Through further examples, this chapter demonstrates that 
the creation of the “injection drug user” was an act of governmentality that continually fashioned 
and re-fashioned a particular drug-using subject. 
Chapter Four 
 Chapter four explores the concurrent use of harm reduction practices and the discourse of 
addiction as disease among health care practitioners who provide care for drug users. Based on 
interviews with 13 health care practitioners, this chapter sought to understand the ways these 
health care practitioners understood the health and drug use of their patients and how these 
understandings may be implicated in governing power. All of the practitioners interviewed 
proclaimed their use of harm reduction, which recognizes and encourages agency among drug 
users so that they can self-govern their drug use. Many of the practitioners also subscribed to the 
notion of addiction as a disease and thus saw drug use as disconnected from “choice” or 
“psychological will”. This chapter argues that these two approaches implicate the will of the 
drug user in conflicting ways. The will of the drug user is recognized in some instances and 
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dismissed in others. As governing projects, addiction as disease and harm reduction call forth 
differing technologies of power—disciplinary and pastoral respectively. The docile body of an 
addict faces institutionalization in an abstinence-only drug treatment facility, while the self-
animating drug user of harm reduction must learn how to regulate autonomy. 
Chapter Five 
Chapter five examines narratives of risk and illness put forth by economically marginalized 
people who inject drugs as they described their main health concerns. This chapter is based on 
interviews with 40 low-income people who inject drugs in New York City. The analysis of these 
interviews is staged by an interrogation of contemporary risk-based understandings of health and 
their connection to neoliberal cultural logics of self-governance and responsibilization. This 
chapter explores how both types of narrative operate to mobilize certain types of selves within 
low-income drug injectors’ discussions of health, and what the implications are for societal 
efforts toward addressing the health and well-being of people who use drugs. Among a minority 
of narrations of risk, there emerged an affinity with the foci of harm reduction interventions—
HIV/AIDS, hepatitis C and overdose. Thus, the health interventions offered by harm reduction 
aligned with the primary health concerns of these individuals. I understand this as partially due to 
the governance enacted through harm reduction, which enjoins drug users to think about their 
health in terms of risk for infectious disease. However, most of the health concerns expressed by 
the interviewees were unrelated to drug use, HIV/AIDS, hepatitis C or overdose, having more to 
do with other health risks and chronic conditions whose impact is often stratified by class, such 
as diabetes, hypertension, and obesity. When discussing their health risks or chronic conditions, 
interviewees were able to construct themselves as personally responsible for managing and 
monitoring their health or illness. This chapter closely examines three narratives of illness that 
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articulate a direct link to poverty, and which work to reveal the narrow potential of harm 
reduction as a pro-health intervention. These narratives also reveal the efforts put forth to be 
personally responsible for managing one’s illness, despite living in conditions of poverty that 
obstruct access to resources supportive of health. By examining narratives that include harm 
reduction discourse and those that do not, this chapter reveals both the impacts and the failures of 
the current iteration of harm reduction-as-public-health-intervention, and through this, urges a 
reflecting back upon the original mission of harm reduction’s foundation to improve the general 
situation of the drug user. I conclude by suggesting that harm reduction as a movement could re-
vision and expand upon the meaning of harm to include the structured impacts of poverty, and 
form networks of care with other organizations and movements to provide a broader range of 
interventions and services that address such issues as housing instability, unemployment, and 
nutrition among other disadvantages. In this way, harm reduction could work to mitigate the 
harm caused by situating a cultural and institutional emphasis on personal responsibility in a 
social environment structured to produce inequality. 
IN/CONCLUSION 
 By examining what health means for people who inject drugs, this project aims to dispel 
any simple conclusions that health is signified by a conglomeration of risks or that health is the 
absence of disease, for instance. By noting that discourses of health can imply certain 
technologies of power, we can see why contemplating the many meanings of health matters. For 
bodies, such as those of low-income people who inject drugs, whose vitality is negatively 
impacted by structured inequality and social marginalization due to stigma, acts of governance 
can mean the difference between life and death. Governance through risk as a way to maintain 
the health of people who use drugs offers individualized ways of taking care of the self, but 
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neglects broader social forces that leave bodies vulnerable to disease. Thus, for low-income 
people who inject drugs, health is often measured by experiences of illness with conditions 
brought on or made worse by poverty. For health care practitioners, the health of drug-using 
patients is at least partially measured by reference to the disease of addiction, which similar to 
the discourse of risk, only sheds light on a narrow component of health and leaves unexamined 
structured vulnerabilities to disease and addiction. Understanding health through the lens of 
addiction as disease also links drug users to the disciplinary institutions of drug treatment. Just as 
the technologies of power that address the drug using body are diverse, so are the ways to 
understand drug user health. In exploring this diversity of power and meaning, this project aims 
to open up a space for discussing health that moves away from narrow foci that inculcate bodies 
in self-care and toward the social processes that underlie health.  
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Chapter Two 
This Research Cannot Be Fixed: The Contextual Instability and Fluidity of Power and Self in 
Qualitative Research 
 
 In January of 2012, I began fieldwork for this project with the goal of interviewing 
economically marginalized people who inject drugs and health care practitioners who provide 
primary care for active drug users. I wanted to understand the discourses that structure the power 
relations embedded in efforts to define the health of people who inject drugs. Through the use of 
in-depth interviews, I was hoping to gain access to the meanings drug injectors and health care 
practitioners assigned to the concept of health, and within these meanings notice over-arching 
discourses. The first person I interviewed for this research project was a doctor, and like many of 
the health care practitioners I subsequently interviewed, she practiced medicine in a setting 
where drug treatment was also provided. In fact, eight of the practitioners I interviewed 
prescribed buprenorphine, and two of those practitioners also worked in methadone clinics. Over 
the course of the next 12 months, I interviewed 12 more health care practitioners. Most of the 
interviews took place in their offices in New York City, at the institutions where they worked. 
The second interview I conducted for this project occurred in late February of 2012 and was with 
a young person who injected drugs. As with a few of the other interviews with people who inject 
drugs, this interview took place at the field site of a separate research study. However, I found 
the most luck recruiting and interviewing these interviewees at two harm reduction organizations 
in Manhattan. This meant that these interviewees had at least some contact with the ideas of 
harm reduction. Since harm reduction was an object of inquiry for this project, I benefited from 
interviewing individuals in these settings. In all, over the course of 14 months, I interviewed 40 
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people who inject drugs. The final leg of my fieldwork began in May of 2013, when I 
interviewed four public health researchers about the risk category that denotes people who inject 
drugs in order to historicize the group of people around which this research centers. 
 Initially, choosing to conduct this research project using qualitative methods seemed like 
an obvious choice to me as I conceived of this project. However, this choice was based on 
several under-articulated epistemological beliefs I held. First, I believed that knowledge could be 
created in an exploratory mode. Rather than determining fixed variables on which to focus, and 
in some ways constructing the outcome I expected to find, I wanted to use the flexible methods 
of qualitative research to seek out the discourses that my interviewees used to talk about the 
health of people who inject drugs. Since qualitative methodology allows for flexible research 
design, often researchers do not know what to look for and what questions to ask until they’ve 
spent time with their subjects of interest (Taylor and Bogdan 1998:8). Even once the research has 
formally begun, qualitative researchers will continually become aware of things they had not 
anticipated and will need to adjust their research model to make the account they produce a more 
careful one (Becker 1996; Katz 1997). Through the acceptance of new ideas and theories, and 
the ability to be flexible in use, qualitative methods reach toward a careful fit between the data 
and its depiction without excluding a diversity of viewpoints and experiences.  
Qualitative methodology in its broadest sense refers to research that produces descriptive 
data and for the most part what are described are viewpoints and meaning. As Taylor and 
Bogdan (1998) assert: “The important reality is what people perceive it to be” (p. 3). To add to 
this, the important meanings are the ones people give to the experiences, phenomena, and objects 
in their social spheres. Practicing these beliefs insists on the co-construction of research findings 
and knowledge generated through interactions between the researcher and study participant. If 
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the perspectives and meanings deployed by the participants are at the core of the research, then 
they are rightfully authors of the products of the research. This is not to obscure the place of the 
researcher in interpreting and subsequently constructing the viewpoints and meanings she is 
presented with during the conduct of research. Rather, it is to show another under-articulated 
epistemological belief I had about social science research—viewpoints and meanings, which 
structure and guide social life, should be included in the production of knowledge. This dovetails 
with the importance of counting everyday experience as part of the knowledge production 
process. Qualitative researchers are concerned with how people think and act in their everyday 
lives, which includes the taken-for-granted assumptions that structure their actions and world 
(Becker 1996). It is in the substance of the everyday that qualitative researchers gain 
understandings of process and power. 
I sought to understand the power of discourses in this research project. Conducting in-
depth interviews allowed access to the space of discourse. While I engaged beliefs from several 
theoretical frameworks, such as feminism with its concern for oppression of different categories 
of people, and post-modernism, which questions the voice and authority of the researcher and 
whether social facts exist, my research was mostly constructed around a post-structural account 
of power. In this analytic approach, subjects are understood as produced and disciplined through 
diffuse networks of power. Examining discourses, such as those of harm reduction and the 
disease model of addiction, in interviews with health care practitioners and people who inject 
drugs was a way to understand how health and the subject attached to it (i.e., people who inject 
drugs) are produced.  
This chapter will proceed by offering a discussion of methodology and a discussion of 
ethics. In particular, the method of in-depth interviewing will be analyzed for the type of 
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knowledge and power relations it produces. Ethics will be discussed on both the macro and 
micro-scale, as well as in relation to “studying-up” and studying a vulnerable group. Finally, I 
will offer a summarized description of my research procedures from recruitment to data analysis, 
highlighting formative, as well as frustrating, moments. The chapter will conclude with a nod to 
reflexivity, though perhaps a critical one, through a discussion of my place within the research.  
Instability and fluidity are central threads tying together much of the discussion to follow. 
My depictions of the power relations of interviews and the practice of reflexivity are threaded 
through with a refusal to offer fixed notions of certain types of people and certainties about the 
directional flows of power. In this sense, my discussion of methodology corresponds with my 
interest in post-structural understandings of power in that I see power as fluid, and thus not fixed 
within individuals. Rather, various modalities of power are manifested through technologies of 
action and inaction. In a Foucauldian sense, the interview is understood as a disciplinary 
technique of confession whereby the interviewee is enjoined to produce his or her “self” through 
articulating truths (Foucault 1978). I was unable to escape this form of power in that I used 
interviews as a data collection tool. However, an oppressive sort of power that elevates the 
researcher and creates status incongruities was not apparent in my fieldwork interactions. Power 
was not inscribed within individuals, but rather it was diffuse, interactional, and continually at 
work, even as I compose this chapter.  
Power that functions through privileged and accepted discourses may produce 
subjectivities (such as the “injection drug user”), but this does not mean that my interviewees 
assumed a fixed positionality during our interviews. This is not to deny that some individuals 
may be more vulnerable to dehumanizing forms of power due to their experience of socially 
structured inequalities, but rather to recognize that the power dynamics of interviews cannot be 
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discussed with reference to simple unidirectional flows and fixed notions of certain 
subjectivities. Indeed, by engaging people who inject drugs in open discussions of health that did 
not center on drug use during in-depth interviews, I aimed to unsettle any fixed notions of an 
“injection drug user” subjectivity. It is the post-structural view that power is diffuse and 
continually circulating rather than possessed by certain individuals that guides my approach to 
understanding the power dynamics of research interviews. 
PRODUCING KNOWLEDGE TOGETHER: ON IN-DEPTH INTERVIEWS 
 I chose to use in-depth interviews as a “search procedure” (Paget 1983) to help me 
understand the meanings attached to the concept of health for people who inject drugs. 
Interviews offer access to interior experiences and perspectives, as well as thoughts and feelings 
(Weiss 1995), all of which I felt were necessary to illuminate the questions that puzzled me. How 
did drug users understand their health? Did they believe themselves to be healthy? Were any 
discourses (e.g., harm reduction, disease) guiding their perspectives? The content of an interview 
is produced by what is puzzling the interviewer. The interviewer follows her perplexities as they 
arise in the conversation: “The questions asked and their sequencing presuppose and reflect a 
project. In-depth interviewing is a search procedure” (Paget 1983:78). In this way the interviewer 
is implicated in constructing, or at least co-constructing, the content of the interview.  
 As an interviewer, I did not take a neutral stance in hopes of “excavating” (Mason 2002) 
objective knowledge from the respondents. It is inevitable that the interviewer’s perspective will 
shape the interview, as well as the findings, and it is now widely accepted among qualitative 
researchers that interviews are “. . . active interactions between two (or more) people leading to 
negotiated, contextually based results” (Fontana and Frey 2005:698). Following the assertion 
that interviewers should not forbid themselves from all personal engagement during the 
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interview (Bourdieu 1996), the interviews I conducted evolved through the periodic insertion of 
my own thoughts and perspectives, and in some ways felt like a casual conversation (Bourdieu 
1996). In this exchange I had with Dan, a 22-year-old who injects drugs, I inserted my opinion 
about the irresponsibility of his health care provider, a hospital emergency room. Dan is 
describing his struggle with receiving adequate medical care for diabetes: 
Dan: Yeah, that’s when my sugar goes completely too high. I black out. I can just die, 
and that’s pretty much the only way they [the emergency room] would take me is if I was 
in DKA [diabetic ketoacidosis]. And I’d have to do three days, and I’d be out for four 
days, three days. My medical bills are ridiculous right now. If I get a regular job, I don’t 
know what the hell I’m going to do, but they’re just going to take all my money. 
Kelly: Oh, man. That seems so wrong. 
Dan: You know what I’m saying? Yeah, it’s just the snowball that just. . . 
Kelly: Yeah. Oh, wow. I just can’t believe they wouldn’t give you insulin to take with 
you. 
Dan: I know. I’m like, “Just give me one pen, one Lantus, and I won’t have to come.”  
“No, no. We can’t do that.” I’m like, “That’s just crazy.” 
Kelly: Yep, that is crazy. 
Dan: I was about to go under the counter and just take it. 
With the addition of my perspective in this exchange, Dan further elaborated on his desperation 
for take-home insulin and his evaluation (“That’s just crazy”) of the actions of the hospital.  
 The internal context of the interview is also an agent in shaping the interview as it 
progresses. Paget (1983) explains that interviews are contextual in their organization in that, “. . . 
they respond to features of the ongoing interaction, to nuances of mood, and to the content of the 
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evolving conversation” (p. 69). As mood or topic shifts so too can the character of the interview. 
This is where creating, if possible, a comfortable flow and exchange for the interviewee is 
important, but this must be balanced with the recognition that in-depth interviews can be 
manipulative of the interviewee (Fontana and Frey 2003). Techniques that nurture rapport can 
lead interviewees to say things they may not actually want to disclose in a research interview 
(O’Connell Davidson 2008). This will be taken up in more detail in the section of this chapter on 
ethics.  
 Another way in which in-depth interviews are co-constructed is through the theoretical 
orientation the researcher brings to the interview. In fact, the mere choice of conducting 
interviews demonstrates a theoretical orientation that sees talk and text as central to ways of 
knowing the social world (Mason 2002). The central components of interviewing--asking, 
listening and interpreting--can be seen as theoretical projects in that they reveal assumptions 
about what is “. . . possible from asking questions and from listening to answers, and what kind 
of knowledge we hear an answer to be. . .,” all based around an implementation of the 
researcher’s theoretical orientations (Mason 2002: 225). As mentioned earlier, my interviews and 
my research project in general were guided by a post-structural theoretical orientation, which 
meant that my questions to drug users tried to get at their experience of power that aimed to 
govern their selves and bodies, and my questions to health care practitioners and IDU research 
experts sought to shed light on their roles in the implementation of this type of power. Due to my 
theoretical affiliation, I co-constructed the interview content by asking certain types of questions 
and interpreting answers in ways that aligned with my particular understanding of power.  
 The choice to use in-depth interviews as my fieldwork method was based on the belief 
that various discourses pertaining to drug use and health would be revealed through talk. By 
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asking interviewees questions that might reveal their understanding of what health means, I 
assumed (and correctly so) that interviewees would deploy a variety of discursive registers to 
explain their perceptions. I asked both questions that were abstract or general and those that 
delved into everyday activities believing that both types of questions would offer varying venues 
for the revelation of guiding discourses. The flexibility of interviews, along with the access they 
give to internal perspectives, and meanings, and depictions of everyday activities provided fertile 
ground for conducting the type of analysis I desired. 
HOW SHOULD ONE BE/ACT?: ON ETHICAL PRACTICE 
 Often when research ethics are discussed, the conversation centers on the policies and 
procedures of Institutional Review Boards (IRB), as they are, at least superficially, the guardians 
of research ethics. While the structure and function of the activities of the IRB directly pertain to 
ethics, there is also a more fine-grained and contextual recognition and analysis of ethics that can 
and should occur in any research endeavor. A differentiation can be made between “procedural 
ethics,” or the set of ethical guidelines that are addressed in the creation of protocols for IRB 
applications, and “ethics in practice,” or the ethics that come to light as the research is carried out 
(Guillemin and Gillam 2004). While it has been suggested that the abstract principles of ethics 
embraced by IRBs—respect for persons, beneficence and justice--may not guarantee moral 
decision-making or moral action (Halse and Honey 2005), they can at least provide some 
guidance in the creation of the study protocol and “ethics in practice” (Guillemin and Gillam 
2004). For example, these principles seek to protect the basic rights and safety of research 
participants from obvious forms of harm, and they offer an “ethics checklist” for researchers 
constructing their protocols (Guillemin and Gillam 2004:268).  
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 Despite the potential usefulness of these abstract ethical principles, there are at least 
several ways in which the procedures of the IRB can interfere with the conduct of certain types 
of social science research. The requirement to define a particular research population, “. . . is an 
act of category construction with profound intellectual and moral implications” (Halse and 
Honey 2005: 2145). Often people do not fit neatly into pre-fabricated categories, or may fit 
within the category but reject the label of the category. At several points while recruiting 
research participants, the inadequacy of the recruitment categories I had provided to the IRB was 
revealed. For example, were people who injected methadone, a legal substance used for drug 
treatment, “injection drug users”? What about those who had recently injected but were trying to 
stop, who were in the act of withdrawing from this category?  
 The concept of informed consent is reliant on a notion of an autonomous liberal humanist 
subject who is able to make rational and independent decisions regardless of context. Further, the 
process of informed consent is premised on researchers being able to provide full and accurate 
information about the research (Halse and Honey 2005). However, there are many contingencies 
of research, and particularly qualitative research, that can lead to a wide variety of outcomes. 
Thus, it seems impossible to offer a full account of what may happen during the research. In the 
consent process for my research, I warned drug users that some of the questions I asked could 
make them feel embarrassed or otherwise upset, but I was unable to predict any other responses 
of which to warn participants. Perhaps, the interviews I conducted could initiate damaging 
emotional and psychological processes, leading participants to question themselves and become 
distrustful of medical care, for example. It is also not possible to be sure that research 
participants understood everything I told them during the consent process.  
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 In creating a research protocol for an IRB application, the researcher must adopt a one-
size-fits-all strategy for both introducing the study to participants and conducting it. This is 
despite the diversity of experiences among participants and the variety of ways in which the 
study might stir up difficult emotions (Halse and Honey 2005). The universalized, rational 
subject articulated in modern research ethics policy is also problematic because, “ . . . it 
constructs the self as disembedded and disembodied, without sensibilities, history, or 
physicality” (Halse and Honey 2005: 2153). In essence, the requirements of the IRB application 
process flatten the multiplicity of research participants. In my research, the occupational label 
“health care practitioner” was used to define a category of people for recruitment. However, 
one’s occupation is only a piece of their felt-identity, and in fact, much of the content of my 
interviews with this group delved into personal views of drug use, stigmatization, and medical 
care. Some participants discussed personal experience with drugs or with friends who used 
drugs, which took them outside the terrain of the professional and into the personal. The two 
cannot be detached despite the implications of the identity categories required by IRB 
applications. 
 Much of my own experience with gaining IRB approval centered around the perceptions 
held toward drug users by individuals on the review board at my institution. This proved to be 
both fascinating and disheartening, in that I was subject to disparaging perceptions by a group of 
individuals whose experience working with people who use drugs was unknown to me. The 
personhood of the individuals I was planning to interview was flattened into a monolithic image 
of a socially deviant drug user. At the beginning of the process, I learned that my application 
would be subject to full-board review. In the end, I revised my application three times before it 
was approved. My first application was met with a memorandum outlining revisions that I 
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needed to make. Many of these had to do with clarity, but some clearly revealed concerns that 
seemed particular to a certain construction of drug users. For instance, I was disallowed from 
using email to communicate with potential study participants because this group was perceived 
to not have access to email. A concern was expressed about intoxicated participants, which came 
up again when I was required to attend a full-board IRB meeting a month later. The IRB 
members stated that an intoxicated person could not participate in the consent processes. 
However, people who inject drugs often inject heroin, and for those who use heroin on a regular 
basis, some amount of “intoxication” must be maintained to avoid the debilitating effects of 
opiate-withdrawal. Individuals who were in withdrawal would most likely not be participating in 
a research study, but would rather be spending their time finding ways to obtain heroin so they 
could address withdrawal symptoms. Unsure that articulating this nuance would be helpful, I 
simply complied with the request that no intoxicated individuals participate in the study.  
 Intoxication came up once again at the in-person full-board meeting I was required to 
attend. Showing a lack of knowledge about the environmental context of the research (New York 
City), one board member asked what I would do if an intoxicated person, who I had turned away 
from the study, attempted to drive a car. I knew from years of experience interviewing a large 
number of people who inject drugs in New York City, that this was quite unlikely as I had never 
seen this happen before. I addressed the concern by indicating that I would have the individual 
wait until he or she was no longer intoxicated. While I will agree that from an outsider 
perspective these concerns seemed valid, many of them were based around uninformed and thus 
unwarranted fears related to working with people who use drugs. In contrast, very little concern 
was shown for the other group of people I planned to interview—health care practitioners—who 
were vulnerable in other ways that went unacknowledged. Later, I added another group of 
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interviewees—experts and activists on injection drug users from the early days of the HIV/AIDS 
epidemic—and this amendment passed through the IRB with one minor revision. My experience 
with gaining IRB approval revealed perceptions of vulnerability that were sociologically 
interesting. While ostensibly aiming to pay particular attention to protections for potentially 
vulnerable research subjects, the concerns raised by the IRB reinforced hegemonic, and in some 
cases stigmatizing perspectives (e.g., inability to access email) of people who use drugs. Through 
a lack of expressed concern, perceptions about the invulnerability of health care practitioners and 
research experts were revealed. Additionally, this experience proved the contextuality of ethics. 
Unfamiliarity with the populations under study can lead to the anticipation of ethical concerns 
that may be irrelevant. 
 While the process of applying for IRB approval reveals ethical issues to be considered 
prior to commencement of research, once research begins, there are many other ethical issues to 
consider in the “doing” of research. One area that can become an ethical quagmire is the creation 
of rapport and intimacy with research participants. During interviews, participants may lose sight 
of the research orientation of the relationship and talk on a more intimate level. While these can 
be revelatory moments where the participant articulates ideas and thoughts important to the 
research, the interviewer may feel uncertain whether the participant is still aware of the nature of 
the interview, which brings up issues of informed consent (O’Connell Davidson 2008). In fact, 
some participants may mistake a good interview for a therapeutic situation and be more willing 
to open up emotionally2 (Kirsch 2005; Walkerdine, Lucey and Melody 2002). In some feminist 
research, a close relationship of accountability is encouraged (Kezar 2003). However, this must 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2	  It has been found that there may be some therapeutic benefit to participation in qualitative 
research interviews (Hutchinson, Wilson, and Wilson 1994; Murray 2003). However, my 
concern here is with the ethics of consenting to exposure to these therapeutic processes. 
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be exercised with caution as researcher and participant priorities can diverge, and the relationship 
can edge close to exploitation (Kirsch 2005). Further, when research ends, participants may feel 
angry and betrayed (Kirsch 2005; Morrison, Gregory, and Thibodeau 2012). Kirsch (2005) 
suggests that researchers base their interactions with participants on an ethic of friendliness 
rather than friendship, as this close bond can imply more than the researcher is willing or able to 
give.  
 In my interactions and interviews with study participants who injected drugs, the group I 
considered to be most vulnerable, I tried to maintain a level of intimacy appropriate for a 
research study, while also seeking to avoid the impression that I was only using these 
participants for the information they could provide. This balance was a difficult one to maintain, 
but I attempted to do this by extending kindness and empathy during interviews, while avoiding 
commitments of time or other resources outside of the research relationship. On occasion, 
interviewees spoke in ways that seemed similar to how one might speak to a therapist. This 
included questioning their drug use and expressing dismay and frustration at their inability to 
stop. For example, nearing the end of my interview with William, a 46-year-old African 
American man, I asked him if there was anything else he’d like to add and he spoke about 
wanting to stop using drugs: 
Right now I want to get out of all this shit. I want to get married. I want freakin' go back 
to my life again. I don't want to do that shit "wait aw damn you know I gotta go do this. I 
gotta do that." I don't wanna do that anymore. Of course, there's other people that they 
don't wanna keep doing the freakin same shit. And it's not the point to put three years in 
and then go start the bullshit again. I want now to just stop all this shit. Not for two years, 
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three years. I just don't want it anymore.  I don't want anymore. It's not fun anymore. I 
don't enjoy myself. This is like the end of the rope. I don't want that anymore, you know. 
William continued to speak about his desire to stop using drugs for several minutes. Our 
conversation eventually turned to the mysterious workings of addiction and the difficulties of 
changing one’s behavior before the interview wound to a close.  
 I did not interrupt the interviewees when they began these types of introspections, but 
rather let them talk for some time. When they seemed to be winding down on this topic, I would 
try to ask a question that connected their thoughts to the research topics. In the few instances 
when this happened, the interviewees did not express feelings of betrayal or anger at my re-
direction, but rather thanked me for listening to them. During the interviews with health care 
practitioners and experts on the risk category “injection drug user,” this type of talk did not 
occur. Most of these interviewees had conducted research themselves, and thus, likely had an 
understanding of the ethics and positionings of research relationships.  
 Reflexivity is an oft-discussed topic in the literature on qualitative methodology and 
ethics. There are perhaps as many definitions and ways to practice this concept as there are 
research topics in the social sciences. Macbeth (2001) asserts that, “. . . although this diversity 
assures us that any account of it can only be tendentious, it may still be useful to try to build one” 
(p. 35). At its root, reflexivity generally refers to a sense of awareness of the researcher’s 
positionality, action, and thought alongside a concern for ethical practice. Reflexivity can be 
practiced throughout the research endeavor, but for clarity I will first discuss its use during the 
conduct of fieldwork, and in this case interviews, and then discuss reflexivity in the construction 
of knowledge and written work that is based on fieldwork. 
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 As Guillemin and Gillam (2004) write, the goal of being reflexive is often related to “. . . 
improving the quality and validity of the research and recognizing the limitations of the 
knowledge that is produced. . .” which can improve the perceived rigor of the research (p. 275; 
Ball 1990). This is accomplished by recognizing the role of the researcher and her social and 
political positionings in the conduct and writing-up of research. However, Guillemin and Gillam 
(2004) suggest that reflexivity should not only be practiced as a way to produce rigor, but also as 
a way to ensure ethical practice throughout fieldwork. In this way, the researcher practices 
reflexivity with regard to the interpersonal aspects of research, as well as the ultimate purpose of 
the research, which may include advancement of the researcher’s career, addressing the 
participants’ self-defined needs, a more broad-based social justice goal, or a mix of these. This 
involves a constant process of critical scrutiny of both the researcher’s and the participants’ 
actions and thoughts throughout the research processes. 
 During the conduct of fieldwork, there are many areas in which the researcher can be 
reflexive. In preparing to conduct research, the researcher may become aware that the ethics 
approval process facilitates a hierarchical power relationship between researchers and 
participants by constructing the researcher as the objective knower and the subject as the object 
of knowledge. This works to construct the research subjects as other (Halse and Honey 2005: 
2154-5). One way a reflexive awareness of this hierarchical construction can aid the researcher is 
in creating interview questions that do not position the interviewees as exotic or deviant. The 
researcher should also be aware that transferences, identifications, and fantasies do not disappear 
when she is engaged in research (Walkerdine et al. 2002). Besides “othering” the research 
participant, the interviewee may be enticed by emotion and desire to view the interviewee in 
certain ways, ask certain questions, and make particular assumptions. During the research 
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process, I certainly identified with some interviewees more than others, and in recognizing this I 
attempted to be aware of how this identification impacted the interview. This involved knowing 
that the questions I asked shaped the discourse (Presser 2004) and the answers I received 
projected “specific, contextually grounded and interactional content” (Paget 1983: 87-8). Being 
reflexive of the self and the research participant during the interactional moments of fieldwork 
can facilitate on-going and fine-grained ethical practice. 
 Reflexivity that occurs during the analysis and writing-up of fieldwork data often appears 
in two forms: self-referential reflexivity and textual reflexivity. Both techniques involve a 
“turning back upon” either the researcher and her social positionings or the text that she 
produces. Macbeth (2001) refers to the former as “positional reflexivity” and notes that it is 
centered around the agency of the researcher, pursues a foundational field of view, and is a 
“demarcation exercise that can warrant the value of an inquiry and the knowledge that it 
produces. . .” (p. 41). Thus, while the explicit goals of positional reflexivity are to remain 
vigilant against privilege or exploitative relationships, the implicit goals remain similar to the 
modernist project of producing a more “real” and rigorous, and thus authoritative representation 
of social experience. Skeggs (2002) notes that this type of reflexivity, or as she calls it “self-
telling,” has historical roots in the act of confession and involves using the lives of others as a 
sort of “temporary possession” to aid the researcher in performing the self (p. 357-8). Both 
authors are concerned that this type of reflexivity has become almost obligatory when the 
researcher discusses her analysis and interpretations of the data.  
 One way in which researchers have attempted to deconstruct the authoritative emphasis 
placed on and assumed by the researcher is through reflexivity exercised while constructing text. 
Textual reflexivity refers to an explicit examination of the work of writing representations, and is 
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often exercised by disrupting claims to realist representations and textual coherence in the text 
itself (Macbeth 2001: 42-3). However, this act of decentering the singular voice of the author 
may ultimately serve to display the cultural capital that is necessary to be able to engage in 
textual play (Skeggs 2002: 363). Similarly, textual play “. . . is about the powerful showing how 
well they understand power by playing with it” (Skeggs 2002: 363). Thus, textual reflexivity 
may not ultimately display the deconstruction of authorial power, but rather reveal that the 
author has sufficient power within her disciplinary context to construct new forms of textual 
representation for an academic audience.  
 The critiques of these two types of reflexivity—positional and textual—seem to create a 
dead end for researchers who would like to engage in some form of reflection on power. 
Completely de-centering the researcher and her relational and authorial power from reflexive 
analyses may not be possible. But, I would like to suggest some potential considerations for 
engaging the act of reflexivity in other ways. Noticing other enactments of reflexivity while 
analyzing data may at least alleviate some of the emphasis on the researcher. This should involve 
recognition of the research participant’s own potential for being reflexive and for mobilizing a 
variety of social positionings during interactions with the researcher. While interviewing men 
who committed violent crimes, Presser (2004) noticed that the research interview became a 
context for the men to deconstruct their socially designated identities. In interviews and other 
fieldwork interactions, research participants may reflect on their social position vis-à-vis the 
researcher and the power relations contained therein. The researcher must be careful not to allow 
the perceived positionings of the research participants to sediment (Walkerdine et al. 2002), as 
they may shift in the course of an interview and as the interviewee reflects on his or her 
relationship to the researcher and the research topic. In advocating for non-violent 
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communication, Bourdieu (1999) advises the researcher to examine the objective of the inquiry 
as perceived by the research participant in an attempt to reduce distortions of the participant’s 
beliefs and ideas. While it is neither possible nor desirable to impute the thoughts of the 
participant, recognition of his or her own potential for reflexivity and flexibility in self-
presentation can guide the researcher away from a singular focus on her own reflexive 
ponderings. As mentioned previously, it may be preferable to practice reflexivity through 
reflecting back upon power and practice during the conduct of research (Skeggs 2002), rather 
than attempting to enact it post-hoc through confessional stories of the self and textual play.  
Studying People who Use Drugs 
 The use of qualitative methods to study drug users has been recognized as underscoring 
the humanity of these individuals along with signaling their value and giving them a personalized 
voice (Carlson, Siegal, and Falck 1995; Keane 2011; Page and Singer 2010). While early 
qualitative research on drug use sought to position it as social deviance (e.g., Dai 1937) and was 
mainly concerned with why people use drugs (e.g., Lindesmith 1947), research in the latter half 
of the 20th century examined drug use using a subcultural paradigm, and sought to understand the 
social and cultural components of drug use involvement rather than why individuals used drugs 
(Page and Singer 2010). Qualitative research on drug users until the appearance of AIDS was 
mostly interested in the micro-social worlds constructed by drug users, and thus did not 
recognize the wider social context that fosters drug use (Page and Singer 2010). In the late 
1980s, the federal government began to fund ethnographic research on drug users to investigate 
the spread of HIV, which spawned another trajectory of drug user research that focuses on health 
risks related to drug use (Singer and Page 2014). The research of social scientists over the last 90 
plus years has culminated in an image of the drug user as cultural other. As Singer and Page 
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(2014) note, three types of cultural others have been created: the drug user as cultural actor and 
knowledge seeker; the drug user as a deviant threat to society; and the drug user as a vulnerable 
person in need of unforced interventions (p. 182). If it were to be categorized, the image of the 
drug user produced by my research endeavor would likely fall into the third category, though 
rather than construct drug users as in need of health-related interventions, my research sought to 
have drug users self-define health and the problems they face with accessing needed health care. 
These accounts could lead to the creation of health-related interventions, but that is not my goal. 
 Among the methodological and ethical considerations mentioned by others who have 
conducted research with drug users is the notion that drug users function outside of mainstream 
norms and values (Carlson et al. 1985) and that researchers may need to exercise cultural 
relativism in order to remain open to the “difficult or shocking realities of drugs, sex, crime, and 
violence” (Bourgois and Schonberg 2009: 7). However, I found that the opposite occurred in my 
interviews with drug users. The respondents articulated what I would consider to be mainstream 
approaches to maintaining their health. They described attending regular medical appointments 
and seeking hospital care when necessary. The interviewees took vitamins, avoided sugar, did 
yoga, and sought other conventional ways to take care of their health. Most of them felt that 
there was some risk involved with injection drug use, but took measures to minimize the risks. 
The interviews seemed to afford the respondents the opportunity to construct a positive image of 
themselves in terms of health.  
 Though much is made in research methodology literature of power asymmetries in 
conducting research and their potential to cause violations of ethical principals (Page and Singer 
2010), the power relations in the interviews I conducted developed in situ and depended on the 
character of the exchange between myself and the respondent (Smith 2005). As mentioned, the 
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research interviews allowed the drug users to present themselves in a positive light and, as 
Presser (2004) noted in her interviews with criminally violent men, the interviewees constructed 
identities that forestalled labeling as deviant. At times I felt as though the respondents were more 
in charge of the interview than I was and while this occasionally meant their talk diverged from 
the central interview topics, it demonstrated the power of which they were capable in this 
interview setting.  
 Early in my interview with David, a 55-year-old Puerto Rican man, the conversation 
turned towards his recent arrest and possible return to prison. He seemed anxious and spent some 
time describing the situation to me and explaining how the cops had set him up. The topic began 
when I asked him, as I did with all interviewees, if he had been incarcerated before. He 
responded affirmatively and explained: “Because I did sell drugs at the time to maintain my habit 
and to have money to get along and eat and live. And it’s cost me. It’s cost me dearly. I’m facing 
one right now.” David explained that an undercover officer approached him and “… asked me do 
I know where to get something. I told him, yes, let me make a phone call.” He continued: “So-
and-so came out of the building and served them two bags of whatever, and all of a sudden the 
guy [the drug dealer] gets away, but they got me. And I’m sitting in front of my building.” The 
story then became a bit confusing as David explained: “It’s all a hoax. Really, it was. Because he 
originally stopped me for a robbery, then turned around and turned into a sale when I got to the 
precinct.” David then described how the police stopped him while he was sitting outside his 
apartment because he fit the description of a robbery suspect. David continued to talk about the 
situation for an extended period of time discussing such topics as police brutality, mandated drug 
treatment, stop-and-frisk policing, and mandatory sentencing laws. Sensing his anxiety and 
frustration, I did not attempt to re-direct the conversation until he seemed finished with the topic. 
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Though David’s story was quite upsetting, it was sociologically interesting in that it revealed the 
intricacies of institutionalized discrimination in the criminal justice system. Eventually, I was 
able to ask him some questions about his health and experience with health care providers but he 
continued to reference his current entanglement with the criminal justice system. He clearly 
preferred to talk about this situation and I was happy to provide him with a listening ear. 
 Another instance in which an interviewee wielded some power over the interview 
happened early in my interview with Joshua, a 27-year-old white male. After responding to my 
question about how he came to live in New York City, Joshua turned the interview around on 
me. He began to ask me questions. 
 Joshua: Where are you from? 
 Kelly:  I’m originally from Michigan but I’ve been in New York for a   
   while. 
 Joshua: Upstate? 
 Kelly:  Both. I’ve been in the city for about seven years and upstate for   
   about three or four years. 
 Joshua: So that’s where you live now? 
 Kelly:  I live in the Hudson Valley. I’m a little... 
 Joshua: In between 
 Kelly:  Yeah, in between, yeah, outside of the city. 
 Joshua: I was actually looking at jobs in the Hudson Valley for renewable   
   energy. That’s like a big focus, but it’s kind of too far from the   
   city. 
 Kelly:  It is. Yeah. 
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 Joshua: Without a car, especially right now 
 Kelly:  Oh yeah, you’d need a car to work out there. 
 Joshua: Anyway, sorry. 
 Kelly:  That’s okay. Where do you live now? 
While this reversal of interviewer-interviewee positionality was brief, Joshua’s questions served 
to set a more conversational tone for the interview. Upon meeting Joshua, I recognized that we 
shared a similar racial and socioeconomic background. Perhaps also noticing this, Joshua seemed 
driven to curiosity about my background. His questioning early in our interview served to level 
the power differential. 
 One area over which the respondents could not exercise control was the representation of 
their voices in the research products. Of course, I did not take this power asymmetry lightly and 
worked to remain thoughtful and reflexive in the ways I portrayed the research participants in the 
text. This includes not editing or splicing together segments of speech or providing speech 
extracts without contextual description. While it is impossible to know exactly what the 
respondents meant at all times during their interviews, I could represent their words unedited and 
embedded within the context of our interaction. The same went for the health care practitioners 
and research experts I interviewed, though, as I will discuss, their social position varied from the 
drug using interviewees. 
Studying Health Care Practitioners 
 In conducting research interviews with health care practitioners, I was participating in 
what some social scientists refer to as “studying up” in that I was studying a group with a higher 
social status than myself and a group whose social status is generally held in high regard. Often, 
social science researchers do not choose to study those who are considered more socially elite, 
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which, unfortunately, leaves the upper reaches of the social system in the shade (Gusterson 
1997). Emphasizing Laura Nader’s 1969 call to “study up,” Gusterson (1997) asserts its 
usefulness for examining operations of power, and thus democratizing access to knowledge 
about how structures of power function. One such structure of power is the health care system in 
the U.S., whose functions I sought to make more transparent through interviews with health care 
practitioners.  
 While the health care system is indeed quite powerful, the power relations I experienced 
in these interviews were less pronounced and felt than expected. Similar to the interviews with 
people who inject drugs, power was expressed relationally and interactionally, and depended on 
the particularities of the person I was interviewing and the discussion that took place. Taking a 
post-structural view of power, which viewed it as mobile and diffuse, Smith (2005) questioned 
whether interviewing a person identified as elite will necessarily lead to asymmetrical power 
relations. Taking into account the post-structural stance that power is not possessed by an 
individual, but rather practiced through certain modalities (such as seduction, manipulation, and 
authority), it is unclear if power in one realm can easily transfer to power within the interview 
setting (Smith 2005). Similarly, Rice (2010) experienced power in his interviews with elites 
involved in the construction of a shopping mall as a “relational effect of social interactions” (p. 
70) and suggested that flexibility with one’s social positioning can reduce any gaps between the 
social statuses of the researcher and the elite. In this way, the researcher can make efforts to 
present herself in such a way that the interviewee may see little if any status incongruity. In fact, 
upon reflection, the researcher may realize that she comes from a similar background of privilege 
as her respondents, and that as an academic she may be in a similar economic class (Kezar 2003; 
Ortner 2010). As a graduate student, I recognized that I was not in the same economic class as 
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the individuals I interviewed and did not have the same amount of social prestige. However, I 
recognized that I had the potential to soon be in similar social structural positions as my 
interviewees and that the interviewees might recognize this. Further, the health care practitioners 
did not all have the same professional status since some of them were nurse practitioners and one 
was a physician’s assistant. The medical doctors were certainly more elite within this group, and 
the social statuses of the nurse practitioners and physician’s assistant were closer to mine. I use 
the term “elite” fully recognizing that it’s meaning is contingent on the social background and 
worldview of the person using the term. From the perspective of the ultra-rich, medical doctors 
may not be considered elite. Likewise, from the perspective of the working poor, a medical 
doctor could be considered elite. I was not privy to other elements of the interviewees’ lives 
beyond occupational role that may have increased or decreased their perceived social status. 
 Examined closely, there are several ways in which the researcher actually exercises 
power over the elite interview. Morris (2009) disputes the claim that researchers are powerless 
when interviewing elites, since they often control the questions asked during the interview, what 
is published, and the meanings contained therein. Interviewers may also be able to employ 
techniques of empowerment adopted from feminist research methodology to assist elites in 
transforming their views to begin a process of questioning power structures (Kezar 2003).  
 In the literature on interviewing elites, there is much concern expressed about gaining 
access to this often protected and private group of people (Gusterson 1997; Odendahl and Shaw 
2002; Ortner 2010). Both Gusterson (1997) and Ortner (2010) experienced such difficulty in 
their research and both innovated strategies to compensate for their inability to conduct 
participant-observation. As I did not conduct participant-observation, this type of access was not 
an issue; however, I did experience some obstacles to access due to the health care practitioners’ 
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busy and constantly changing schedules. Often interviews would need to be re-scheduled several 
times, and in one instance, a physician was not present at our agreed meeting time and place. 
Perhaps, these could be viewed as micro-expressions of power as it demonstrates the level of 
importance these participants gave to the research interview, though the health care practitioners 
seemed to have legitimately busy schedules and their work commitments undoubtedly took 
precedence over research interviews.  
 I found that in several of the interviews another type of access was denied to me—access 
to personal thoughts and perspectives. Kezer (2003) notes that elites often highlight the 
institutional perspective and bury their own personal views. Portions of the interviews I 
conducted tended to stay at a superficial level with the interviewee making statements about the 
approach to care their hospital or health care center offered. Sometimes it felt as though they 
were functioning as a public relations executive for their workplace by responding to questions 
about what they thought with answers that reflected the mission of their institution. Again, it 
could be considered a micro-expression of power to side-step a question about one’s personal 
thoughts by responding with institutional rhetoric. Fortunately, these were rare occurrences, and 
most of the interviewees were forthcoming with their thoughts about drug use, health, and health 
care.  
 The interviews I conducted with drug use research experts proceeded similarly in terms 
of power relations and institutional rhetoric. Like my interviews with health care practitioners, 
the gap in social status between myself and the interviewee was present in the character of the 
interview, though the gap may not have been that wide. As drug use researchers in the fields of 
sociology, anthropology, and public health these interviewees seemed interested in helping me 
with my project to understand the history of the “inject drug user” risk category. In some ways, 
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the interview relationship felt similar to a mentor/mentee relationship. In this way, the interviews 
diverged from those with health care practitioners, as this group was interested in drug users, but 
approached this interest from a medical perspective and perhaps saw me as a disciplinary 
outsider whose interest in drug users overlapped with theirs in some ways.  
MY RESEARCH PRACTICE 
 As mentioned earlier, the main modality of data collection for this project was in-depth 
interviews that I conducted with three different groups of people. In the following sub-sections, I 
will discuss these groups of people, how I recruited them and carried out interviews, and finally 
how I analyzed the data. The recruitment and interview of study participants proceeded at a 
steady pace throughout 2012 and 2013, and all together, I completed 57 interviews with 57 
unique individuals. Forty interviews were with people who inject drugs; thirteen with health care 
practitioners; and four with drug use research experts.  
Who I Interviewed 
 I was granted IRB approval to begin interviewing people who inject drugs and health care 
practitioners in late December 2011. Very quickly in early 2012, I connected with two health 
care practitioners through a local drug user organization and conducted interviews with them. 
Like eight other health care practitioners I would interview, these two practitioners provided 
primary care in affiliation with drug treatment. However, the care these two practitioners 
provided was in the context of a residential drug treatment program whereas the other health care 
practitioners either prescribed buprenorphine in the context of a primary care clinic, or 
methadone in a clinic where they also provided primary care to some clinic patients, or both. 
Thus, a majority of the health care practitioners I interviewed provided care for people who 
inject drugs because they work in affiliation with programs of drug treatment. Additionally, 
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seven of the thirteen health care practitioners devoted a portion of their professional time to 
various research endeavors broadly related to illness and disease, medicine, and substance use, 
which situates them in a field of knowledge consumption and production that undoubtedly 
shaped their perspectives and suggests they had thought extensively about the health of drug 
users. 
 Ten of the health care practitioners were medical doctors, two were nurse practitioners, 
and one was a physician’s assistant. They all currently provide care at various types of facilities 
in three of New York City’s boroughs—Manhattan, Brooklyn, and the Bronx.  The types of 
facilities include a residential drug treatment program, a methadone clinic, primary care clinics 
within hospitals, free-standing primary care clinics, clinics within community-based 
organizations, and community health care clinics. Some of the health care practitioners also held 
administrative positions at their hospital or clinic and taught medical school courses if they were 
affiliated with a teaching hospital. This indicated that they had devoted time to reflecting on the 
provision of health care.  
 The other group I interviewed was low-income people who were currently injecting 
drugs. This proved to be a diverse group of individuals ranging in age from 21 to 59 and with 
differing access to resources. Some were homeless at the time of our interview and staying in 
shelters, 24-hour internet cafes3, or couch surfing. Others were stably housed in their own 
apartments. All resided in New York City or in a nearby city in New Jersey. In terms of race and 
ethnicity, 18 of these participants were white, 6 were African American, 14 were Latino, 1 was 
multi-racial, 1 was Arab, and 1 refused to state race or ethnicity. About half of the interviewees 
had received some type of health care in the past six months, ranging from hospitalization to a 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3	  It was an interesting discovery to hear that some of the interviewees paid a small sum of money 
to be allowed by the proprietor of an internet café to sit at a computer desk over night and sleep.  
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regularly scheduled visit with their primary care physician. Several of the interviewees had not 
received any medical care in the recent past, but said that they had connections to a doctor or 
clinic. Several had received a medical check-up at their methadone clinic or through their 
homeless shelter. Thirty-three of the participants were recruited from and interviewed at a harm 
reduction center and had access to medical and social services, as well as syringe exchange, 
through the center, though that does not guarantee they were accessing these services. The harm 
reduction centers did not provide drug treatment. They mainly provided education and basic 
necessities to their clients. The education received by clients of harm reduction centers usually 
comes in the form of pamphlets, one-on-one counseling sessions, groups or training activities. 
Recruiting people who inject drugs from these centers meant that these individuals had been 
privy to some form of harm reduction education on the prevention of infectious disease. 
 In early 2013, I received IRB approval via a protocol amendment to interview four 
researchers who specialize in research on drug users and had been conducting research when the 
“injection drug user” risk category came into being. The main affiliation of two interviewees was 
a university, while the other two were mainly affiliated with a research institute. Since all four of 
these research participants elected to disclose their identity—this option was available on their 
consent form--I have described their research backgrounds and current work in the appendix. 
Recruitment 
 In trying to locate and recruit participants, I used one strategy for recruiting people who 
inject drugs and another for the health care practitioners and research experts. To recruit people 
who use drugs, I hung fliers at a research study field site many injectors frequented and two harm 
reduction centers. Interested parties where asked to call my cell phone number. Several 
interviews were set up this way, but the majority of interviews were set up when word spread at 
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the harm reduction center that I was conducting interviews and interested individuals would 
approach me on site.  
 One tool that seemed to be helpful in recruiting people who inject drugs was monetary 
compensation, though this practice is not without its ethical concerns. Going into the research, I 
assumed, based on past experience, that clients of the harm reduction centers, as well as the 
research field site, were accustomed to receiving at least $20 compensation for time spent in an 
interview. Monetary compensation raises concerns about voluntary participation since 
economically marginalized individuals may feel compelled to participate in the research. I am 
unsure if the participants felt this way. However, with the exception of two participants, I did not 
detect any reticence toward answering interview questions, and during the consent process I told 
each participant that they did not need to answer every question. Many of the interviewees 
seemed to enjoy telling me stories about their experiences and several thanked me for listening to 
them. With the two participants who gave short answers, I tried without success to build 
conversational rapport, but eventually gave up allowing the interview to end quickly.  
 Recruiting health care practitioners proved to be a much harder task. Initially, I attempted 
snowball sampling, but that only yielded one interview and then came to a standstill. A physician 
friend of mine tried to help recruit participants from her workplace, but that too fell through 
when her institution, in consultation with their legal department, disallowed hanging a 
recruitment flyer at their facilities. Finally, a colleague connected me to a physician researcher 
who provided me with links to two invaluable individuals. Ironically, neither of them were 
physicians, but they had both conducted qualitative interviews with health care practitioners in 
the past and were willing to connect me to potential interviewees. Over the next six months, I 
would correspond over email on a near daily basis with health care practitioners—sending them 
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information about my research, answering their questions, sending follow-up emails, and 
scheduling and re-scheduling interview times. I kept a chronicle of these recruitment efforts and 
below are notes from one attempt (which was ultimately successful) to recruit and interview a 
physician. Notably, this physician also held administrative responsibilities at his hospital, and 
thus had a professional assistant. 
 6/28/12 
 Emailed physician Phillip to see if he was interested in an interview. 
 7/16/12 
Phillip responded to my June 28th email. He can do a “focused” 30 minute interview in 
the fall. 
Heard from Phillip’s assistant about setting up the interview in late Sept. After a couple 
of emails we settle on Sept. 26. 
9/19/12 
Received an email from Phillip’s assistant asking if we can reschedule the interview for 
Oct. 2nd. I reply yes. 
9/26/12 
Received an email from Phillip’s assistant asking if we can reschedule the interview for 
Oct. 4th. I reply yes. 
10/4/12 
Interview Phillip. He was amiable and nice. 
It was not uncommon for a month or two to elapse between my initial email and the actual 
interview. In all, I attempted to recruit 20 health care practitioners. Six did not respond to 
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multiple emails and one replied that he does not come in contact with injecting patients. Thirteen 
health care practitioners were successfully interviewed. 
 In the interest of equality, I also offered compensation to the health care practitioner 
participants in the form of a $20 Amazon.com gift card. Knowing that I could not compensate 
them at the level they receive in their professional capacity4, I chose to offer the gift card as a 
token of my gratitude for their contribution to the study.  
 Recruitment of research experts was also conducted through the help of personal and 
professional connections. However, I personally knew two of the researchers I interviewed and 
encountered no difficulty recruiting them. The other two were recommended by colleagues. 
These interviews were shorter—averaging around 30 minutes. 
Conducting Interviews 
 The interviews I conducted with people who inject drugs took place in several different 
locations. The primary location was a private room at a harm reduction center. Six interviews 
were conducted in a private room at another research study field site, and two interviews took 
place at a donut shop at a table in the back corner. The interviews usually lasted about 45 
minutes, but some went for over an hour. As mentioned, most interviewees were quite 
forthcoming with their responses to my questions. During the consent process, when I told them 
they did not need to answer every question, there were many who said something like: “You can 
ask me anything. I am a very open person.”  
 The interviews with health care practitioners took place in the offices of the participants 
with the exception of three individuals. One opted to do the interview in a café near his hospital, 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
4	  I learned from one of the individuals, who connected me to health care practitioners and had 
conducted qualitative interviews with this group previously, that a compensation of $200 per 
interview was used.  
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and two chose to be interviewed in their homes. Most of the interviews lasted around 50 minutes, 
with the exception of Phillip’s “focused interview,” which was 25 minutes. For the most part, the 
interviewees identified with my interest in the health and health care of people who inject drugs 
and offered thoughtful responses to my questions. The third interview I conducted, which was 
with Christine, the medical director of a methadone clinic, presented an interesting, but at the 
time anxiety-producing, resistance to the framing of my research. This exchange occurred near 
the beginning of the interview after I had just started to ask her questions about health care for 
people who inject drugs: 
Christine: when I was looking over your stuff, I am sort of curious why this separation of 
people who inject drugs?  I see this as a very academically derived group because from 
the bottom I don't see that as a very distinct group. 
Kelly:  When I first started it had to do with who I thought was stigmatized the most. And 
then it's sort of grown through talking to my advisor and my committee to looking at the 
creation of this public health, epidemiological population of injection drug users and how 
that sort of moves within biomedicine so that's going to be a piece of my research which I 
didn't put in my description which is looking at the history of that label. 
Christine:  Yeah.  When you talk about a group of people who are stigmatized you 
probably want to talk about poor drug users. I mean there's huge overlap with those 
groups but... 
A couple minutes later I ask again about people who inject: 
Kelly:  Do you see common characteristics among the people, the injectors that you do 
see? 
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Christine:  I'm not even sure that I could sort out injectors from non-injectors.  I can't 
describe my patient population. They all have a history of opiate dependence and most of 
them have probably injected at one point or another but I don't see injectors as a separate 
group.  
Finally, after a series of questions about the identification of patients who inject and certain 
conversations she has when learning that patients inject, I still felt resistance to acknowledging 
injectors as a separate group. I decided to yield to her preference: 
Kelly:  Well I don't know, since you don't make that distinction...  I'm glad that you're 
putting that out there. You're pushing it. So I want to steer the questions to, I guess to not 
talking about injection drug users as a specific subset but just talking more about active 
drug users. 
Christine:  That's easier for me. I mean most of them are injection drug users but I don't... 
I'd say like seventy thirty maybe. Seventy percent have injected sometime probably and 
thirty percent haven't. I just couldn't say like if I think of ten of my actively using 
patients, I'm not sure I could identify ones who are sniffing versus injecting and I mean I 
could think of some of them. I don't see a huge distinction between them. 
These exchanges with Christine served as both a frustrating and revelatory moment in realizing 
that my specific research topic might seem irrelevant or incongruous to the experiences of the 
health care practitioners I would interview. I don’t believe Christine was attempting to 
destabilize the interview as a way to assert her power, as one of my colleagues suggested, but 
rather she seemed to be trying to help me better understand her on-the-ground experience with 
providing care to drug users. This interaction caused me to reflect on my choice to investigate 
this particular group of drug user and add questions to my interview guide that asked health care 
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practitioners about the relevancy of this categorization to their work. No other health care 
practitioners questioned my focus on people who use drugs by injection and several noted the 
specificities of this particular type of drug use.  
 The interviews conducted with research experts occurred in the offices of the researchers. 
Through these interviews, I was hoping to learn more about the productive effects of the 
“injection drug user” risk category. All four interviewees didn’t quite understand this concept 
when I stated it plainly, which was a point of frustration for me. However, after concluding the 
interviews and upon further reflection, I realized that the interviewees provided useful insights 
into the practices and effects of governance over people who inject drugs. Their contributions 
offered observations of how this group is defined through its label and whether the group has 
self-awareness.  
Data Analysis 
 Data transcription and analysis took place during the same period of time when 
interviews were conducted and several months after interviews concluded. I used the qualitative 
data analysis software HyperResearch to organize and code the interviews. In analyzing data, I 
looked at whether and how descriptions of drug user health included references to harm 
reduction strategies or concerns, as well as the disease model of addiction. I found that 
references to harm reduction were made by most participants, but the health care practitioners 
were the only ones who spoke about drug use as a disease. In my analysis of the interviews 
conducted with experts on drug use research, I had questions in mind about the governance of 
drug users. None of my analyses were based in the exploratory and productive goals of 
“grounded theory,” but rather I approached the analysis of data with particular questions in mind. 
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However, I did conduct open coding of all interviews so that I could be aware of recurring topics 
and interests among the participants. These may prove to be useful in future writing endeavors.  
ON BEING REFLEXIVE 
 As mentioned earlier, self-referential reflexivity is not without its criticisms. Among 
them are: concerns about the author’s stable representation of self and other; the use of others as 
a type of possession that enables a “self-telling” (Skeggs 2002); a lack of awareness toward the 
produced nature of subjectivities, both the author’s and the study participants’ (Walkerdine et al. 
2002); and collusion with the modernist goal to produce a more penetrating, rigorous, and 
foundational view (Macbeth 2001). However, despite these strong and warranted critiques, it still 
seems important to discuss where I fit within this project, though my position, assumptions, and 
perspectives were always shifting and contingent on context. Since I am the one who conducted 
and analyzed the interviews, and wrote manuscripts and other research products, I should make 
an accounting of my (shifting and contingent) positionings and beliefs. I do this as more of an 
ethical practice than as a way to signify that my research is more rigorous or “real” in its 
depiction of the health of people who inject drugs. That there are critiques of self-referential 
reflexivity does not permit the creation of an invisible author.  
 I entered the research field with certain assumptions about the people I would interview. I 
saw people who inject drugs as highly stigmatized, and thus often mistreated on an individual 
level and also at the level of social institutions. My sense from working with people who use 
illicit drugs for nearly five years prior to graduate school was that they felt great ambivalence 
about their drug use—receiving societal messages that they should stop, but feeling and knowing 
on some level that their drug use served a particular purpose in their life. This was my 
perspective—formed through and contingent on my past experiences. I intentionally adopted the 
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stance that drug use was neither wrong nor bad, but just something that people did. In this way, 
the mistreatment of drug users by health care practitioners was deeply troubling to me as was the 
apprehension drug users felt towards seeking care.  
I firmly believed when I started fieldwork that an antagonistic relationship existed 
between drug users and health care practitioners. This was based on my prior work experience 
with drug users and the many informal conversations I had with them about their experiences 
with receiving or attempting to receive health care. I attributed this difficult relationship to the 
normative aims and disciplinary practices of health care. A part of my assumption proved to be 
incorrect—very few antagonistic doctor-patient relationships were described to me. The health 
care practitioners I interviewed seemed very understanding toward the plight of low-income drug 
users and were concerned with the quality of health care their patients received. In fact, they 
worried about their drug-using patients’ interactions with other less sympathetic health care 
practitioners. Also disproving my assumption, many of the interviewees who inject drugs 
reported that they had a positive relationship with their health care provider, though they’d had 
bad experiences in the past. However, part of my assumption was at least partially correct—
power was at play in the provision of health care to people who inject drugs and within 
constructed notions of health, though it was less noticeably disciplinary and more soft or pastoral 
in nature. This will be taken up in more detail in chapter four. 
As mentioned, much of my orientation toward drug use and people who use illicit drugs 
was formed through several years of past experience working with drug users in New York 
City—first as a counselor at a methadone clinic and then as a research interviewer for a public 
health study on hepatitis C. In some ways, having lived a stable and privileged life as a middle 
class white person may have conditioned my interest in the outlaw and bohemian cultures 
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associated with drug use. My background may have also made harm reduction and syringe 
exchange more exciting or interesting. There is, indeed, a contingent of young, white, hip people 
involved in harm reduction programs and services. However, as my time as a harm reduction 
adherent and practitioner wore on, I became increasingly aware of the limited scope of 
intervention this approach offered. I was certainly interested in the health of drug users, but I felt 
there was a lot more going on than simply health. However, at the time, I didn’t have the 
vocabulary to name it. Graduate school and sociology would subsequently assist in providing 
schematics for a broader social analysis.  
My ability to tell this brief story linking my social background to my orientation toward 
the people I researched is a “self-telling” (Skeggs 2002) that relies on fixed notions of drug 
users, as well as the harm reduction movement. Neither the people nor the movement are stable 
and fixed, but in my mind, at various points in time, I produced generalizations about them that 
helped me understand how I got to be involved in this line of work and in this type of research. It 
is a story I told myself to help make meaning out of the trajectory of my interests. However, that 
story is about how I became interested in drug users and harm reduction. My enduring interest in 
this research field is less directly attached to romanticized notions of a drug use culture and has 
more to do with humanitarian concerns and an interest in the operations of power. An 
accumulation of sad and frustrating experiences with friends and colleagues who used drugs 
slowly worked to unsettle any notions of “cool” I had attached to drug use. As that happened, my 
studies and work in graduate school led me to understandings of power that ignited my interest 
and seemed to apply to the troubled relationship I perceived between drug users and health care. 
Thus, I shifted as my contexts shifted.  
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CONCLUSION: ON BEING EVERYWHERE AND NOWHERE 
 Where does this flexible approach to research and power leave me? Has it allowed me to 
avoid recognizing power asymmetries? My hope, of course, is that it has not. During fieldwork, I 
aimed to avoid coercion and exploitation as any good researcher would. In some ways, entering 
fieldwork with fixed, preconceived notions of what the power relations should or could be, and 
what the people will be like in thought and action, can be profoundly disrespectful. Assumptions 
that remain fixed can interfere with relationships, as well as the careful collection of data. I found 
myself interested in qualitative methods because of their flexibility and responsiveness to 
context. Similarly, in-depth interviews allowed for fluidity and an organization unique to the 
context of the interview (Paget 1983). In attempting to mimic natural conversations, in-depth 
interviews permit an openness that can occasion a reconfiguration of power relations.  
 In my interview practice, my attempts at reflexivity, and the presentation of data, I aimed 
to avoid a fixing of the study participants into stable subjectivities, even as I described the 
production of subjectivity enacted by medical and public health governance. While IRB 
application procedures may require the researcher to construct a category that flattens the 
multiplicities of participants, this does not mean the research must be carried out with this 
assumption of flatness. Further, the three principles of ethics the IRB guardians—beneficence, 
justice, and respect for people—provide for no practical advice when dealing with the messiness 
of the field. Again, fixed notions are not helpful. Even the concept of “do no harm” can be 
difficult to implement when there are many pathways of action, and the harm they may produce 
is unknown. Being reflexive about self and other in these micro-ethical instances is helpful, 
though reflexivity is a slippery concept. 
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 Doing reflexivity in fieldwork is generally recommended as preferential to merely being 
reflexive when composing research findings (Guillemin and Gillam 2004; Skeggs 2002). 
Positional reflexivity, where the author uses study participants in a “self-telling,” fixes at the 
same time as it produces the subjectivities of both researcher and researched (Skeggs 2002; 
Walkerdine et al. 2002). However, as I found, avoiding positional reflexivity due to these 
critiques serves to make the author invisible, which is not ethically sound. A reflexive accounting 
that recognizes the instability of subjectivity and the fluid (rather than fixed) operation of power 
works to address the critiques. This type of reflexive account resonates more soundly with my 
research experience. My assumptions shifted, my interview practices were fluid, power relations 
felt more interactional, and both my subjectivity and that of the interviewees could not be 
considered stable in any way. So, while this research project was surely conducted somewhere in 
the realm of people, power, discourse, and ideas, it is difficult to pinpoint the exact (fixed) 
location. 
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Chapter 3 
Who is the Injection Drug User?: The Intertwined Construction and Governance of an Emergent 
HIV/AIDS Risk Group 
 
 “Definitions of risk may serve to identify Self and Other, to apportion blame upon stigmatized 
minorities, or as a political weapon”. 
      Deborah Lupton (2013[1993]:489) 
 
 Previously considered a risk group for hepatitis B, the “intravenous drug abuser5” began 
to receive increasing interest from public health and medical researchers in the early 1980s. 
While researchers had long been interested in individuals who use illicit drugs and their cultural 
attributes and practices, those who inject their drugs came under particular focus at this time as a 
high rate of AIDS, as high as a 50% prevalence rate in some places (Des Jarlais et al. 1989), was 
documented among this group. Identified as an AIDS risk group by epidemiologists, the figure of 
the “intravenous drug abuser” was subsequently linked to various traits through numerous 
research studies and corresponding publications, and then submitted to behavior change 
interventions emanating from the state, as well as communities of people who use drugs. As 
public health researchers, as well as those of other disciplines, notably ethnographers with 
anthropology and sociology backgrounds, labored to understand how and why AIDS, and then 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
5	  A note about language: There have been several terms used in the scientific literature to label this risk group. The 
initial term that predominated was “intravenous drug abuser,” which was then changed in the late 1980s to 
“intravenous drug user” and very soon after to “injection drug user.” None of these changes were across the board; 
for example, some still use “intravenous drug user.” Recently, there has been a push among people who conduct 
research on injection drug use to use the term “people who inject drugs” because it represents people-centered 
language. In agreement with this change, I have attempted to use this language in my own writings, including this 
chapter. However, when writing about older research that used older terms, I use the terms employed by the authors 
and put them in quotes. Any inconsistency is a result of my own reticence to use older language. 
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later HIV, was spreading through drug using communities, they also actively constructed the 
meanings attached to a category of people who had not been so clearly defined previously. Since 
the social process of constructing this category was supported by the modernist rationalities of 
science, it was understood as a necessity, an obvious tool in the fight against AIDS. The path 
taken in constructing the figure of the person who injects drugs was determined in part by 
science, but also through acts of interpretation and morally-shaded concern. Much of this 
research can be linked to the desire to govern a newly emerged category of people who inspired 
concern and fear in the midst of a moral panic surrounding the AIDS epidemic. This chapter will 
in part focus on representations in research articles early in the AIDS epidemic (from 1984 to 
1988) that built the “injection drug user” (née “intravenous drug abuser”) and their connection to 
acts of governance over certain individuals and groups. The implementation of behavior change 
interventions aimed at this group, as well as efforts towards self-care, will also be examined as 
acts of governance. 
 This analysis shows how this risk category was created as an act of governmentality by a 
diffuse set of actors laboring under a concern for managing a population and the individuals it 
contains. The Foucauldian concept of governmentality aids in understanding how power is 
exercised at both the level of the population and the level of the individual. In governmentality, 
the sphere of the social is constituted by two types of power—policing at the population level 
and pastoral care at the level of the individual. These form the, “… double itinerary of a power 
that moves between managing social relations and governing individual conduct” (Orr 2010: 
549). The on-going construction of the figure of the person who injects drugs involves an 
intersection of these two types of power, as efforts are made to regulate the population and 
individuals are activated to participate in self-care.  
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The Foucauldian concept of bio-politics, which is a form of policing power that focuses 
on health and vitality, also guides this analysis as it seeks to understand how and why a category 
was created to manage the health of the population. As Foucault (1984) writes, beginning in the 
17th century, the exercise of power was reconfigured in the West such that it became “… bent on 
generating forces, making them grow, and ordering them, rather than . . . dedicated to impeding 
them, making them submit, or destroying them” (p. 259). This type of power is interested in the 
propagation of life, in managing life so that it can flourish. The fact of living enters the 
power/knowledge nexus, such that power over life is maintained through the production of 
knowledge of life processes, health, and disease. Foucault (1984) states, “… one would have to 
speak of bio-power to designate what brought life and its mechanisms into the realm of explicit 
calculations and made knowledge-power an agent of transformation of human life” (p. 265). The 
management of life through calculations reveals a historic shift away from reliance on faith and 
religion as authors of transformation. 
Regarding the construction of the injection drug user, as knowledge was produced about 
this type of drug user, more power could be exerted over this group to change their behaviors and 
on a deeper level, their subjectivity. Going a step further, the mere creation of this category and 
its attribution to certain individuals signifies a powerful process of differentiation whereby the 
individual is produced as distinct and deviant from an elusive “norm.” In examining Foucault’s 
genealogy of the modern individual as subject, Dreyfus and Rabinow (1982) write: “Foucault’s 
thesis is that sexuality was invented as an instrument-effect in the spread of bio-power” (p. 168). 
The invention of the injection drug user is both a way to serve the ongoing processes of bio-
power and an effect of it.  While there is no doubt about the importance of stemming the spread 
of HIV among people who use drugs, a biopolitical lens offers the analysis of the creation of this 
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risk category a way to examine the governmental, political, and managerial power infused in the 
activities of the science of public health and the population it created.  
An individualizing form of power theorized by Foucault also guides this analysis, as the 
figure of the person who injects drugs was not merely considered or analyzed at the level of 
population, but also on the individual level. Foucault’s notion of “technologies of the self” aids 
in understanding how power operates through permitting, “… individuals to effect by their own 
means or with the help of others a certain number of operations on their own bodies and souls, 
thoughts, conduct, and way of being, so as to transform themselves in order to attain a certain 
state of happiness, purity, wisdom, perfection, or immortality” (Foucault 1988: 18). Through 
pastoral acts of power, individuals understand themselves as certain types of subjects and 
manage themselves according to guidance provided by diffuse networks of power. Practices of 
self-care work to determine who the person is: “As there are different forms of care, there are 
different forms of self” (Foucault 1988: 22). Behavior change interventions aimed at people who 
inject drugs often engage individuals in their own self-care and management, while at the same 
time constructing their subject position or “who they are.”  
Pastoral power with its emphasis on self-care has an affinity with a neoliberal rationality 
of governance and its production of the self-activated, entrepreneurial subject. Provocations of 
self-care resonate with a neoliberal rationality which “. . . involves creating a sphere of freedom 
for subjects so that they are able to exercise a regulated autonomy” (Petersen 1997: 194). 
Neoliberal governance demands self-development within the context of the devolution of public 
welfare, which effectively “privatize[s] social inequalities” (Orr 2010:550). Pastoral and 
neoliberal forms of power become most relevant to those who inject drugs when considering 
self-advocacy and self-care movements that began in the mid-to-late 1980s.  
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 The analysis in this chapter is informed by an understanding of science as socially and 
culturally constructed. Simultaneous to the public health construction of the risk group of people 
who inject was the construction by the scientific community of AIDS and HIV, the disease and 
the virus. In her analysis of the battles fought over the scientific discovery and naming of the 
virus associated with AIDS (which eventually was called HIV), Treichler (1992) showed how 
scientists constructed the reality of the virus, showing that what is considered “real” is often the 
result of conflict between competing perspectives. In summarizing part of her argument as to 
how science is culturally constructed, Treichler (1992) states: “The point is that these data 
always engage with an already constructed perceptual and interpretive apparatus, albeit one 
designed to mitigate or erase its own effects (e.g., scientific method)” (p. 72-3). As with data 
collected on people who inject drugs, the findings must be understood as filtered through 
“perceptual and interpretive” apparatuses that have been constructed to understand results in 
ways that fit with prevailing logics. As Rosenberg (1989) asserts, the sociological study of 
epidemics offers a “cross-sectional perspective” that reveals the “continuing interaction among 
incident, perception, interpretation, and response” (p. 3). Understanding that science is a 
constructive process allows social and cultural analyses of the creation of “facts” or 
“populations” to reveal the workings of power, as well as the constructed-ness of “reality” 
(Knorr-Cetina 1981; Latour 1987).  
 To trace the construction and correspondent governance of the “injection drug user” in 
the scientific community, I reviewed the course of scientific publications about people who inject 
drugs from the early 1980s onward, looking at the meanings and concerns attached to this group. 
I carefully examined several highly-cited publications that appeared between 1984 and 1988 to 
get at what this group was coming to mean for public health researchers and how they proposed 
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to act upon it. Additionally, I interviewed four prominent public health researchers of drug use 
and AIDS/HIV in the New York City area to get their perspective on the construction of this risk 
category. Those interviews revealed insights about group awareness among people who inject 
drugs and the motivations behind transitions in the language used for the risk group label.  
The New Public Health 
 The creation of this risk category must be understood in the context of the prevailing 
paradigm in public health at the time. According to Petersen and Lupton (1996), the new public 
health emerged in the mid-1970s as new knowledges and practices that focused on health status, 
particularly that of the “population” and aspects of “lifestyle” conducive to ill health, began to 
proliferate (p. 15). The new public health has a broad reach since it takes as its foci the categories 
of “population” and “environment” in their widest sense, which allows it to stretch into 
psychological, social, and physical elements (Petersen and Lupton 1996:ix). Arriving at a time of 
economic and cultural neo-liberalism, which emphasizes individual freedom yet self-
responsibility, the new public health regulates at a distance by providing norms by which 
individuals are monitored and classified. In this way, it aims to persuade people to conform 
voluntarily to the goals of the state and other agencies (Petersen and Lupton 1996).  
 The field of epidemiology, as a modernist and rational method employed by the apparatus 
of the new public health, aims to identify, define, and manage public health “problems.” In doing 
so, epidemiology creates categories by which people are classified, which in turn, shapes the data 
collection. Petersen and Lupton (1996) quote Bloor (1995) to explain the self-fulfilling nature of 
category creation: “The ways of seeing that are endorsed by the adoption of particular 
classificatory schemes become themselves the basis for the everyday interpretative acts of those 
who compile and construct the statistical tables” (p. 40). In attempting to organize and contain 
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disorder, epidemiology creates categories such as “injection drug user.” This act of category 
creation installs a particular field of visibility, as well as certain practices of seeing and 
interpreting that self-perpetuate as data is presented and new data is collected. Commenting on 
the method of scientific classification mobilized by the field of epidemiology during the early 
years of the AIDS epidemic, Oppenheimer (1988) writes that it “defined the questions raised and 
thus answered.” Further, the ceaseless measurement, standardization, and comparison used by 
epidemiology to control disorder also works to contain disorder by clearly identifying social 
groups as being at-risk. In turn, such groups become “… reservoirs for shared anxieties and 
dreads on the part of majority groups, who are presented as members of ‘the public’ who require 
protection from ‘contaminating others’” (Petersen and Lupton 1996:56). A concern for 
containing AIDS/HIV within the community of people who inject drugs, and thus not allowing it 
to escape from that group and infect others, is apparent in popular scientific literature and will be 
shown later in this chapter. Understanding current practices and activities of the new public 
health, such as its regulation-at-a-distance and reliance on epidemiological measurement and 
categorization, offers context for recognizing the construction of the “injection drug user” risk 
group in the public health imaginary of the 1980s. Re-visioning this group as a socially 
constructed category in 1980 offers a penetrating reflection, in the mode of a Foucauldian-style 
genealogy, on the constructive acts of power, as it literally brings certain subjects into being on 
both a discursive and material level.  
Risk Groups 
 The epidemiological concept of “risk group” has been vital to predominant 
understandings of HIV/AIDS transmission from the early days of the epidemic onward.  
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The popularization of the concept of AIDS risk groups was made possible by efforts initiated 
early-on by the Centers for Disease Control (CDC) to identify subgroups at risk for AIDS. The 
CDC feared that since homosexual and bisexual males were such a large proportion of AIDS 
cases, dynamics of transmission in this group would overshadow those of other groups unless the 
data were examined separately (Glick Schiller, Crystal, and Lewellen 1994; citing Centers for 
Disease Control 1989). The CDC constructed a highly-criticized hierarchy of exposure 
categories that was used when AIDS cases were reported to local registries. This strategy served 
to obscure modes of exposure by assuming that if homosexual sex or injection drug use were 
reported, then that was the mode of transmission. There was no consideration for the HIV status 
of the person’s partner(s) in sex and drug use, nor, if the person had injected drugs, whether 
he/she shared needles (Glick Schiller et al. 1994; citing Schoepf 1991). Glick Schiller et al. 
(1994) assert that: “The end result of the logic of classification utilized by the CDC was that, in 
the United States and industrialized nations, anyone who was gay or who used intravenous drugs 
became identified as a member of a risk group, whether or not he or she engaged in behavior that 
transmitted HIV” (p. 1338). Further, the CDC classification system obscured the fact that semen 
and blood transmit the virus—not sexual orientation and the use of drugs (Glick Schiller et al. 
1994). Since prior to 1984 no microbe had been isolated as the etiologic cause of AIDS, and thus 
being part of an AIDS risk group was equated with being a carrier of the disease (Oppenheimer 
1988). 
 Another concern with the creation of AIDS risk groups is that they have led to the 
fabrication of what are believed to be pathologic subcultures. In trying to understand the 
transmission of AIDS among people who used injection drugs, the federal government funded 
ethnographic study of this risk group after a significant push from the social science community 
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to do so. The cultural analysis of this group resulted in the production of language and imagery 
that further exoticized, stereotyped, and isolated an already highly stigmatized sector of society 
(Kane and Mason 1992) and produced the notion that HIV risk is confined to only marginalized 
sectors of the U.S. population (Glick Schiller et al. 1994). Noting the social processes of 
differentiation associated with the concept of an epidemic, Berlant (2010) states: “… we learned 
most recently from AIDS, after all, that the epidemic concept is not a neutral description, but 
always a contribution to ongoing mechanisms of social distinction. Who's degenerate, who's 
competent, and who's out of and in control?" (p. 31). In fact moral attribution has historically 
been a component of a society’s attempt to understand the randomness of an epidemic. In 
analyzing the episodic quality of epidemics, Rosenberg (1989) found that: “Men and women 
have often expressed moral convictions as they have sought to explain and rationalize epidemics, 
but such values have ordinarily been articulated in terms of those mundane biological processes 
that ordinarily result in sickness or health” (p. 5). The concept of an epidemic renders the 
expression of moral values, which may be articulated through social differentiation, the 
appearance of natural-ness.  
Problematically, culture was represented in early research on people who inject drugs as a 
natural descriptor, such as age or sex, by which populations could be divided into bounded 
subgroups, which facilitated the partition and marginalization of this group (Glick Schiller et al. 
1994). The categorization by risk group also served to obscure the within-group diversity, which 
was found by Glick Schiller et al. (1994) to be much greater than the differences between 
members of the risk group and individuals outside of it. By focusing on the behavioral practices 
and so-called culture of this group, researchers failed to account for the production of risk by the 
law, poverty, and social stigmatization (Kane and Mason 1992). The AIDS risk group led to the 
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manufacture of a subculture that was found at fault for its pathologic practices and further 
pushed to the margins. Later in this chapter, I will discuss a rift between researchers over the 
attribution of cultural traits to the IDU risk group.  
Ironically, it was through recognition by the CDC that people who inject drugs were also 
at risk for AIDS, that the lifestyle model of analysis, which hinged on the moralistic notion of 
promiscuity, was dropped in favor of the hepatitis B analogy (Oppenheimer 1988). Under the 
hepatitis B analogy the transmission of AIDS was re-understood as related to a biological agent 
whose vector was blood and/or its constituents. However, lifestyle factors could still be 
incorporated into explanations for transmission, though to a lesser degree (Oppenheimer 1988). 
ACTS OF CONSTRUCTION AND GOVERNANCE 
 My aim in this section is to closely follow the figure of the “intravenous drug user” 
through the early days of the AIDS epidemic from 1984 to 1988, and then give an overview of 
the continuing social construction and governance of this figure from 1989 to the present. I will 
accomplish this by conducting an analysis of five acts of construction and governance 
represented in popular research publications that focus on injection drug use, as well as literature 
that addresses the progression of the HIV/AIDS epidemic and interviews with prominent public 
health researchers of drug use. I’ve identified five groupings of constructive and governmental 
acts that loosely flow chronologically, but are not completely mutually exclusive: 1.) suspicion 
and concerns; 2.) surveillance and differentiation; 3.) behavior change and self-activation; 4.) 
sociological intervention; and 5.) the expansion of power. As Rosenberg (1989) asserts, the 
negotiated public responses to epidemics have historically provided social scientists with insight 
into social values at particular times, as well as structures of authority and belief. Following the 
construction of this risk group offers the opportunity to glimpse popular values and beliefs, and 
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their connection to new technologies of managing public health as revealed through responses to 
the AIDS epidemic.   
 Notably, there are historical patterns to how epidemics and their social response proceed. 
Rosenberg (1989) likens the progression of epidemics to acts of a play owing to the fact that he 
sees epidemics as taking on the quality of a pageant, “… mobilizing communities to act out 
proprietary rituals that incorporate and reaffirm fundamental social values and modes of 
understanding” (p. 2). This resonates with the understanding discussed earlier that the practices 
and assertions of science, public health science included, reveal hegemonic styles of 
interpretation, as well as social values. The “proprietary rituals” mentioned by Rosenberg can be 
understood as the epidemiological response to AIDS and the way research on IDUs proceeded. 
These both reveal dominant structures of thought and feeling (Williams 1977) that created and 
facilitated the social and public response to AIDS.  
 Recently, Des Jarlais, Arasteh, and Friedman (2011) published a brief historical account 
of HIV among people who use drugs at Beth Israel Medical Center in New York City over the 
previous 25 years. Their historicization relied on a different method of organization that hinged 
on disease prevalence and transmission rates. In tracing the epidemic among “injection drug 
users” from the mid-1970s through the early 2000s, they believe the epidemic can best be 
described in four successive stages—introduction and rapid transmission (1978-1983), 
stabilization of HIV prevalence at high levels (mid-80s through mid-90s), decline in incidence 
and prevalence following the arrival of syringe exchange programs (mid-90s through early-to-
mid-2000s), and a phase where sexual transmission is more important than injecting-related 
transmission among IDUs (mid-2000s to the present) (Des Jarlais et al. 2011: 131). As this 
chapter follows the public health literature on HIV/AIDS and people who inject drugs, this 
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construction of history will be engaged along with other research articles by Des Jarlais and 
Friedman since they both were and are influential researchers in this relatively small field of 
knowledge production.  
Suspicions and Concerns (late 1970s-1985) 
 Several years before the CDC officially released its 1981 report on what was to become 
known as the AIDS epidemic, substance abuse researcher Don Des Jarlais and his colleagues at 
the New York State Division of Substance Abuse Services, including a group of former drug 
users called the Street Research Unit who monitored drug use and sales for the state, noticed an 
increase in pneumonia deaths among people who use drugs (Des Jarlais 2009). People who use 
drugs had long been the subject of social science and public health research, and those who inject 
drugs (then referred to as “intravenous drug abusers” or “intravenous drug users”) had been 
traditionally considered a “subculture” within anthropological and sociological research (Des 
Jarlais, Friedman, and Strug 1986; Singer 2012). Much of the early sociological and 
anthropological literature on drug use was not focused on or organized around certain ways of 
administering drugs, but rather tended to focus on a particular drug or simply on “addicts” (e.g., 
Agar 1973; Becker 1963; Feldman 1976; Preble and Casey 1976). A more explicit focus on those 
who inject drugs is an artifact of the AIDS epidemic.  
 Using its risk group schematic, the CDC reported the first cases of AIDS among people 
who inject drugs in late 1981. The risk group organizational principle introduced more fully by 
the CDC in 1983 (Oppenheimer 1988) served to make order out of the disorder generated by this 
new disease. It seems to have achieved a fixed stability at this time as much, if not all, of the 
literature to follow utilizes it. This risk categorization continues to be used today in research 
literature reminding us that when supported by hegemonic systems of rationalization, which 
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themselves may be undergirded by “stories,” there can be a “hardening of the categories” 
(Haraway 1997:139; citing Watson-Verran 1994). Samuel (Sam) Friedman6, a long-time 
researcher at the National Development and Research Institutes (NDRI), attested: “When I 
started, when I got my job [in 1983] we were studying that group. It was already all set up.” By 
about 1983, there was indication that people who use drugs knew about this new disease and had 
some sense that it was spread through needles. Prior to AIDS, those who injected drugs had 
known that hepatitis B could be spread through sharing needles, and thus they extrapolated this 
to the new ailment going around, which many referred to as “walking pneumonia” (Des Jarlais 
2009; Des Jarlais, Friedman, and Hopkins 1985). Well before AIDS, researchers showed that 
those who injected cohered as a group within drug using culture and may have formed something 
of a subculture, which included communicating with each other about illness (Des Jarlais et al. 
1986). 
In 1984 and 1985, the virus that causes AIDS, then referred to by two names as the result 
of conflict in the scientific community—lymphadenopathy-associated virus and human T-cell 
lymphotrophic virus type III (LAV/HTLV-III)—had been isolated and the anti-body test 
developed. This led to the discovery that at least half of the injection drug users in New York 
City were infected with the virus (Des Jarlais et al. 2011). Prior to this discovery, 
epidemiologists who were studying AIDS had not researched drug users because they believed 
there was a relatively small number of research subjects available (Oppenheimer 1988). This was 
proved incorrect by the anti-body test. Researchers were also reluctant to study drug users before 
1984 due to a feeling also reflected in the attitudes of society at large, “that addicts are of less 
social consequence than other patients” (Oppenheimer 1988; citing Schultz 1987). 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
6	  See Appendix for professional profiles of the four researchers interviewed for this chapter. 
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 In medical, social science, and public health academic literature on AIDS, this risk group 
began to cohere around 1984 and was identified as “intravenous drug users,” a label that had 
been previously used in medical literature documenting particular medical conditions among this 
group. One of the more popular research articles that focused on AIDS and people who use drugs 
in 1984 came from a group of researchers affiliated with the New York University School of 
Medicine, and also included Des Jarlais and Friedman as authors. Michael Marmor, Ph.D., an 
epidemiologist was first author of the article, which was published in the first volume of the 
Journal of Substance Abuse Treatment7. In correspondence with the journal title, the article 
focused on “drug abusers,” which is emblematic of both the current language in use and the 
moral attribution of people who use drugs at that time. The article proposes the suspicion that 
AIDS is spread among drug abusers “presumably” by the transmission of the virus via sharing 
needles, works (drug injection equipment such as cookers), and drug-containing solutions 
(Marmor et al. 1984:237). The article also plays a role in the initiation of a refrain heard in many 
research articles to follow: that AIDS can be spread from IV drug abusers through sex and 
perinatal transmission. This claim constructs the person who injects drugs as a vector in the 
spread of AIDS and also points to the necessity of containing the virus within this group.  
 Another article published in 1984 by Harold M. Ginzburg, a psychiatrist and an associate 
director in the Division of Clinical Research at the National Institute of Drug Abuse (NIDA), 
uses the term “intravenous drug user” and worries about the “… occasional recreational drug 
user who shares a needle and syringe when he or she self-administers cocaine or amphetamines 
at a party on the weekend” (1984:206). In fact, Ginzburg (1984) voices a variety of concerns 
with respect to “intravenous drug users” and AIDS ranging from their possible infection of drug 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
7	  The shared timing of the first volume of this journal and the appearance of “intravenous drug 
users” in research literature on AIDS appears to be coincidental. 
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treatment program staff to their lack of organized advocacy to the diversity of this group 
impeding prevention efforts. Voicing another concern, Ginzberg (1984) states: “Because the 
drug-abusing community is poorly defined and services to it are typically provided by a 
potpourri of resources, containment of AIDS among this group becomes a serious public health 
issue” (p. 207). Similar to Marmor and his colleagues (1984), people who inject drugs are 
described as drug-abusing, which again reveals the moralistic shading of the risk group. The 
issue of containment is also raised, which positions the “intravenous drug user” as a threatening 
figure that must be bounded. Finally, similar to Marmor and colleagues (1984), Ginzberg (1984) 
makes a preliminary claim about the significance of sharing needles in the transmission of AIDS, 
which shows that researchers were not yet completely convinced that sharing needles was a 
mode of transmission.  
 Containment was raised again in an article published in 1985 by Des Jarlais, Friedman, 
and Hopkins in the Annals of Internal Medicine. The authors state that “intravenous drug users” 
(the label used in this article) are a “bridge” for the transmission of AIDS to other groups, most 
notably children and heterosexual partners (p. 98). As two socially-sanctioned groups, children 
and heterosexuals are positioned as the innocent victims of the socially-maligned “intravenous 
drug user.” Furthermore, this claim enacts a partition between the “intravenous drug user” and 
heterosexuals and children, effectively keeping this type of drug user distinct from those two 
(supposedly) non-infectious groups. However, Des Jarlais, Friedman, and Hopkins (1985) show 
concern for the plight of the person who injects drug and say as much: “Public health control of 
the AIDS epidemic must include control within the intravenous drug use group, because of both 
the large numbers of intravenous drug users at risk and the possibility of outward spread to 
nondrug users” (p. 756). Notably, this article explicitly shows concern for people who inject 
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drugs and works actively to dispel negative stereotypes about them, which in turn works to 
construct who this drug user is. Firstly, the authors worry that “intravenous drug users” may be 
impeded from recognizing AIDS as a health risk because it is difficult to distinguish between 
AIDS as the cause of death and other causes of death in this group. IV-drug users may 
experience AIDS-related symptoms simply from the travails of drug use, and thus may not 
recognize that they have the early signs of AIDS. Secondly, Des Jarlais, Friedman, and Hopkins 
(1985) use research they conducted through the Street Research Unit to show that “intravenous 
drug users” are capable of changing their behavior and concerned about their health. Des Jarlais 
and Friedman repeat this assertion elsewhere (Friedman, Des Jarlais, and Sotheran 1986; Des 
Jarlais 2009) and in doing so reveal an effort to counteract de-humanizing assumptions about 
people who inject drugs and to reformulate the predominant image of this group within research 
circles. Through their policy oriented research, Des Jarlais and Friedman endeavor to education 
readers about the relevant characteristics and behaviors of IV-drug users and advocate for their 
protection from AIDS. 
 The research articles during this time of concern and suspicion show the early stirrings of 
governmentality as the researchers and authors begin to suspect that the sharing of needles 
transmits the new virus, and thus reveal nascent ideas about pathways of intervention. Further, 
the researchers begin to enact a boundary around this group of individuals by expressing the 
need to contain the virus. Ginzberg (1984) issues a call for a more precise construction of the risk 
group when he says that it is “poorly defined” (p. 207). A clearer picture of the parameters and 
characteristics of this risk group will facilitate efforts to manage its members’ behaviors. To the 
mounting concerns over how to implement prevention programs, Des Jarlais, Friedman, and 
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Hopkins (1985) add that “intravenous drug users” seem to be conducive to and capable of 
changing their behavior in the name of health. 
Surveillance and Differentiation (1986 and onward)  
 For the figure of the “intravenous drug user,” 1986 brought the publication of research 
articles based on ethnographic surveillance of cultural attributes of this group. As Campbell and 
Shaw (2008) write: “Ethnographic drug research has been a central discourse through which the 
construction of identity categories has metamorphosed into the IDU subject position” (p. 707). 
Friedman and Des Jarlais, along with collaborators, published two articles, which aimed to 
describe the culture of intravenous drug use in order to understand why and in what contexts 
needles were shared. Friedman, Des Jarlais, and Sotheran (1986) described the characteristics of 
this “subculture” as a way to propose effective methods of health education for this group. They 
explicitly state that “IV drug users” (the term they use) are not ensconced in a pathological 
culture, but rather one that provides them with rewards. They describe the attributes of this 
subculture as mistrust, violence, oral communication, and difficulties in reading and writing 
(Friedman, Des Jarlais, and Sotheran 1986: 385). Further, needle sharing is deeply embedded in 
this culture and serves social bonding and economic functions (Friedman et al. 1986). An article 
published by Des Jarlais, Friedman, and Strug (1986) in an edited collection on the social 
dimensions of AIDS delves further into explanations for sharing needles. They see it as a 
ritualistic part of the initiation into drug injection, a necessity and way of demonstrating trust 
between sexual partners or friends (i.e., running partners), and an economic and utilitarian 
exchange in shooting galleries where drugs can be injected with less fear of police interruption. It 
appears that this early exploration of “sharing,” a behavior not well-understood, was primarily 
based on interview material rather than direct observation (Page and Singer 2010:72).  
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Both articles point out that the entrenchment of these cultural attributes and practices of 
“intravenous drug users” is such that behavioral change among this group will be difficult. For 
instance, refusing to share needles could endanger personal relationships that people who use 
drugs need to survive (Des Jarlais, Friedman, and Strug 1986; Friedman et al. 1986). The cultural 
traits, though deemed not pathological by the authors, are practices that are widely stigmatized 
(Stoller 1998). Further, by showing the IV drug user culture as generative of risk, the authors 
present a degree of hopelessness for change and fail to recognize that external social and 
economic factors shape risky behavior (Clatts 1994; Schiller Glick, Crystal, and Lewellen 1994). 
In fact, cultural representations of needle sharing as ritualistic bonding among people who inject 
drugs were used at least as a partial excuse by the federal government for not supporting needle 
exchange or distribution programs (Stoller 1998:98). Stoller reports: “It seems that people at the 
CDC believed (or said they believed) that even if you gave junkies clean needles they would still 
share” (p. 98).  
 Showing a crack in the on-going scientific construction of the association between drug 
use and AIDS, an article appeared in 1986 that questioned the hegemonic focus on needle 
sharing as the main risk factor for AIDS. Brown et al. (1986) hypothesized that the overall 
physical experience of drug abuse (not just injection drug use, but all types of “abuse”) could 
cause immunologic aberrancies that put one at increased risk for developing AIDS. In fact, in the 
late 1980s and early 1990s, controversy arose over the attribution of HIV to AIDS. A prominent 
molecular biologist at the University of California at Berkeley and a member of the National 
Academy of Sciences, Peter Duesberg, asserted that HIV was one of many viral infections of 
AIDS patients, rather than the cause of AIDS. Instead, Duesberg hypothesized that the AIDS 
epidemic was attributable to long-term consumption of recreational drugs, as well as the toxic 
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effects of AZT (Epstein 1996; citing Duesberg 1987). This focus on the drug user lifestyle is 
emblematic of new public health approaches that highlight the association between lifestyle and 
ill-health (Petersen and Lupton 1996). With their lack of specificity, the hypotheses of Brown et 
al. (1986) and Duesberg (1987) reveal a wholesale stigmatization of people who use drugs rather 
than the more targeted approach of researchers who constructed representations of the culture of 
needle sharing.  
However, these articles all work to differentiate and then malign the lifestyle and culture 
of drug users by directly connecting it to the acquisition of AIDS. Through surveillance of 
intravenous drug users, Des Jarlais, Friedman, Strug, and Sotheran make claims about the 
peculiarities of the culture they enact, a culture that in many cases runs counter to the logics of 
mainstream culture. Specifying that it is the culture, or in the case of Brown et al. (1986) the 
lifestyle of drug use, that promotes transmission of the virus opens a surface upon which 
interventions can spread, a surface upon which power can play. 
Although on-going throughout the 1980s and 1990s, and thus concurrent with other acts 
of construction and governance, changes made to the language used in the risk category label 
exhibit an emphasis on precise differentiation of this emerging public health population. All of 
the researchers interviewed acknowledged transitions in terminology for naming this risk group, 
but placed differing levels and kinds of significance on the terminology. As Sam and Brian 
Edlin, a physician-researcher at NDRI who conducts research on hepatitis C and people who 
inject drugs, explain the initial name for the group involved the term abuse. Brian: “… when I 
was in my medical training [in the early ‘80s] we used the term IVDA, which stood for 
intravenous drug abuser.” Sam: “When I came in ’83 everyone was talking about, to the extent 
they talked about it at all, was intravenous substance abusers, sometimes abbreviated IVSA, or 
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intravenous drug abusers; always abuser, abuser, abuser.” Noticing this convention when he 
began working with Don Des Jarlais in 1983, Sam felt compelled to push toward changing the 
term to “intravenous drug user” or IVDU. He explains how he did this: “So when I first got here 
and was working on papers Don would write or some of our colleagues on the project, I’d keep 
writing notes saying, ‘We can’t use that terminology. No one thinks of themselves as an abuser. 
It’s totally misleading in every respect because it’s the injection that’s the risk. It’s got nothing to 
do with use or abuse.’” Both Brian and Sherry Deren, a researcher of injection drug use at New 
York University, noted that when NIDA put out its large funding initiative to support research 
into drug injection and HIV/AIDS, the federal institute used the term “injection drug user.” 
Sherry explained: “I think that’s part of what defines it because people start using that in writing 
their proposals and in writing their papers.” When Brian arrived at the CDC in 1989, they were 
in the process of changing the term from IVDA to IVDU. He explained, 
… from the epidemiologic and public health standpoint, in other words the CDC 
standpoint, we were interested in talking about behavior. We were not interested in 
judging or characterizing behavior. We weren’t even interested in treating addiction. We 
were a public health agency and we were interested in doing epidemiology. So 
epidemiologists want to use terms that are as neutral and descriptive and precise as 
possible. So these were people who were using drugs whether they were abusing or not 
was baggage we didn’t want to bring into the terminology that we use. So it would be 
intravenous drug user.  
The concern for neutrality also appeared in Sam’s description of the transition from abuser to 
user, though he sites different origins: “That comes out of my radical past. That came out of 
simple concepts and crude mainline sociology that in some ways I disagree with, which is value 
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neutrality.” Sam put his past training in sociology, as well as his radical beliefs, into practice by 
fighting for the term “user,” which has a more neutral signification.  
All of the researchers brought up precision or accuracy as a reason for the transition from 
“intravenous drug user” to “injection drug user.” Injectors were not always shooting substances 
directly into their veins. In explaining this transition, Brian said it was due in part to the 
recognition that people on the west coast were skin popping (or shooting under the skin rather 
than into a vein) black tar heroin.  
De-stigmatization also played and continues to play a role in the language transitions that 
accompany this risk category from the 1980s until now. By de-stigmatizing or neutralizing the 
label, prevention efforts could be made more palatable to recipients, as well as attain scientific 
accuracy. When discussing the early use of the term “intravenous drug abuser,” Sam stated: “It’s 
both stigmatizing and inaccurate scientifically because it’s not what we’re talking about and as a 
prevention tool, totally puts people off, so how can you use it?” As Brian stated earlier, the abuse 
of drugs was not being studied as a factor contributing to HIV transmission so it was “inaccurate 
scientifically” to use that term. Further, as Sam explained, using the term abuser when 
interacting with people who inject drugs as part of prevention efforts “totally puts people off.”  
These risk group language games were played in the name of de-stigmatization, 
neutrality, and accuracy and serve to further differentiate the group of individuals who were the 
target of HIV/AIDS prevention campaigns. Precise differentiation constructs subject positions 
that are both ready for and malleable to governance.  
Behavior Change and Self-Activation (1987-1988) 
 On March 12th of 1987 the first meeting of the AIDS Coalition to Unleash Power (ACT-
UP) took place. This activist group was, at least initially, dominated by the concerns of middle-
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class gay men, as that group had been hit very hard by AIDS and had the resources to form a 
powerful coalition (Patton 1990). That same year, Friedman, Des Jarlais, Sotheran, Garber, 
Cohen, and Smith (1987) published what was to become a very popular article that examined the 
possibilities for self-organization among “intravenous drug users” (the term they used). They 
compared the developing efforts among “intravenous drug users” to inject more safely to the 
more widespread attempts by the gay community to protect themselves from HIV, asserting that 
the gay community had achieved more risk-reduction behavior change than “intravenous drug 
users.” Finding that “intravenous drug users” are more likely to protect themselves (i.e., refuse to 
share needles) if their friends and acquaintances do, Friedman et al. (1987) suggested that 
collective self-organization could develop peer support for risk reduction. However, they noted 
serious obstacles to this self-organization on the individual, group, and societal levels. On the 
individual level, addiction exhausts time and energy, and poverty limits access to resources. On 
the group level, the obstacles involve the predatory social relationships of the drug market, which 
result in mistrust and a lack of solidarity. On the societal level, the obstacles are legal repression 
and stigma, including a hostile press and public. Despite this, Friedman et al. (1987) reported 
that a group of people who formerly used drugs had formed in New York. Calling themselves the 
Association for Drug Abuse Prevention and Treatment, or ADAPT, this group, which was non-
judgmental toward people actively using drugs, worked to address the problems of AIDS among 
people who use drugs. 
 Friedman et al.’s (1987) article presented a further delineated picture of the “intravenous 
drug user” as concerned about his/her health. In this new rendering, the “intravenous drug user” 
may also be civically-minded, or at least the members of ADAPT were. Adhering to neoliberal 
cultural rationalities, many of the practices of the new public health have to do with a widespread 
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tendency to establish links between personal goals and “the public good” (Petersen 1997: 203). 
The obstacles to self-organization presented, while appealing to the reality of coalition 
formation, also work to form the image of the “intravenous drug user.” However, more salient at 
this moment in time may have been a shift in the discourse that revealed support for the efforts of 
people who use drugs to protect themselves from infection (Stoler 1998:100). Under the new 
public health, as well as neoliberal rationalities, health promoters, such as Friedman and 
colleagues, see themselves as working from a distance to forge collaborative ventures and 
promote community action (Petersen 1997). By supporting and collaborating with current and 
former drug users, researchers could spur self-governance among this group. Through the 
interplay of research activities and grassroots actions, the image of the activist “intravenous drug 
user” was beginning to form.  
Around this time, syringe exchange programs were beginning to legally open in the cities 
of Tacoma, Washington in 1988, San Francisco also in 1988, Portland, Oregon in 1989, and New 
York City in 1992 after the brief appearance of a legal syringe exchange in 1988 (Lane et al. 
1993). These exchanges were being organized by the voluntary efforts of people who currently 
and formerly injected drugs, activists, researchers, and other advocates. In representations of the 
figure of the “injection drug user” in research publications, as well as reports and news coverage 
of the newly opened syringe exchanges, the emerging discourse of the “injection drug user” as an 
active participant in self-care and advocacy appeared (Stoller 1998). People who inject drugs 
were forming legally sanctioned organizations to protect themselves. In this mode of activity, 
they were not docile bodies being molded through outside disciplinary forces, but rather a group 
that had organized itself and provided the means for their own behavioral change.  
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On the subject of group awareness and the formation of a community among people who 
inject drugs during this time of self-activation, some disagreement emerged among the 
researchers interviewed. Ric Curtis, a Professor of Anthropology at John Jay College of Criminal 
Justice who conducts research on drug users, felt that researchers had no impact on the formation 
of this group. He states: “I don’t think the presence of the researchers led to any more or any less 
community among the community of injectors. I don’t think our presence would have made that 
much difference, to tell you the truth.” Furthermore, Ric is doubtful as to the existence of any 
significant amount of self-identification among people who inject: 
I don’t think anybody necessarily wants to have their primary identity as that of an 
injecting drug user. I mean, who wants to self-identify as that? “I’m a man first,” you 
know what I’m saying? So no one would ever identify in that fashion first and foremost 
as an injection drug user unless they were looking for something specifically related to 
that. Like, “I’m an injection drug user. Can I get that free bag of dope that you’re 
offering?”  
Ric further explained that drug dealers might advertise their product by giving a free bag of dope 
to an injector who is more “the real deal” than a sniffer, because this person would subsequently 
advertise the product to other users. In this instance, a person who injects drugs might identify as 
such, but otherwise he or she would not want to take on this identity. Ric’s observation that 
people will identify as an “injection drug user” in very limited circumstances casts doubt over 
claims about self-organization among people who inject drugs. 
 However, Sam’s take on group awareness and self-organization was quite different. 
Discussing his activist work beginning in the mid-1980s with self-organization among people 
who use drugs, Sam showed that there was group awareness: 
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Meanwhile in terms of the self-concept of drug users and drug user organizing, that has a 
long history, some of it before I came on the scene. There was the NAMA group, 
National Association of Methadone Advocates, and also an early version of ADAPT 
(Association for Drug Abuse Prevention and Treatment). It all started before I came 
around. Now, in ’85 a group of us kind of re-created ADAPT to focus on AIDS. And 
through various AIDS meetings and harm reduction meetings, once they started to 
happen, and syringe exchange conventions, we had meetings to set up U.S. users groups 
in coalition. Now, it was slow, disorganized. Part of the problem was some of the U.S. 
user groups had to hide the fact that they were users groups because they were publicly 
out as other things. This was high tide in the war on drugs so it created some difficulties. 
We had meetings, various kinds of other meetings in the U.S. trying to organize them. 
In Sam’s depiction, people who use drug were making attempts to organize themselves along 
with the help of other advocates, such as Sam, revealing their group awareness and showing that 
this risk group category did not only exist in the minds of researchers, but also, materialized in 
activist efforts to address the spread of AIDS. 
Around the same time as the beginnings of self-organization among people who inject 
drugs, the federal government provided wide-scale funding to support research that investigated 
HIV among people who inject drugs, using a variety of research methods, including 
ethnography, surveys, and intervention trials. While the National Institutes of Health (NIH) had 
supported four research centers in 1986, between 1987 and 1988, forty-one projects in sixty-
three different sites were funded. A study model was designed called the National AIDS 
Demonstration Research (NADR) project, which involved initial research by ethnographers to 
establish contact with networks of “injection drug users” (the term used by federal funders) and 
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then assignment of willing research participants into enhanced or standard-of-care risk reduction 
interventions. The findings of this research were mixed, with some support for the enhanced 
intervention (Page and Singer 2010). Mostly, this research was fixated on why people who inject 
drugs share needles and how to prevent them from doing so.  
 Popular publications that came out in 1988 focused on behavior change, particularly in 
terms of needle use, among people who inject drugs. Des Jarlais and Friedman (1988) published 
an article that proposed a theoretical framework to be used in designing new AIDS prevention 
programs for “intravenous drug users” (the term they used). The components of this framework 
involved the attachment of new cognitive and emotional meanings to sharing needles, making 
available the means of behavior change, such as through the provision of clean needles, bleach, 
and drug treatment, and reinforcement of new behavior patterns. After examining several other 
research studies, Becker and Joseph (1988) show that, contrary to the common stereotype, 
“intravenous drug users” (the term they use) are changing their behaviors, but caution that this 
group doesn’t trust public health authorities.  
 The publications in 1988 show a new effort being put forth to examine the intricacies of 
behavior change among people who inject drugs. This group was now being viewed in terms of 
its malleability, as researchers began to prepare a major project, NADR, aimed at exacting 
behavior change. Reflecting on his own participation as a researcher in NIH-funded AIDS 
prevention research, Clatts (1994) suggested that this research became an exercise in behavior 
modification theory and had more to do with social control than the prevention of disease. 
Further, Clatts (1994) saw this research as fitting the subject to the prevention technology, rather 
than the other way around. That this type of interventionist research occurred concurrently with 
the self-organizational and self-care efforts of people who inject drugs reveals the “double 
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itinerary of power” functioning on the population and individual (i.e., self-care) level within 
operations of governmentality (Orr 2010: 549). 
Sociological Interventions (1994) 
 As mentioned previously, the practice of sharing needles was represented as firmly 
embedded within the culture of people who inject drugs and served social, as well as economic, 
needs. People who inject drugs purportedly shared needles with close friends and lovers as a way 
to forge bonds and express trust, and the managers of shooting galleries allowed customers to 
inject with available (often previously used) needles for a fee. In the early-to-mid nineties, this 
assertion about injection drug use culture was questioned by the ethnographer Stephen Koester, 
who was working for a NADR project in Denver. The reliance on a vague and simplistic notion 
of needle sharing was being questioned by researchers who sought to understand the social 
context, as well as the micro-practices of sharing (Page and Singer 2010). Thus, researchers were 
beginning to unpack the reasons for and practices of sharing with the aim of moving away from 
any simplistic notion of this practice.  
Koester (1994) troubled the previous, culture-bound depiction of sharing through his 
ethnographic research in Denver, which revealed that syringe sharing took place largely because 
access to new syringes was blocked by legal restriction. Koester (1994) specifically noted that 
cultural or psychological explanations could not be relied upon to understand needle-sharing 
practices. The illegality of syringe possession further works against carrying needles on one’s 
person since many people who inject drugs have outstanding warrants that may be called-up if 
they were to be stopped by the police for needle possession. Koester’s work represented a shift 
from individual and group-level explanations for needle-sharing to an analysis that examined the 
law and criminal justice practices.  
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Similarly, Clatts (1994) questioned the notion that a universal culture of needle sharing 
existed that crossed boundaries of time and place. He asserted: “. . . I have never talked to a drug 
injector who wants to share needles” (1994: 94). Rather, it is the larger social and economic 
circumstance that put most people at risk for AIDS, and further much of the suffering caused by 
AIDS is connected to the social rather than medical response to the virus. Clatts (1994) wrote: “I 
maintain that the anguish and suffering that I have witnessed over the last ten years is not caused 
by a virus. Rather, it is generated by people and is what we do to make more out of an affliction 
than the merely medical, and to make something other of the afflicted than merely sufferers of 
disease” (p. 93-4). The construction by researchers of the pathological subculture of injection 
drug use positioned those who inject drugs in ways that increased rather than soothed their 
suffering.  
These sociological interventions provoked much needed reflection and criticism with 
respect to individualizing behavioral change interventions that had been standard practice. They 
focused attention on social structural circumstances that made risk reduction among people who 
inject drugs difficult, as well as the harm that had been done by constructing this group as 
pathological in a variety of ways. While the analysis presented by Koester (1994) was formative 
for future research and structural interventions, it cannot be understood outside of the operations 
of power. Structural adjustments, such as removing legal prohibitions on carrying syringes, allow 
for more autonomy, and thus more choices for individuals. Increasing freedom, which is a key 
aim of neoliberal rationalities of governance, places individuals in the position to make choices 
that are in accord with cultural norms and social institutions (Reith 2004). Through this 
governance-at-a-distance, freedom is expanded, but expectations of appropriate thought and 
behavior remain intact and function to carry out this veiled form of governance. 
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Expansion of Power (1990s-present)  
In the early and mid-90s, another concern regarding the health of people who inject drugs 
began to appear in the literature—hepatitis C. Prior to AIDS, infection with hepatitis B had been 
a widespread health concern for people who injected drugs, and a research interest for those who 
studied this group. In fact, those who injected had discerned that hepatitis B was spread through 
sharing needles and had made some efforts to avoid this behavior (Des Jarlais 2009). Unlike 
hepatitis B, there is no vaccine for the hepatitis C virus (HCV), and it has and continues to run 
rampant among people who inject drugs, though syringe exchanges have helped stem the tide to 
some degree (Hagan et al. 1995; Edlin 2011). HCV is spread primarily through blood-to-blood 
contact, and thus there is not the concern of people who inject drugs infecting innocents through 
sexual contact, though sexual transmission does happen in rare instances. The federal 
government has provided relatively little funding to investigate this virus, despite the fact that 
five times as many people are infected with HCV as HIV in the United States (Edlin 2011). 
There is concern that if this health concern is left unaddressed by research and social programs, 
people who inject drugs and are infected with chronic HCV will be a significant cost to our 
public health care system. The estimated costs are in the tens of billions (Edlin 2011; citing 
Pyenson et al. 2009). Hepatitis C has become part of the public health identity of the risk group 
along with the worries, economic and humanitarian, that come attached to the high prevalence of 
this infection. Additionally, people infected with chronic hepatitis C, many of whom inject 
drugs, are positioned to cost society billions upon billions of dollars in the near future.  
Finally, in an interesting twist, public health researchers began to speak about the non-
injection drug user or NIDU in the early 2000s (e.g., Neaigus et al. 2001; Gyarmathy et al. 
2002). This corresponds to stage four of the chronology of injection drug users and HIV 
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constructed by Des Jarlais, Arasteh, and Friedman (2011). At this time, the research gaze turns to 
HIV transmission among people who use drugs, but do not inject. Thus, sexual transmission of 
HIV between drug users becomes the concern. As Des Jarlais, Arasteh, and Friedman (2011) 
report, HIV prevalence among heroin and cocaine users who have never injected is around the 
same level as HIV prevalence among people who inject (citing Des Jarlais et al. 2007). In light 
of this, Des Jarlais, Arasteh, and Friedman (2011) recommend a re-organization of HIV risk 
groups, such that heroin and cocaine users--whether they inject or not--are considered a single 
population. They note that there are many transitions between injecting and non-injecting drug 
use, and that heroin and cocaine users may change behavior over time (Des Jarlais et al. 2011). 
This development reveals that a “hardening of the categories” (Haraway 1997:139) may not 
always be complete or enduring. Perhaps, what could be called a softening of the category is 
evident in the appearance of the NIDU in research literature.  
A breakdown in the immutability of the risk categorization “injection drug user” was 
evident in one of my research interviews with a health care practitioner. When I began asking 
Christine, a medical doctor who directs a methadone clinic and provides primary care to drug 
users, questions about her injection drug using patients, she stated: “I am sort of curious why this 
separation of people who inject drugs? I see this as a very academically derived group because 
from the bottom I don't see that as a very distinct group.” She continued: “I’m not even sure that 
I could sort out injectors from non-injectors.” Probing further, I questioned whether she asked 
her patients about injection, and if that in turn triggered any certain types of medical discussions. 
She replied: “Well because all of our patients are at such high risk for HIV and hepatitis, 
everybody gets screened…” This resonates with the expansion of risk group categorization 
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proposed by Des Jarlais, Arasteh, and Friedman (2011) whereby all users of cocaine and heroin 
are considered to be equally at risk for HIV transmission.  
Both of these developments—the increasing recognition of HCV risk and the appearance 
of the NIDU--offer an expanded field of intervention upon which power can play. The revelation 
that hepatitis C is highly prevalent among people who inject drugs indicates that governance 
specific to this virus is needed. Now that syringe exchanges and the possession of needles is 
legal in some localities, people who inject drugs must participate in self-surveillance and care to 
avoid hepatitis C. The re-organization of HIV risk groups suggested by Des Jarlais, Arasteh, and 
Friedman (2011) widens the risk group to include drug users who do not inject (NIDUs), and 
thus subjects new bodies to governance practices that had been reserved for people who inject 
drugs. Christine enacts this breakdown in the IDU risk categorization by screening all of her 
patients—whether or not they inject—for HIV and hepatitis. 
Another change in the power play of governmentality over people who inject drugs is the 
recent push to begin calling this group “people who inject drugs” (PWID) rather than the 
previous term “injection drug users.” Using people centered language can be considered 
symbolic of the individualizing tendencies of neoliberalism, where governance is exacted at the 
personal level. Three of the researchers interviewed, Sam, Brian, and Sherry, favored this shift in 
language because it was humanizing and more respectful. Sherry described her interest in this 
term: 
And then the last year or so, now they are PWID and I actually incorporated that. I’m 
writing a proposal and that’s the term I use. And that’s certainly not commonly used at all 
but they are people who inject drugs obviously and I think that it’s just sort of a more 
respectful way of describing them. They’re not just known as injection drug users. 
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They’re people and they inject drugs and they also do other things. I don’t actually know 
how that change came about but a couple of my colleagues started incorporating it in 
their work and I’ve decided to do that as well. 
Brian also explained that he had incorporated the new term, which he referred to as “person-
centered language” into almost all if not all of his work. He had also written a letter to the 
American Journal of Public Health advocating the journal adopt the term when the authors of an 
article he was reviewing for the journal were hesitant to switch from injection drug user to 
people who inject drugs, which the journal responded to “enthusiastically.”  
 Sam applauded the nascent terminology change, but recognized that some apprehension 
existed:  
In the last few years there’s been a push for person who injects drugs, although I have to 
tell you, some of the people really don’t like it even though in some ways they invented it 
because it’s abbreviated PWID. I said this is what’s going to happen. The “people who” 
is absolutely essential and that’s something which came out of chiefly the users groups 
themselves.  
Similar to person with AIDS or PWA, PWID acknowledges the person first and then the 
behavior or illness of interest. The researchers see this new term as a further step towards de-
stigmatizing people who inject drugs, though it comes with some reservations in connection with 
the way it sounds when spoken. While this term may be seen as suggestive of a neoliberal 
emphasis on the individual and personal responsibility, for the researchers, it represented a move 
toward more respect and a fuller recognition of one’s humanity.  
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CONCLUSION 
“… the ways in which these categorizations are made, and which categories come to have effects 
in the world, are never neutral”  
David Valentine (2007:5) 
 While the researchers interviewed for this chapter may have felt that the adoption of the 
“injection drug user” label provided a more neutral identification, the constructive process that 
generated knowledge on this risk category reveals a host of concerns and attributions that malign 
this group at the same time as they facilitate the opening of a space for governing power. 
Through the early days of AIDs, when concerns about containment of the virus and a lack of 
knowledge about the people at risk dominated, until the present state involving expansion and 
specification of this risk group, a range of operations of power at the population and individual 
level have simultaneously constructed and governed this particular type of drug user. Producing 
knowledge about this group, as occurred in the period of surveillance and differentiation, is 
simultaneously an act of governance as it determines what personal characteristics and behaviors 
will be acted upon and in what ways. Descriptive information generated about “intravenous drug 
users” in this period discursively manufactured governable subjects. These subjects were then 
managed through behavioral change interventions, and governed-at-a-distance through support 
and facilitation of self-activation. Through self-organization and the proliferation of syringe 
exchanges, the activist “injection drug user” participated in self-care and self-governance. 
Sociological interventions into the production of knowledge about this risk group supported a 
more free and autonomous “injection drug user” who could self-manage in an environment with 
minimally restricted access to new syringes. Prior to these interventions, knowledge generated 
through public health research had focused on the pathological culture of injection drug use and 
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ignored the structural constraints that made risk reduction difficult or impossible for those who 
injected drugs. By freeing “injection drug users” from these constraints (such as legal 
prohibitions against needle possession), they could participate in self-care as neoliberal 
autonomous decision-makers. Finally, the specification and expansion of the risk category by the 
appearance of hepatitis C and the figure of the NIDU allowed for both new and expanded 
surfaces upon which governance could be enacted.   
 A re-visioning of the construction of this risk group category through the lens of 
governmentality allows for a reflection on the productivity of power. The person who injects 
drugs was constructed and re-constructed throughout the last three decades, and this had effects 
on the levels of research, discourse, identity, and practice. However, this entire process was 
enveloped within a general humanitarian concern for a vulnerable group of people. As the 
research publications and the interviews with researchers show, an interest in protecting and 
improving health was coupled with a concern for de-stigmatizing a group that participated in 
illegal activities and was labeled socially deviant. Acts of “caring for” individuals can be 
understood as forms of governance (Deverteuil and Wilton 2009), whereby power works through 
enactments of care and protection and the promise of well-being. Laboring under a desire to 
install policy and practice to reduce the transmission of HIV/AIDS, public health researchers 
mobilized epidemiological organizational principles and ethnographic modes of understanding to 
manage the disorder caused by disease and fear.  
 An analysis of the frameworks that were mobilized to understand and organize the spread 
of HIV/AIDS, such as the notorious CDC hierarchy of infection, and the practices they 
engendered, such as behavior change interventions, casts light on the dominance of particular 
social values. This genealogical analysis of a risk categorization reveals that the use of 
	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   	   	  
	   	   	   	  
123 
epidemiology and other public health modes of analysis to understand the spread of HIV/AIDS, 
led to the creation of a subject position and an identity category. Using the individual person as 
the unit of analysis rather than the virus aligns with cultural logics of neoliberalism that place 
responsibility for the monitoring of risk and illness on the individual. The way HIV/AIDS was 
studied and organized affirms the social value of individualism, and more specifically, the belief 
that individuals can be governed through education that urges behavior change. 
 This dissertation research project cannot escape the claim that it too constructs the figure 
of the person who injects drugs by utilizing the subject position to conduct analyses of power and 
health. After all, sociology as a practice of knowledge production is deeply intertwined with “the 
social” as a field invented by governmentality to enact certain rationalities and produce power 
effects (Orr 2010). Ironically, by using the Foucauldian concept of “governmentality” as an 
analytic tool, the re-visioning of the construction of this risk group offered here can perhaps lead 
to a “method for making up and re-making again what’s real” (Orr 2010: 554). Telling the 
history of epidemiological risk categories with an understanding that they are produced by 
power, that they are power-effects, can un-do what may be seen as “real” for those involved in 
public health research and for those upon whom the label has been bestowed. This opens a space 
for a shift towards focusing on acts of power rather than the individuals who are produced 
through their effects, as well as a shift towards disrupting settled accounts of the identity of the 
person that injects drugs. This is important when we consider that representations of this group in 
scientific literature may be used by policy makers, as well as the media, to craft opinions and 
recommendations on policy and law, which have material effects on individuals and work to 
construct and reinforce the “real” existence of this group. 
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Chapter 4 
Contingencies of the Will: Uses of Harm Reduction and the Disease Model of Addiction Among 
Health Care Practitioners 
 
For health care practitioners, understanding the relationship between health and drug use 
for patients who use drugs is complicated by at least two conflicting yet overlapping frameworks 
from which to draw. The harm reduction approach offers practitioners a picture of drug users at 
risk for infectious disease and other harms associated with drug use, but willing and able to 
protect their health given the right tools, such as new syringes and risk information (Fraser 2004; 
O’Malley 1999). The disease model of addiction, which is firmly embedded within established 
medical knowledge, positions drug users as pathologic and excessive consumers. This chapter 
will show how these two approaches to defining and intervening upon the health of drug 
injecting patients take shape and overlap in the medical practices and discourses of a sample of 
health care providers in New York City by examining qualitative interviews conducted with 
them in 2012. Despite its philosophical differences with the medical model of care, which largely 
hinge on the attribution of autonomy (Heller, McCoy and Cunningham 2004), a harm reduction 
approach to care was embraced by all in this group. This did not prevent them from also holding 
a disease concept of addiction, and, in fact, allowed some interviewees to articulate rationales for 
the disease concept. Harm reduction principles were evident in descriptions of the disease model 
of addiction offered by several health care practitioners. In the discourses of the health care 
practitioners, an affinity emerged between the “objective” medicalized discourse of addiction as 
disease and the non-judgmental approach of harm reduction. Placing commitments to harm 
reduction alongside the discourse of disease, including that which drew in neuroscience, this 
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chapter offers a window into the ongoing and occasionally conjoint constructions of both harm 
reduction philosophy and the disease model of addiction in the context of health care. In offering 
this window, this chapter shows how differential technologies of power manifest in the context 
of primary care.  
Harm reduction has been analyzed through the lens of governmentality, wherein drug-
taking individuals express their regulated autonomy through technologies of the self that accord 
with ideologies and calculations of risk emanating from diffuse sets of institutions, experts, and 
other health promotion organizations (Campbell and Shaw 2008; Fischer et al. 2004; McLean 
2011; O’Malley 1999). In contrast, notions of addiction as disease, which denote excessive and 
troubled patterns of consumption associated with a lack of autonomy, remove the option of self-
governance and place responsibility for care in the hands of addiction experts and health care 
professionals. The absence of will symbolized by addiction as a disease offers the gateway 
through which health care practitioners can bring in ideological commitments associated with 
harm reduction, such as the de-stigmatization of drug use. However, harm reduction in practice 
and discourse places great emphasis on drug user autonomy (Denning 2001). It has been posited 
that discourses of self-governance or personal responsibility sow the seeds for contradictory 
discourses of excessive consumption such as addiction (Reith 2004), but the health care 
practitioners articulated no great conflict between the seeming opposition between the 
facilitation of autonomy found in harm reduction discourse and the refusal of autonomy 
expressed by discourses of addiction. Rather, both approaches to the health care of people who 
use drugs could be deployed and in some ways intertwined, though they addressed the will of the 
drug user in distinct and contingent ways. 
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In tracing inscriptions of the will of the drug user as it was expressed in contingent 
discursive contexts the findings of this chapter offer an examination of the incorporation of harm 
reduction, broadly defined, into the medical practices of the interviewees, as well as an 
examination of how the health care practitioners articulated various constructions of the disease 
model of addiction drawing in harm reduction principles. 
Any analysis of the disease model of addiction must recognize that it is a social 
construction linked to historical conditions, cultural standards of normative behavior, and 
advances in biotechnology (Campbell 2010; Kaye 2012a; Keane 2003; Reinarman 2005). To 
contextualize this, a discussion of the medicalization of addiction and various critiques of the 
disease model of addiction is offered. In scrutinizing the inclusion of harm reduction philosophy 
in the construction of addiction as disease, points of conflict between the medical approach to 
providing care and that of harm reduction will be discussed. Given the recognition of drug user 
autonomy rooted in the philosophy of harm reduction, it is remarkable that health care 
practitioners are incorporating elements of it into their practices of medicine. 
The practice of medicine has been studied as a site of disciplinary power where 
authoritative judgments are bestowed by credentialed health care providers onto docile patients 
who play the “sick role” (Foucault 1979; 2007b; Lupton 1994; Parsons 1951; Szott 2014). 
Incorporating a discourse, such as harm reduction, which mobilizes a form of power that works 
to bolster the will of the individual toward self-care, into the disciplinary context of medical care 
presents contradiction in terms of individual autonomy. However, this contradiction does not 
preclude the ability of these two forms of power to work together in a single setting. This chapter 
explores the implications of the co-presence of technologies of power noting how one type of 
power may beget another. 
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Harm Reduction Philosophy 
I think that most doctors don’t use it [harm reduction]. I think that the health care system 
works under a different philosophy. People talk about it because it’s kind of sexy and 
they don’t know exactly what they’re talking about.   
        Monica, M.D.  
 As Monica, one of the health care practitioners I interviewed, explained, the health care 
system in the United States operates under a framework that differs from the philosophy of harm 
reduction in significant ways. Further, she intimates that while health care practitioners might 
give lip service to harm reduction, their knowledge of it is superficial, and therefore their 
practice of it inadequate. Examining the philosophical framework of harm reduction reveals that 
it runs counter to the hegemonic practices and philosophy of medical care. This may be why 
Monica disparages the knowledge level of people working in our health care system. If they 
knew what harm reduction was really about, they’d realize they were not practicing it, since it 
looks quite different than the way care is provided in mainstream medical contexts. 
The philosophy behind harm reduction is seen as revolutionizing the way we respond to 
human problems, namely addiction and AIDS, and as a middle-road alternative to the moral 
model (as exhibited by the War on Drugs) and the disease model of addiction. In contrast to 
harm reduction, both of these models tend to support abstinence as the primary goal. Harm 
reduction is rooted in a “bottom-up” approach based on drug user advocacy and accepts 
alternatives to abstinence that reduce harm (Marlatt 1996: 779). An amoral or neutral stance 
toward drug use is often adopted, despite the difficulty of enacting this approach (Keane 2003). 
In contrast to criminal and medical approaches to managing drug users, harm reduction 
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recognizes and respects drug user autonomy, though this autonomy may be regulated by risk 
calculations (O’Malley 1999) and the neo-liberal logic of individual responsibility (Fraser 2004). 
While there have been calls for the use of the harm reduction approach in medical 
settings, its successful inclusion is quite rare (Rachlis et al. 2009; Strike et al. 2014). In an article 
well-known to the harm reduction social movement community in New York City8, Heller et al. 
(2004) list philosophical clashes between harm reduction and medical models in several domains 
of practice and care. The authors themselves encountered these clashes while working to develop 
a collaborative relationship between a harm reduction center in the South Bronx and a local 
hospital. Many of the clashes stem from differences in where authority lies and who creates 
knowledge. Heller et al. (2004) see harm reduction as centered on the autonomy of the drug user, 
and thus valuing of self-knowledge and individual choice. Medicine, on the other hand, places 
the locus of authority in the physician and his or her discrete and stable medical knowledge. 
Another difference lies in the theoretical framework for understanding drug use, where harm 
reduction uses a model (referred to as “drug, set, and setting” (Zinberg 1984)) that encompasses 
pharmacology, psychology, and macro- and micro-level social setting to aid drug users in 
assessing the benefits and harms of their drug use, as well as finding strategies for changing risky 
practices. This model emerged from research Zinberg (1984) conducted on a group of heroin 
users who presented evidence of “controlled use,” thus substantiating a long-standing harm 
reduction assertion that there can be “functional users.” Another theoretical framework presented 
by a central proponent of harm reduction psychotherapy involves addressing “the continuum of 
drug use and the particular harms that are associated with different drug use styles” (Denning 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
8	  Throughout my field work, as I interacted with the staff at harm reduction centers and also 
during interviews with health care practitioners, I was referred to this article. It was clear that this 
is a well-known and well-regarded piece among those interested in the health care of drug users.	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2001:24). This approach draws attention to the potential for certain types of harm rather than 
focusing on the perceived necessity of abstinence. 
In the field of medicine, the disease model is employed to understand drug use. Active 
drug use is given a formal psychiatric diagnosis--in the fifth edition of the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-5), it is called “substance use disorder,” 
(American Psychiatric Association 2013) and patients who use drugs are referred for drug 
treatment that usually requires abstinence (Heller et al. 2004: 37). While the DSM-5 diagnosis of 
“substance use disorder” takes into account pharmacology, psychology, and social context 
(though in a more limited way), it is the authoritative way in which the diagnosis is applied that 
differentiates it from the “drug, set, and setting” model or that of harm reduction psychotherapy. 
The diagnosis is not used as a way to guide drug users towards self-assessment of the various 
components of their drug use practices and to find places where adjustment might decrease 
riskiness. Rather, it is applied in a definitive manner backed by the authority of medical 
knowledge, and serves as the initiation point for a pathway to abstinence-based treatment. This 
accords with the belief that the will of the drug user has been compromised through drug use and 
its restoration is dependent on complete abstinence. In recognition of the autonomy of the 
individual who uses drugs, harm reduction practitioners simply provide a way (“drug, set, and 
setting”) to understand drug use and information about the health risks it poses.  
In the United States, one of the key stewards of harm reduction, the Harm Reduction 
Coalition, which is an educational and policy advocacy organization, sets out eight principles 
that define their construction of the approach. Notably, the first principle states that harm 
reduction: “Accepts, for better and or worse, that licit and illicit drug use is part of our world and 
chooses to work to minimize its harmful effects rather than simply ignore or condemn them” 
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(Harm Reduction Coalition). The fourth principle states that harm reduction: “Calls for the non-
judgmental, non-coercive provision of services to people who use drugs. . .” (Harm Reduction 
Coalition). This principle alludes to an amoral stance towards drug use in calling for a non-
judgmental approach. While Keane (2003) asserts the identity of harm reduction is best 
articulated as pragmatic rhetoric and flexible practices, the principles set down by the key harm 
reduction organization in the United States alludes to ideals of acceptance and non-judgment. 
Both constructions of harm reduction conflict with the established model of medical care in the 
U.S., in that medicine approaches the provision of care with a stable and discrete, rather than 
flexible, set of knowledge, which gives way to standardized treatment prescriptions (drug 
treatment requiring abstinence) that leave little room for patient autonomy and symbolically 
denounce the use of drugs. 
Critiques of Addiction as Disease 
 Defining addiction as a disease is a product of a larger social process of medicalization 
that has expanded the jurisdictional domain of medicine into areas formerly considered social 
problems. Earlier formulations of the concept of medicalization focused on the definitional 
activities of the social process. Conrad (2005) explains: “The essence of medicalization became 
the definitional issue: defining a problem in medical terms, usually as an illness or disorder, or 
using a medical intervention to treat it” (p. 3). The medicalization of a problem also results in 
new forms of medical social control, which works, “. . . to secure adherence to social norms—
specifically, by using medical means to minimize, eliminate, or normalize deviant behavior” 
(Conrad and Schneider 1992: 242). A clear example, and one which Conrad and Schneider 
(1992) explore, is the use of methadone administered in a clinic setting to normalize the deviant 
behavior of illicit opiate use. Besides addiction, other social problems that have been re-defined 
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as medical conditions are obesity, child abuse, and hyperactivity. Zola ([1972] 2013) similarly 
warned of the expanding presence of medicine in our social world. Medicalization is an 
“insidious and often undramatic process” that affects much of our daily living ([1972] 2013: 
497). He asserts: “the labels ‘healthy’ and ‘ill’ are becoming relevant to more and more parts of 
human existence” ([1972] 2013: 497). In fact, anything that can be found to affect the workings 
of the body and to a lesser extent the mind can be labeled an illness (Zola [1972] 2013: 501). 
Zola ([1972] 2013) points to drug addiction as an example of the process of medicalization 
stating: “It was once considered a human foible and weakness” (pp. 501-2). When something 
becomes labeled as an illness, the issue is not whether to deal with it, but how and when to deal 
with it. This pushes aside the fundamental question of what freedoms an individual should have 
over her body (Zola [1972] 2013: 504).  
 The forces behind medicalization that propelled its wide expansion in the late 20th and 
early 21st centuries are many. Previously, social scientists took a social constructionist approach 
that positioned moral entrepreneurs, professional dominance, and claims-making as the engines 
of medicalization (Conrad 2005). Zola ([1972] 2013) asserted that medicalization was due to our 
increasingly complex technological and bureaucratic system, which had led us to reluctantly rely 
on experts. More recent theorization sees the drivers of medicalization as commercial and market 
interests, biotechnology, managed care, and consumers themselves (Conrad 2005). The process 
of biomedicalization as theorized by Clarke et al. (2010) denotes the co-constructive 
relationships between medicine, biotechnology, risk and surveillance, late capitalism, and 
privatization. Explaining the difference between medicalization and biomedicalization, Clark et 
al. (2010) state: "Medicalization practices typically emphasize exercising control over medical 
phenomena--diseases, illnesses, injuries, bodily malfunctions. In contrast, biomedicalization 
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practices emphasize transformations of such medical phenomena and of bodies, largely through 
sooner-rather-than-later technoscientific interventions not only for treatment but also 
increasingly for enhancement" (p. 2). Similar to Zola’s perspective, the theory of 
biomedicalization notes the increased focus on the maintenance of health, as opposed to the 
earlier medical foci of illness and injury (Clarke et al. 2003: 162). Under this regime of health, 
new identities are forged based on personal relationships to health and embodied health risks 
(Clarke et al. 2010). Further, Clarke et al. (2003) point to a reorientation of the medical gaze, 
such that bodies are viewed at the molecular and genetic level based on the medical assumption 
that, “… it is ‘better’ (faster and more effective though likely not cheaper) to redesign and 
reconstitute the problematic body than to diagnose and treat specific problems in the body” (pp. 
175-6). Viewing the brains of addicts through magnetic resonance imaging, as well as research 
that searches for genetic components of addiction, are two such examples of the reoriented gaze 
of medicine. These new forms and practices of technoscience offer high-tech formats for 
interpreting addiction as a neurobiological disease, and thus further sediment notions of 
biological determinism. 
While the study and treatment of addiction has certainly been re-shaped by the 
transformative social processes of biomedicalization, defining addiction as a disease is a process 
that began over two hundred years ago with the emergence of a new paradigm that defined 
addiction as a central problem of drug use and diagnosed it as a disease, or disease-like (Levine 
1978). Members of the temperance movement argued that habitual drunkenness was a disease 
and a natural consequence of moderate alcohol use. These claims underscored the necessity of 
outlawing alcohol since it was thought that even drinking in moderate amounts could lead to the 
disease of addiction. The temperance movement found the source of addiction in the drug itself, 
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while post-prohibition thought located the source in the individual body (Levine 1978). The 
beginnings of this individualized notion of the disease of addiction can be seen in the 
prohibition-era federally-funded research of Lawrence Kolb, which concluded that 
psychopathology and personality disorders were the root causes of addiction (Courtwright 2010: 
139). The disease concept of addiction gained further traction with the 1935 opening of the 
Addiction Research Center, a congressionally mandated narcotics farm that sought to investigate 
physiological components of addiction (Campbell 2007). Methadone maintenance treatment, 
which was developed in the 1960s as a system of clinics, further medicalized addiction by using 
a so-called medication to aid addicts in stabilizing their lives and their relationship to opiates. 
The idea behind methadone treatment was partially based on the belief that opiate addicts created 
a permanent biochemical change in their physiology (Conrad and Schneider 1992: 135). Vincent 
Dole and Marie Nyswander, two U.S. physicians who developed and advocated the use of 
methadone for the treatment of opiate addiction, believed that opiate addiction was a metabolic 
disorder. Methadone clinics were embraced by the Nixon administration as a cure for the heroin 
epidemic. Even though the public raised concern over potential diversion of methadone, the 
clinics stayed in place in part because they served as a mechanism of social control (Conrad and 
Schneider 1992: 140). The multitude of rules enacted at clinics mean that the patients’ lives are 
highly regulated and surveilled, and there is little room for resistance since patients need regular 
access to methadone to avoid using illicit opiates. The current approach to understanding 
addiction focuses on the brain, and its chemical activity and receptor behavior, as a way to 
explain addiction. Campbell (2010) asserts: “Placing addiction in the brain—effectively 
displacing it from the social body—has been the culmination of a long social process by which 
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addiction was redefined as a CRBD [Chronic Relapsing Brain Disease] in the mid-1990s” (p. 
90).  
In fact, simply defining addiction as a disease was the culmination of a long social 
process enveloped in particular and changing historical and cultural contexts. As Reinarman 
(2005) shows: “…  addiction-as-disease did not emerge from the natural accumulation of 
scientific discoveries; its ubiquity is a different species of social accomplishment” (p. 308).  
Societal institutions such as government-funded research institutes, policy think tanks, and the 
treatment industry have been instrumental in crafting and cementing the notion of addiction as a 
disease. One such example is the National Council on Alcoholism (NCA), which was 
specifically formed in the 1940s by Marty Mann, a public relations executive and former 
“drunk,” and Dr. E.M. Jellinek at Yale. They joined together to create an organization whose 
purpose was, “… to popularize the disease concept by putting it on a scientific footing” 
(Reinarman 2005: 313). Reinarman (2005) specifically notes the chronology of the NCA’s 
endeavor: “… science was not the source of the concept but a resource for promoting it” (p. 
313). Similarly, the current emphasis on neurological explanations of addiction must be put in 
relation to historical efforts to understand the physiology of addiction and the rise of various 
technoscientific advances. Campbell (2010) provides a summary of the conditions of possibility 
that allowed the conception of addiction as a CRBD to emerge: 
…  visualization of opiate receptors; discovery of the role of endogenous opioids, which 
unseated the once easier distinction between ‘natural’ and ‘artificial’ rewards; 
importation of the concept of the ‘brain reward system’; invention of brain imaging 
technologies (Dumit, 2002); and evolution of technosocial structures within which 
federally funded research could be conducted and disseminated (p. 96). 
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While some of the activities listed by Campbell are attributable to basic science, such as the 
discovery of endogenous opioids, other conditions of possibility relate to advances in technology 
and structures that support research. Though it may be framed as the natural and logical 
progression of science, the application of neuroscience to the study of addiction is strongly tied 
to advances in technoscience and institutional structures (Campbell 2010; Hammer et al. 2013; 
Vrecko 2010). Neuroscience in the 1990s produced “an expansion of the biological” allowing 
addiction to be seen in the brain, and undermining previous distinctions between physical and 
psychological drug dependence (Keane and Hamill 2010: 55-6). Further, neuroimaging research 
on addiction has resulted in new ways of envisioning the relationships between brain images, 
“brain types” and perceptions of individualized disease (Dingel, Karkazis and Koenig 2011). 
Tiger (2013) sums up the use of technology to forward certain types of claims about addiction: 
“Brain scans and medical diagnoses tell us little about the values of sobriety and abstinence from 
drugs, but they are products of these values” (p. 35). 
 The often-unacknowledged interpretive work involved in scientific research is, of course, 
present in the study of addiction. Campbell (2010) notes: “The capacity to make claims stick 
depends not only upon what happens in the magnet [meaning MRI scans], but also on the 
interpretive work—from signal processing to literature reviews—that occupies this culture of 
science” (p. 90). The production of viable scientific claims involves interpretative work, which 
can be complicated by the cultural meanings attached to addiction. Through her interviews with 
drug court advocates who deployed disease model discourse, Tiger (2013) noticed that: 
“Loopholes and gaps in the ‘science of addiction’ allow for moral and personal considerations to 
guide the construction and presentation of the science” (2013: 35). Tiger found that while 
advocates of drug courts were armed with the latest scientific findings on addiction, “… many 
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appealed to their personal experience with addiction as the source of their knowledge” (p. 35). 
Laboring under the rubric of addiction as disease, scientists and drug treatment adjudicators alike 
use their interpretive skills to support and further the medicalization of drug use. 
 The medicalization of addiction, including the disease model of addiction, continues the 
cultural work of instilling meaning within the concept of addiction. Normative judgment with 
regard to human behavior and the intake of substances inheres within these cultural meanings. 
Despite its scientific sheen, a medical framing of addiction still has social normalization and 
improvement as its goal (Keane 2002). As Keane (2002) explains: “It is this therapeutic impulse, 
the will to improve the body and the self of the individual, which unites the medical ‘scientific’ 
study of addiction and the burgeoning popular literature of addiction and recovery” (p. 5). 
Medical discourse constructs parameters of addictive desire that work to judge behavior as 
diseased or healthy, and in doing so operationalizes a variety of profoundly normative 
hierarchical dichotomies such as natural/chemical, internal/external and order/disorder (Keane 
2002: 6). Diseases, and particularly addiction, are initially recognized through violations of 
culturally created behavioral norms. Disease is seen in the body when an individual fails to 
accomplish certain tasks (Kaye 2012a: 36). The practice of attributing addiction to certain 
individuals works to reveal which types of tasks and behaviors our culture values. Thus, 
addiction’s formulation as a disease reveals the maintenance of socially constructed notions of 
health and self-control as paramount social values.  
 Addiction was produced and continues to be re-produced as a disease in a particular 
cultural context. For as Keane (2002) explains: “…addiction is not a universal feature of human 
existence, but a historically and culturally specific way of understanding, classifying and 
regulating particular problems of individual conduct.  It is tied to modernity, medical rationality 
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and a particular notion of the unique and autonomous individual” (p. 6). These features of our 
culture are the conditions of possibility for addiction as we know it. A concept of addiction is 
produced because these features have the capacity to individualize failure, make it knowable, and 
label it a disease. Recognizing that biology, as well as culture, play a role in our current construct 
of addiction, Kaye (2012a) conceptualizes addiction as biocultural explaining that this does not 
deny the usefulness of biological information or even biological intervention. Rather: “… it 
seeks to re-situate these material possibilities in relation to cultural and political realms that 
socially materialize the biological and bring it ‘to matter’” (Kaye 2012a: 43). Thus, it is the 
cultural that makes the biological matter. 
 Working from the stance that addiction exists as a problematic condition that is present in 
society on the individual and community level, other social scientists have pointed out that there 
are social and cultural factors, rather than simply biological ones, associated with addiction. 
Problematizing the National Institute on Drug Abuse’s (NIDA) focus on the neuroscience of 
addiction, Courtwright (2010) points out that the prevalence and incidence of drug abuse is 
largely determined by demographic variables, such as migration and family stability, and social 
forces, such as pharmaceutical marketing strategies and bohemian fashion to name a few. 
Knowing that there are social patterns of drug abuse raises questions about focusing on 
individual biological pathology (Courtwright 2010: 140). The study of addiction as an 
individualized biological disease oversimplifies its causes and removes it from its social 
environment (Dingel et al. 2011; Levine 1978). There is concern that resources will be funneled 
to pharmaceutical responses to addiction and away from prevention or response efforts that take 
into account social contexts (Dingel et al. 2011). 
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 Looking more broadly at the social management of addiction reveals that the complete 
medicalization of addiction has not occurred (Campbell 2013; Courtwright 2010; Meurk et al. 
2013; Tiger 2013). The societal response to drug addiction is not solely medical, as many people 
who use drugs are managed through the criminal justice system for their addiction (Gowan and 
Whetstone 2012; Kaye 2012b; Tiger 2013). The incomplete-ness of medicalization is also 
evident at the level of addiction treatment, where the 12-step model predominates (Gowan and 
Whetstone 2012; Tiger 2013). While the 12-step model may refer to addiction as a disease, it 
does not involve or allow pharmaceutical treatment, but instead relies on behavioral and 
personality change. Tracking the rise of drug courts in the U.S., Tiger (2013) found that their 
advocates draw on medical theories of addiction to advocate for enhanced criminal justice and by 
doing so they are contributing to the medicalization of addiction in a particular way. Drug courts, 
which coerce those convicted of drug-related crimes into drug treatment programs, represent an 
approach in-between medicalization and de-medicalization. This approach is constituted by “… 
the appropriation of medicalization that simultaneously emphasizes the veracity of the disease 
model while de-emphasizing the hold the medical system should have on curing the problem” 
(Tiger 2013: 87). Drug court participants are sent to treatment programs that emphasize 
behavioral change and thus, “… fit within the progression of punitive interventions that aim to 
cure deviance and promote conformity” (Tiger 2013: 87). Criminal justice approaches, including 
coercive therapeutics, such as mandated drug treatment imply a loss of will among drug users 
who must be forced into disciplinary treatment settings. 
 Similarly, Courtwright (2010) finds that the medicalization of addiction is incomplete and 
resisted from several sources, including medical personnel, social scientists, police, and political 
actors. These groups have not wholeheartedly embraced the medicalization of addiction for a 
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variety of reasons. Despite strong support for medicalization in their field, medical personnel 
have not used their substantial powers to fight the prison-oriented war on drugs because they 
have little in the way to offer as therapeutic treatment for addiction9. The medical profession is: 
“Stuck in therapeutic limbo, with pathological insight but little ability to cure the underlying 
pathology…” (Courtwright 2010: 143). While NIDA continues to march forward with its 
emphasis on the neurobiology of addiction, criminalization is still standard practice. For 
example, in New York City in 2010, the police department made 50,300 arrests for marijuana 
possession, which is more than for any other offense and one out of seven arrests in New York 
City (Levine and Siegel 2011). Statewide in 2011, 137,000 drug arrests were made, which is 
approximately 24 percent of all arrests in New York State. This puts the per capita drug arrest 
rate at 703.6 arrests per 100,000 New Yorkers, which is among the highest rates of drug-related 
arrests per capita nationwide (New York State Division of Criminal Justice Services 2012 and 
Federal Bureau of Investigation 2011; as cited in Pugh et al. 2013: 13). Further, drug offenses are 
the leading causes of new commitments to New York State prisons, accounting for about 25 
percent of all commitments (Pugh et al. 2013: 13). Arrest and imprisonment related to drugs is a 
sizeable sector within New York’s criminal justice system at both the city and state levels. It 
could be said that the criminalization of drug use in New York State is thriving. 
 The continued criminalization of drug use raises questions about the status of addiction as 
a disease. Why would someone with a disease be sent to prison for attending to their medical 
condition? NIDA cleared up any confusion around the status of addiction in its 2007 (revised in 
2010) publication Drugs, Brains and Behavior: The Science of Addiction which states that: 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
9	  At present medical personnel only have the ability, using a small number of pharmaceuticals, to 
treat drug addiction—not cure it—with maintenance medications, such as methadone and 
buprenorphine, and a medication, naltrexone, that blocks the euphoric effects of opiates.	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“Addiction is defined as a chronic, relapsing brain disease that is characterized by compulsive 
drug seeking and use despite harmful consequences.” The report explains how addiction changes 
the structure and function of the brain and has long lasting neurobiological effects. Further, 
scientists estimate that genetic factors account for between 40 and 60% of a person’s 
vulnerability to addiction (NIDA 2007). This formulation of addiction is known as the NIDA 
paradigm and remains hegemonic in many addiction research circles (Dingel et al. 2011). Since 
the 1990s in the United States, the disease of addiction has been a neurological disease, which 
aligns with trends of the technoscientization of biomedicine  “. . . where interventions for 
treatment and enhancement are progressively more reliant on sciences and technologies, are 
conceived in those terms and are ever more promptly applied” (Clarke et al. 2010: 2). However, 
the NIDA paradigm and its “molecularization” and “geneticization” (Clarke et al. 2010) does not 
track with notions of regulated agency apparent in discourses and practices of harm reduction. 
Rather it embeds addiction deeper within the body, and thus intensifies the erasure of will. 
As this chapter contends, there is flexibility with the disease concept of addiction, such 
that it can be used in conjunction with principles of harm reduction, which regulate rather than 
deny autonomy. Through researching drug courts, Tiger (2013) concluded that: “Addiction’s 
flexibility as a biomedical category is evidenced by the fact that it is characterized both as a 
disease, cured through individually tailored treatment, and a moral failing, punished through a 
variety of coercive sanctions” (p. 77). The investigation here of the uses of the disease model by 
health care practitioners notices another type of flexible usage that allows contingent recognition 
of the will of the drug user.  
The Health Care Practitioners 
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While all of the health care practitioners practice primary care, they do so in a variety of 
settings and several also provide drug treatment using the pharmacotherapies buprenorphine and 
methadone. Additionally, seven of the thirteen health care practitioners devote a portion of their 
professional time to various research endeavors broadly related to illness and disease, medicine 
and substance use, which situates them in a field of knowledge consumption and production that 
undoubtedly shapes their perspectives and suggests they had thought extensively about the health 
of drug users. Among the health care practitioners who prescribed buprenorphine to treat opiate 
dependence, the dominance of the disease model was nearly complete, though practitioners who 
did not prescribe buprenorphine also used the model. Since buprenorphine is a medical approach 
to treating addiction, it logically follows that the practitioners who prescribe it would deploy the 
disease model in the interviews. The use of harm reduction was claimed by all of the health care 
practitioners, though they articulated its meaning and usage in differing ways. 
While all of the health care practitioners provide care for low-income drug users and 
many of them work in clinics situated in economically marginalized neighborhoods like the 
South Bronx, they may not necessarily represent the typical doctor encountered by a low-income 
person who injects drugs. A particular community of health care practitioners who had 
purposefully chosen the career track of working with underserved populations was tapped into 
during the recruitment process. Further, a majority of interviewees specifically sought to serve 
people who use drugs. While low-income individuals who inject drugs might encounter these 
health care practitioners, there is a whole other world of practitioners, who did not choose to 
focus their careers on the care of marginalized populations, and who drug users might encounter 
in their quests for health care. The health care practitioners interviewed were particularly 
sympathetic to the plight of drug users and made efforts to treat them respectfully. However, 
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having worked with a variety of drug using patients, they also expressed exasperated familiarity 
with patterns of difficult behavior they ascribed to drug users, though often this was done with a 
sympathetic tone. 
FINDINGS 
Practices of harm reduction  
Looking at the ways the health care practitioners described their harm reduction practices 
reveals their understanding of where harm reduction can fit within biomedical practice. While 
some of the uses of harm reduction strictly addressed the risks of injection drug use, other 
practices sought to retain people who use drugs in care or treatment. Harm reduction 
implemented in the context of methadone or buprenorphine treatment took on particular 
attributes that aligned with the goals of treating a chronic disease. While the inclusion of harm 
reduction in a medical context might seem contradictory given the philosophical clashes between 
the differing models of care, the health care practitioners did not articulate any dissonance in 
their own practice.  
Many of the health care practitioners, whether they provided care in the context of drug 
treatment or only provided primary care, reported that they incorporated assessments and 
education around opiate and needle use practices in their care for patients who inject drugs. Julia, 
a medical doctor who works in a primary care clinic in the Bronx, said that she knows some of 
her patients use drugs, but she was not sure if they currently injected them. When asked to speak 
about her experiences providing care to patients who were actively injecting drugs, she reflected 
on the time she spent several years ago caring for drug users at a syringe exchange. She 
explained her incorporation of harm reduction into her practices of care: 
What I would try to do when I was talking to my patients about whatever medical 
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problem they had is try to talk to them, if they were coming in because they were having 
infections and abscesses. I would talk to them about appropriate skin care and wound 
care and ways to not make themselves sick when they were injecting. And so rather than 
being like, “You should really just stop injecting drugs all together,” it makes a lot more 
sense to be like, “If you’re going to inject, you use alcohol [swabs on the injection site] 
before--not after,” which is a common thing. I had a lot of my patients be like, “well I 
always rub with alcohol after I shoot.” I’m like, “no, no, no, before you shoot you have to 
clean it.” If I’m aware where they’re getting their water for cooking, and all of these 
things. So I can talk to them a little bit about that, and that tends to be useful…  So that’s 
sort of the way that I use harm reduction principles as a practitioner… 
Julia spent time educating her patients about wound care and safer injection techniques, if they 
were seeing her for infections and abscesses, instead of simply telling them to stop injecting 
drugs. This reflects the core tenet of harm reduction to avoid exhortations to abstinence and 
accept that “. . . licit and illicit drug use is part of our world. . . and that some ways of using 
drugs are clearly safer than others” (Harm Reduction Coalition).   
 One of the common refrains of harm reduction discourse is to meet drug users “where 
they’re at,” meaning to accept the current drug use practices of individuals without judgment. 
The Harm Reduction Coalition’s Principles of Harm Reduction defines the harm reduction 
approach in part as incorporating, “. . .  a spectrum of strategies from safer use, to managed use, 
to abstinence to meet drug users ‘where they’re at,’ addressing conditions of use along with the 
use itself.” This refrain was found among the health care practitioners’ inclusion of harm 
reduction in their medical practices, though with slightly different meanings. Andrew, a 
physician who provides primary care for drug users, and methadone and buprenorphine patients 
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under the auspices of a well-respected hospital, framed this approach as a way to guide drug 
users towards treatment:   
I think that’s also one of the things for people who are actively using, if you get them into 
medical care, develop a relationship with them and you are non-judgmental about their 
use and are like, “Okay, what can we do to make you healthier and much safer when 
you’re using?” and you build that level of trust, I think it’s easier to make that 
progression to like, “Okay, let’s try buprenorphine or methadone or some sort of 
treatment.” But you have to get them to trust you and be willing to do that. I think that 
also helps engage this population but you have to be willing to not do “STOP USING!” 
sort of thing. You have to be willing to meet them where they are and help them where 
they are. A closed door can stop them. 
For Andrew, meeting drug users “where they’re at” contributes to their engagement with health 
care and potentially leads them towards seeking drug treatment. Though harm reduction is 
centered around reducing the riskiness of drug use and not forcing abstinence on drug users, 
Andrew employs its message of meeting drug users where they’re at as a strategy that may 
eventually lead to consideration of drug treatment. 
 Doctors who provided pharmaceutically-mediated addiction treatment, whether 
methadone or buprenorphine, incorporated practices of harm reduction into their approach 
towards providing addiction treatment by refusing to terminate their patients’ treatment if they 
continued to use licit and illicit substances. The federal government, through its agency the 
Substance Abuse and Mental Health Services Administration (SAMHSA), provides clinical 
guidelines for the use of buprenorphine in the treatment of opioid addiction. In a section on 
“unstable patients,” these best practices guidelines recommend that doctors discontinue 
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buprenorphine treatment after eight weeks with patients who continue to use opiates or use other 
illicit substances (Center for Substance Abuse Treatment). The health care practitioners who 
went against this recommendation cited this as a practice of harm reduction. Nisha is a medical 
doctor who directs inpatient HIV services, sees patients in an ambulatory HIV clinic, and created 
and directs a buprenorphine drug treatment program at a public hospital located in a low-income 
area. She explained that in creating the buprenorphine program at her hospital, she and her 
colleagues had to determine a policy regarding allowable substance use during treatment with 
buprenorphine. Asked to describe their approach, she stated: 
It’s like they say, things can’t be perfect. In an ideal world, there would be no problems 
with addiction and everybody would be able to be abstinent, but that’s not the reality, so I 
have patients who are dependent on alcohol and heroin and are injecting heroin, and if I 
can get them off the heroin and give them Suboxone, then if they’re still drinking, I’m not 
going to withhold treatment for the heroin addiction, because then they have two 
problems instead of the one. I’m definitely a proponent of the harm reduction model. 
Other health care practitioners enacted harm reduction in the context of drug treatment by 
allowing the continued use of any drug, including opiates, despite receiving treatment that 
specifically targets opiate addiction. Monica, a primary care doctor and buprenorphine prescriber 
who works at a community health care clinic, said: 
I provide drug treatment and people relapse and people still use drugs. It’s part of the 
conversation and I try to figure out new goals for treatment. I certainly don’t kick people 
out because they use drugs because they’ve come to me because they use drugs. So I 
think a lot of it is trying to understand what people’s goals are and try to work with them 
on their goals.  
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Monica’s approach of refiguring goals is also an enactment of the “meet them where they’re at” 
approach, in that she recognizes that people relapse and continue to use drugs, and she meets 
them at that stage to rework goals.  
 The use of what the health care practitioners themselves termed harm reduction was 
consistent throughout the interviews, with each practitioner revealing what harm reduction meant 
in their context of care. Whether it was education around injection techniques or refusing to 
terminate patients for continued opiate use, the health care practitioners made attempts to reduce 
the harms associated with injecting and oriented themselves to the acceptance of some drug use. 
Two overlapping philosophical principles of harm reduction were apparent in the care these 
practitioners provided—the “meet them where they’re at” approach and the acceptance of some 
drug use. Both principles are supportive of a regulated autonomy for people who use drugs by 
acknowledging the choice to take drugs, but also constructing space for interventions into the 
modes of drug use. The health care practitioners demonstrated recognition of their patients’ 
choice to use drugs, while offering expert advice and treatment. By allowing the continued use of 
substances, both Monica and Nisha provided their patients with space to self-govern while they 
continued treatment in the disciplinary context of medicine. As noted by Andrew, the freedom 
allotted patients by harm reduction clinical policies may facilitate stronger ties to medical care.  
The Uses of Disease 
 One way the health care practitioners envisioned the health of drug using patients was by 
defining drug use, addiction, and dependence as a disease. The health care practitioners deployed 
both the disease model and neuroscience to explain drug addiction and dependence, sometimes 
simultaneously and other times independently. Several of the health care practitioners who 
asserted their belief in the disease model also remarked that this model could be strategically 
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deployed to reduce the stigma of addiction for less sympathetic audiences of colleagues. 
Attempts by health care practitioners to remove blame and reduce stigma through use of the 
disease model coincide with principles of acceptance and non-judgment found in constructions 
of harm reduction.  
 Andrew, the primary care physician mentioned earlier, articulated a clear explanation of 
how he understands addiction. He framed his explanation by saying that this is how he teaches 
addiction to medical students:  
There are several models that people believe in about addiction. I firmly believe in the 
biological model, that it is like any other sort of disease. In this case you lack the natural 
production of endorphins when it's heroin or opiates. So I explain it to people like it's 
diabetes. Like your body can no longer make insulin, you have a sort of dependence, you 
need medication, you need help to do that. If you treat it like any other disease, it makes 
it easier to understand that it is actually a chemical imbalance. There's a lack of a 
chemical in your body and that explains why you have cravings or why you sort of have 
those feelings and it's not just your psychological will or psychological decision. There's 
nothing wrong with you anymore than there's something wrong with someone who has 
diabetes. 
In describing his understanding of opiate addiction, Andrew states that he believes opiate 
addiction is like a disease. His explanation is neurochemical and, as found among other health 
care practitioners, Andrew describes addiction as similar to diabetes in that the body cannot 
produce a certain chemical (insulin or endorphins) that it needs. In Andrew’s explanation, the 
assignment of a chemical imbalance to the drug using body releases it from governance over its 
own psychological will. 
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 Julia, who was mentioned earlier, provides a similar explanation, though she specifically 
refers to chronic drug use as a disease. Additionally, she’s more explicit about the effects of drug 
use on the brain: 
When I think about like chronic use, so sort of leaving aside casual pot smokers, and 
chronic drug use as a medical problem, it’s a disease. That’s what I’ve been taught and 
it’s clearly the case from working with drug users, clearly a disease, not a choice. It’s just 
not people deciding to do this for kicks. My understanding of the physiological effects on 
the brain is that when people use drugs their brain and body chemistry changes and then 
they become physically addicted but also psychologically different. Their brains respond 
differently to the drugs than people who haven’t used the drugs. Dealing with it as a 
problem requires a medical model the way that we deal with diabetes. It’s a chronic 
disease. It’s not something that tends to be quick and then be over. 
Julia directly associates the disease of “chronic use” with the will of drug users when she says 
drug use is “clearly a disease, not a choice,” pointing out the lack of agency inherent in 
constructions of disease.  
 Within both Julia and Andrew’s explanations of addiction, the lack of “psychological 
will” or “choice” is evident, and works to remove responsibility for drug use from the patient. In 
describing the use of harm reduction in their medical practices, both Julia and Andrew expressed 
the importance of avoiding exhortations of abstinence when caring for drug using patients. 
Deploying a formulation of the disease model, which releases the drug user from control over the 
usage of drugs, means that drug use can now be accepted and moral judgment avoided—two 
core principles of harm reduction. As proponents of harm reduction, Julia and Andrew can 
practice their commitments to harm reduction through the use of the disease model by a 
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contingent negation of the will. 
 Demonstrating self-reflexivity and an activist approach, Andrew explained that deploying 
a biological model of addiction can work to destigmatize drug use. He stated: “And it's the same 
model when I'm teaching residents and med students that is what I try to focus on as well to 
minimize all the stigma, the judgment that goes into it.” Andrew’s use of this model allows his 
commitment to the destigmatization of drug use to come through in his medical educational 
endeavors. 
 Another primary care physician who prescribes buprenorphine, Elizabeth, described how 
she uses certain language to discuss drug use with her colleagues in order to reduce stigma. 
Elizabeth provides care in a primary care clinic and an HIV clinic at a public hospital. She also 
supervises what she refers to as a  “harm reduction program” in the HIV clinic, which provides 
patients with access to an on-site substance abuse counselor. This statement came in the midst of 
a discussion during my interview with Elizabeth about the ways disease itself can be 
stigmatizing:   “. . . when I talk to my medical colleagues about it [drug use], I do emphasize 
what we know about the neurochemical aspects of substance use disorders because it’s a 
language that they understand. . . . And I think it is de-stigmatizing for them.” Elizabeth is 
interested in de-stigmatizing drug use for her colleagues, and thus deploys neurochemical 
vernacular when talking to them. Elizabeth’s deliberate and strategic use of a biological 
explanation aims to increase the acceptance and reduce the judgment surrounding illicit drug use 
among her medical colleagues. 
 Elizabeth also offered a nuanced description of when, in providing health care to drug 
users, it’s appropriate to use the disease model and when a harm reduction approach is more 
relevant. Her differentiated use of the two models reveals a contingent recognition of 
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autonomy—in some contexts the will of the drug user is relevant, while in others it is not. She 
explained:  
If I was counseling someone in a harm reduction program, I’m not sure I’d spend my 
time on the disease model or think of them in that way necessarily. But where it’s most 
meaningful to me is in the primary care context. There are people with unhealthy or risky 
patterns of use who do not have a substance use disorder, who do not have maybe the 
disease of dependence, whether abuse is a disease or not, I truly don’t know, but who 
don’t have dependence. I think dependence is something that is palpable and evidence-
based and distinguishes the level of treatment or the level of intervention that it might 
take for that person to make changes in their substance use. So in that context, I think it 
[the disease model] works. But for the full spectrum, I’m not sure that it does.  
For Elizabeth the disease model does not have a place when counseling someone at a harm 
reduction program, someone who may have “risky patterns of use.” Where it does belong, 
according to Elizabeth, is in determining the “level of intervention” needed to change the 
patient’s substance use. Elizabeth describes the palpable presence of opioid dependence and 
refers to it as a disease. While discussing the disease model and harm reduction, Elizabeth also 
noted that she feels she does not need to adopt a harm reduction perspective when treating 
patients for addiction: “So I think that from my perspective, I buy it [harm reduction], but I don’t 
feel like I need to employ it in every case. If a patient is seeing me for [drug] treatment in clinic, 
then that’s my perspective towards them.” Using a contextual approach, Elizabeth reserves the 
disease concept for patients she is treating with buprenorphine and uses harm reduction to 
counsel those with risky patterns of drug use. Both types of patients, the diseased patient and the 
	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   	   	  
	   	   	   	  
151 
risky drug user, will be met with interventions, the levels of which differ along with the 
gradations of autonomy. 
As Elizabeth, Andrew, and Julia show use of the disease model is deliberate and 
strategic, while at the same time, what disease means and where it should and can be applied is 
flexible. Though mobilizing it in different ways, all three physicians maintain their usage of the 
concept of disease to describe addiction (Andrew), chronic use (Julia) or drug dependence 
(Elizabeth). Flexibility in meaning and usage allows the disease concept to maintain its relevance 
through continuous re-constructions. Through deploying the model, some health care 
practitioners can bring their ideological commitment to the de-stigmatization of drug use into the 
medical context. This opens the question or concern of whether harm reduction logics are being 
usurped by the power of the medical field. Similar to the encroachment of medical jurisdiction 
emphasized by theorizations of medicalization (Conrad and Schneider 1992; Zola [1972] 2013), 
the disease concept of addiction, as articulated by the health care practitioners, is incorporating 
ideas from harm reduction. Here, it is important to point out that the interviewees were a self-
selected group of health care practitioners particularly sympathetic toward drug users and 
interested in their well-being. 
CONCLUSION 
 In revealing rectifications and recuperations of the disease model of addiction among 
health care practitioners who embrace and practice harm reduction, this analysis notices a 
conflicted, as well as contingent, mobilization of drug user autonomy. The health care 
practitioners activated harm reduction in their medical practice by educating their patients about 
safer drug use practices and accepting on-going drug use without judgment. When practicing 
harm reduction, the health care practitioners implicitly acknowledged their patients’ autonomy in 
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decision making about taking drugs. In discussing their use of the disease model of addiction, the 
health care practitioners noted that addiction negated “psychological will” (as voiced by 
Andrew) and “choice” (as voiced by Julia), and that it required a certain level of medical 
intervention. These depictions allowed the health care practitioners to deploy ideological 
principles of acceptance and non-judgment associated with harm reduction philosophy. The 
disease model was used by the health care practitioners to excuse drug users from responsibility 
over their use of drugs and to de-stigmatize drug use when speaking to medical colleagues. The 
lack of will in these constructions of addiction as disease served as the mechanism through 
which harm reduction’s ideological principles could be made visible.  
 The use of models of care that simultaneously recognize and negate the will of people 
who use drugs is indicative of the operation of two technologies of power—pastoral and 
disciplinary. Both Foucauldian constructs, pastoral power denotes the devolution of care to the 
individual, such that technologies of the self, such as personal risk reduction and psychological 
therapeutics, are voluntarily practiced at the level of the individual (Orr 2010). Disciplinary 
power marks the reformation of docile bodies through internalized institutional power (Foucault 
1979). With the recognition that “addiction treatment has become a primary site for the 
reeducation and reform of poor people,” the connection between addiction and “old-fashioned” 
disciplinary institutions becomes clearer (Gowan 2013). As institutions are expressions of 
regimes of power (Foucault 2007a), addiction treatment programs are expressions of disciplinary 
power directed at the docile body whose will must be reconfigured. The attenuation of will 
constructed by notions of addiction as disease is the discursive technique that lends reason to 
disciplinary technologies of power. The resultant institutions of disciplinary power in the form of 
drug treatment facilities have been found to transform the biomedical diagnosis of addiction into 
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a moment for moral and cultural reinvention (Gowan and Whetstone 2012). These facilities are 
often linked to the state through funding sources, such as Medicaid reimbursements, and the 
criminal justice system when it mandates drug treatment. This reveals a link between the state 
and biomedicine whereby a medical diagnosis may lead to state sanctioned re-socialization. 
 Medical settings, such as primary care clinics, can also be understood as sites of 
disciplinary power where patients are evaluated by reference to norms and subject to attempts at 
reformation. The deployment of discourses that support self-governance, such as that of harm 
reduction, in a medical setting may be used as a strategy to further engage patients in medical 
care. Thus, pastoral power may work to facilitate attachments to disciplinary institutions. 
 The analysis in this chapter reveals that within biomedicine drug users may be subject to 
two forms of normalizing power—one enacted through self-care and the other through 
disciplinary reformation. While drug users have been drawn into the wide nets cast by diffuse 
channels of power that govern through encouragement of self-care, such as that exhibited by 
harm reduction, they are still subject to forms of power recognized as disciplinary. The continued 
obliteration of the will enacted by the construct of addiction assures this. 
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Chapter 5 
A Broader Sensibility: Examining Narratives of Risk and Illness toward Expanding the Mission 
of the Harm Reduction Movement 
 
“These days my health concern is not to contract HIV”  
Dorian, white, age 40 
“Health-wise, I feel good except for right now I have this thing called sciatica.” 
       Ricardo, Latino, age 42 
 
 Asking economically marginalized people who inject drugs about their health resulted in 
a wide variety of responses ranging from psychiatric concerns to worries over the genetic 
predisposition of disease to managing diabetes. As evidenced by the quotes from Dorian and 
Ricardo above, health concerns were occasionally related to injection drug use and other times 
they were not. Discussing health with the drug users I interviewed resulted in two types of 
narratives--those of risk and those of illness. The interviewees tended to speak of risk in two 
ways. Some spoke utilizing the discourse of harm reduction--describing their desire to avoid 
infectious diseases, such as HIV and hepatitis C, and their desire to avoid overdose. These 
individuals talked about needle usage or prescribed ways of avoiding opiate overdose, for 
instance. Other risk narratives centered on such worries as genetic predisposition for disease and 
obesity, and thus did not involve harm reduction discourse. The narratives of illness voiced by 
the interviewees were often stories of survival in conditions of absolute poverty. They, too, did 
not include allusions to the risks of drug use, but rather focused on immediate health needs. This 
chapter will explore how both types of narrative operate to mobilize certain types of selves 
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within low-income drug injectors’ discussions of health and what the implications are for 
societal efforts toward addressing the health and well-being of people who use drugs. Since all 
but eight of the interviews I conducted with people who inject drugs were carried out onsite at 
harm reduction centers, and six of those eight interviews were conducted at a research field site 
that provides harm reduction education, it is important to discuss the implications of my findings 
for the harm reduction movement, especially since it is frontline in addressing the health 
concerns of drug users.  
 Rather than focusing on the overall health of drug users, harm reduction in the U.S. has 
evolved such that technical interventions on needle use and drug consumption remain its primary 
focus. Most historical accounts of harm reduction place its origins in the Junkiebond of the 
Netherlands, which functioned as a type of trade union, “to improve the housing and the general 
situation of the addict” (Marlatt 1996: 784; cited in Wijngaart 1991: 39). Through a series of 
politicized and contextually influenced transitions, harm reduction in the U.S. became an 
institutionalized, technical response to the proximate harms of drug use. The transmission of 
HIV/AIDS was initially the harm focused upon by the movement, but the movement has since 
expanded its focus to the transmission of hepatitis C and overdose prevention. In Northern 
European countries, Canada, and Australia, harm reduction has also become institutionalized 
within a public health framework (Keane 2003; Marlatt 1996), and thus in terms of drug use, 
remains largely focused on technical rather than social interventions. Notably, many of these 
countries have sanctioned more politically radical harm reduction practices such as prescribed 
heroin and supervised injection spaces. While these may lessen the vulnerability of drug users to 
arrest and the health risks of injection drug use, they still leave individuals vulnerable to the 
ravages of social and economic marginality. However, there exists a sizable contingent of 
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academics abroad writing critically against this direction (e.g., Fischer et al. 2004; Fraser 2004; 
Moore and Fraser 2006; Roe 2005; Smith 2012). 
 Harm reduction discourse was peppered throughout most of my interviews with people 
who inject drugs, but when describing health concerns most interviewees discussed situations 
and worries that did not align with the current focus of harm reduction’s pro-health interventions. 
While it may be impossible to restore harm reduction to its earlier iteration as a movement 
broadly aimed at improving the lives of drug users, remembering the roots of harm reduction, 
namely the Junkiebond, can influence future efforts toward recognizing a broader range of 
concerns among marginalized people.     
This chapter will show how the narratives of risk and narratives of illness voiced by the 
drug users I interviewed reveal two ways in which individuals construct themselves as personally 
and ethically responsible subjects. Narrative analysis has long been used in sociological studies 
of the illness experience to reveal the meanings and knowledge produced by the sufferer. Illness 
narratives draw attention to the lived experience of illness as a field of knowledge that works 
along with medical knowledge to socially construct illness and health (Bell 2000). Studying 
narratives of illness, “… draws attention away from medical settings and medical perspectives on 
disease and toward the nonmedical settings and nonmedical perspectives of everyday life” (Bell 
2000: 184). Specifically important to the analysis here, illness narratives in many cases exhibit a 
“narrative reconstruction,” in which “… disturbance and suffering are brought under some form 
of meaningful control” (Bury and Monaghan 2013: 82). Furthermore, illness narratives may 
function as moral narratives that offer “… ways of presenting the self as virtuous in comparison 
with others” (Bury and Monaghan 2013: 83). In this way the illness narratives offered by 
interviewees presented windows into the construction of the self in relation to ideas of personal 
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responsibility and ethicality often in settings of poverty. 
Similar to narratives of illness, narratives of risk reveal the meaning individuals attribute 
to particular risks they encounter and also offer opportunity for the construction of responsible 
and ethical selves. Some of the narratives of risk found in this research were linked to the agenda 
of the harm reduction movement in the U.S. That is, the health risks mentioned offered a 
conceptualization of health that is fully recognizable to and supported by the harm reduction 
movement. The concept of health addressed by harm reduction as it appears in the U.S. is linked 
to risk and particularly the proximate risks, such as HIV and hepatitis C, associated with drug 
use.  
Risk 
In fact, risk has become a dominant way in which health is measured in the U.S. A 
calculus of risk factors has come to stand in for health in biomedical and epidemiologic contexts. 
It is not that the treatment of injuries or diseases has lost priority to the anticipation of ill health, 
but rather that risk factor calculations on the individual and aggregate level play a large role in 
shaping our current understandings of health. The whole of modern medicine has seen a shift in 
which the calculation of health risks has come to replace the individualized interview between 
practitioner and client (Castel 1991: 281).  As Castel sees it: "The new strategies [of risk 
calculation] dissolve the notion of a subject or a concrete individual, and put in place a 
combinatory of factors, the factors of risk" (1991: 281). On the individual level, this means that 
health is determined by quantitative and qualitative measures of risk for future ill health. In the 
biomedical context, this tabulation of risks comes to stand in for one’s level of health. On the 
population level, health is ascertained through surveillance and calculated based on risk.  As 
Clarke et al. (2003) find, something else is borne of this process of surveillance and calculation--
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more specificity and standardization. They state: “Risk and surveillance mutually construct one 
another: Risks are calculated and assessed in order to rationalize surveillance, and through 
surveillance risks are conceptualized and standardized into ever more precise calculations and 
algorithms” (2003: 172; citing Howson 1998; Lupton 1995, 1999). Through mutual re-
enforcement, risk and surveillance beget more risk and surveillance, and our conceptualization of 
health becomes more refined by an increased specificity of risk.   
 As an individual, to be healthy means to have a relatively low level of risk factors or to 
be successfully managing the risk factors one is presumed to have. Through the identification of 
health risks, individuals are enjoined to self-manage and pursue an increasingly out-of-reach 
notion of health. As Petersen (1997) sees it, risk plays a crucial role in ‘neo-liberal’ societies by, 
“… distancing experts from direct intervention into personal lives, while employing the agency 
of the subjects in their own self-regulation (‘risk management’)” (p. 203). For those on the losing 
end of socially structured inequality, such as low-income people who inject drugs, the imperative 
of self-management can translate into blame for the effects, health or otherwise, of poverty and 
discrimination. People who inject drugs are, of course, recipients of, and participants in, the 
proliferation of risks and their synonymous association with current notions of health. Harm 
reduction-based, public health interventions employ the agency of drug users in their own 
governance, and thus facilitate practices of risk management.  
 The atomizing emphasis of pastoral power is in effect when people who inject drugs 
claim personal responsibility for managing their health risks and chronic illnesses. Governed by 
discourses of risk, as well as political ideologies that organize structures of public assistance, 
these individuals often must expend a tremendous amount of energy and determination to 
maintain their health within conditions of social and economic marginality. Gowan (2012/2013) 
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explains: “The great risks collectivized by the welfare states—unemployment, poverty, sickness, 
and death—shift to the domain of individual responsibility and self-care, rewarded and punished 
with conditional cash benefits and deductions.” Governmentality is still relevant for those who 
express their health concerns in terms of illness rather than risk because they are subject to the 
governing of the welfare state. 
In this chapter, I will first examine the narratives of risk, which were inflected with harm 
reduction discourse. It is important to recognize that harm reduction has shaped the ways some 
drug users talk about their health and their selves though these instances were limited in scope 
and number. Then, I will discuss the other narratives of risk I encountered, which revealed the 
non-drug use related health concerns of low-income people who inject drugs. Next, I will present 
narratives of illness, which were also unrelated to drug use, and offer a way to understand the 
link between health and structural inequality. These are representative of the health concerns I 
heard most often from the drug injectors I interviewed. They present health concerns that fell 
outside of the harm-reduction-as-public-health-intervention paradigm. However, all of the 
narratives I heard contained elements of a concern for personal responsibility toward managing 
health and illness, and thus allowed interviewees to construct responsible and ethical selves in 
the face of harrowing conditions of poverty and social stigmatization as drug users. Interviewees 
were able to construct themselves as “good” citizens through the help of harm reduction 
discourse, as well as narratives of pro-health endeavors. Their constructions support Metzl’s 
(2010) claim that more than being a desired state, health is also a “prescribed state” and an 
“ideological position" (pp. 1-2).   
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FINDINGS 
Narratives of Risk 
In this section of the chapter, I will examine the limited ways the discourse disseminated 
by harm reduction has impacted interviewees’ understandings of their health and ultimately their 
selves. In this section, all references to “harm reduction” are to its existence as a public health 
intervention rather than its historical configuration as a broader social justice movement. The 
behavioral practices advocated by harm reduction allow drug users to reduce the riskiness of 
their drug use, and thus promote a healthier way to use drugs. This claim toward healthiness has 
reshaped the conceptual contours of bodily health in some limited ways for the targets of these 
interventions—people who inject drugs.  
Since all but two of the interviews were conducted in settings where harm reduction was 
promoted, it is perhaps unsurprising that this type of discourse emerged in the interviews. Some 
of the typical messages that adorned posters on office walls asked if individuals had been tested 
for HIV or hepatitis C and enjoined injectors to only use a needle one time. One poster at the 
research field site read “It’s All About the Blood. Prevent Hepatitis C” and showed pictures of 
injection equipment contaminated with blood. Another poster simply said, “Naloxone Saves 
Lives” referring to the antidote for opiate overdose that individuals can be trained to administer, 
and is distributed from harm reduction centers. At harm reduction centers, as well as at the 
research field site, participants receive structured and unstructured education on harm reduction 
matters through interactions with staff. As my interviews show, the messages that circulate in 
these settings are internalized by injectors with varying motives for their deployment. Even the 
two interviewees—Dwight and Victor--who were not interviewed in locations that promoted 
harm reduction, spoke about their health and their selves in terms of infectious disease and 
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needle sharing, showing that they had encountered harm reduction messages at some point. Their 
narratives of risk will be discussed below. 
Two themes emerged in the ways harm reduction discourse appeared within risk 
narratives found among the forty interviews conducted with economically marginalized people 
who inject drugs. First, infectious disease and overdose were mentioned as a health risk for 
several interviewees, above and beyond other health problems, reflecting two of the main goals 
of harm reduction—to reduce the spread of blood-borne pathogens like HIV and hepatitis C and 
to prevent opiate overdose. Second, in some narratives of risk adherence to harm reduction 
practices was put forth by interviewees to position themselves as responsible, ethical drug users. 
Thus, harm reduction as a practice was able to link the avoidance of risk through certain 
behavioral practices to ethical and responsible subjecthood for some of the interviewees. 
Injectors who self-govern to decrease risk for themselves and others were able to construct 
ethical selves through the use of harm reduction discourse. These narratives reveal how the shift 
to individual risk as a way to define health results in the application of ethics on the individual 
level rather than the social structural level. In a turn typical of neoliberalism, the emphasis is on 
crafting the individual as ethical rather than focusing on improving the ethics of social structures 
and institutions.  
 Before discussing the deployment of harm reduction discourse by the interviewees in this 
study, it is important to point out that several researchers have found that when interrogated 
about their injection practices, as people who inject drugs often are when participating in public 
health research or receiving harm reduction services10, they will repeat the tenets of safer 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
10	  There is often a blurring of the line between academic researchers and social workers since 
researchers often provide material and educational resources while collecting "data."  Likewise, 
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injection communicated in health promotion material and by community health outreach workers 
(Bourgois and Schonberg 2009; Campbell and Shaw 2008; Fraser 2004). Drug users know how 
to answer the questions of social science and public health researchers about needle use 
practices, and will repeat pre-packaged claims of bleach use and refusal to share needles. 
Campbell and Shaw (2008) assert that: "Repeated invocations have multiple aims, including the 
dismissal of moralistic claims issuing from the public health domain, shielding users from further 
'intervention,' and establishing ethical harmony between participant and researcher" (p. 696). In 
their ethnography of homeless injectors in San Francisco, Bourgois and Schonberg (2009) also 
found that their subjects would assert their public health worthiness by repeating standard HIV 
prevention instructions despite the structural and environmental obstacles to following them. A 
lack of consistency between what is told to researchers and actual behaviors was noted among 
Campbell and Shaw's (2008) study participants highlighting the Foucauldian notion of 
"incitement to discourse" which denotes the results of disciplinary power flowing through the act 
of confession or here, the research interview.  
 Bourgois and Schonberg (2009) discussed how counselors seeking to prevent the spread 
of hepatitis C engendered resistance among the long-term street-based addicts when they 
exhorted them to take personal responsibility for damaging their bodies. They write: "The 
interaction reaffirmed the 'hope-to-die-with-my-boots-on' righteous dopefiend subjectivity 
among the Edgewater homeless. Being willfully and oppositionally self-destructive feels like an 
empowering alternative to conceiving of oneself as a sick failure who lacks self-control" (2009: 
109). The men in Bourgois and Schonberg’s ethnography were effectively coached on what to 
say in terms of their injection practices, but chose to resist this disciplining. Thus, there can be 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
social workers may also ask research-like questions to gather "data" about their client base, in 
addition to providing material and educational resources. 
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inconsistency between what drug users say to community health workers and researchers about 
their injection practices and the actual behaviors in which they participate, as well as outright 
resistance to the normative standards of health imposed by these interlopers. At other times, as 
Campbell and Shaw (2008) and Fraser (2004) found, drug users may feel compelled to repeat the 
public health messages they’ve received in order to appear ethical and responsible, and to ward 
off further interrogation into their drug use practices.  
 These investigations into the deployment of harm reduction discourse are instructive for 
understanding the ways injectors responded to the health-related questions asked in my research 
study. The possibility that interviewees in this study are incited to discourse, as Campbell and 
Shaw (2008) describe, must be recognized, though it may be impossible to know from the 
interviews alone what exactly is happening in terms of discourse and “true” beliefs. As Bourgois 
and Schonberg (2009) show, sometimes discipline is resisted and self-destructive behavior is 
openly discussed, and at other times, as shown by Campbell and Shaw (2008) and Fraser (2004), 
drug users may adopt the language and logics of public health interventions. In terms of making 
sense of the discourse used by people who inject drugs, it is important to recognize that even if 
they are simply repeating harm reduction messages they’ve heard elsewhere, they are still 
reproducing the messages in a way that makes sense to them, which makes these utterances 
indicative of the interviewees’ thoughts and feelings. It is sociologically interesting to understand 
what I heard from my interviewees as both representative of what they thought I wanted to hear, 
as well as simply what they were thinking in that context and at that time. The thoughts and ideas 
of the interviewees presented here should be read with this tension in mind. 
 Infectious disease and overdose. One way that I understood harm reduction interventions 
to impact the interviewees’ relationship to health was through the specter of two infectious 
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diseases—HIV/AIDS and hepatitis C—within the narratives of risk. One of the more telling 
questions I asked during interviews examined the main health concerns of the interviewees. The 
immediate response to this question of Dorian, a 40-year-old white bike messenger, provides an 
example of the mental proximity of harm reduction discourse for some of the interviewees. 
Dorian answered this inquiry right away with a concern about risk, although he may not have 
completely understood the question.   
 Kelly:  These days what are your main health concerns? 
Dorian:   These days my health concern is not to contract HIV.  I have…  say that 
again? 
Kelly: (repeats the question) 
Dorian: I had hepatitis C since I have been 18 years old. I’ve been diagnosed with 
it. I am an exposure victim, not a carrier. 
Dorian went on to describe his liver biopsy and non-existent viral load using technical language.  
 I was exposed to the virus and developed an antibody for it. It did not integrate into my 
liver because I had the biopsy done even though the biopsy is not 100%.  I had the 
[screening] done on the biopsy looking for liver particles, looking for the DNA of the 
viral particles, which none were found. I haven't done it since then but I also have no 
elevated enzymes, no elevated liver levels, none of that, no viral load in my blood stream. 
I test positive for antibodies but [for the actual virus] I come up negative.   
Through his use of biomedical language, such as viral particles, enzymes and viral load, Dorian 
demonstrates that he’s taken personal responsibility for monitoring his liver health by learning 
about hepatitis C and the tests that are conducted to diagnose it. He has also made efforts to 
manage his health by submitting to such tests. 
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 Dorian defines his health concerns through and with two of the key drug user health 
problems addressed by harm reduction interventions—HIV and hepatitis C. He is also able, 
through his discussion of hepatitis C, to express the responsibility he has exercised in addressing 
this potential health concern.  
 Another example of the deployment of harm reduction discourse while defining one’s 
health concerns occurred during my interview with Yusuf, a 24 year-old homeless Arab man. 
When I asked him about his health concerns and whether he had any worries about his health, he 
replied: “Yeah. I don’t use other people’s syringes. I could get hep C or AIDS or HIV like that. 
That’s my main concern. Or overdose.” Yusuf’s immediate reference to syringe use, hepatitis C, 
and HIV/AIDS shows how close at hand harm reduction discourse can be for some people who 
inject drugs when they talk about health. Yusuf links his understanding of his own health to the 
risks of syringe use, and thus harm reduction educational messages about syringe use resonate 
with his main health concerns as stated. Further, Yusuf is able to show that he is a responsible 
drug injector by mentioning harm reduction’s three main targets of intervention and how he 
avoids at least two of them by not using other people’s syringes.  
 My interview with Dwight, a 53-year-old African-American man, was one of two 
interviews that took place in a setting unrelated to harm reduction. I met with him at a donut 
shop. As soon as I began to ask the questions pertaining to health in the interview guide, he 
proclaimed his HIV status. The exchange went like this: 
Kelly:  Ok let's talk about your health. This is a study about health so how do you feel 
these days? How's your health? 
Dwight:  It's fair. I have no AIDS. No AIDS.   
Kelly:  No HIV or? 
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Dwight:  No HIV. Let me show you something. [retrieves a folded document from his 
wallet] I took an AIDS test over here... No hepatitis, no anything. 
Kelly:  That's great. 
Dwight:  Male, African male… I took it ten, twelve, two thousand eleven and it's been 
dated by these people. Ok, non-reactive and anything else non-reactive. 
 
To my surprise and without even asking, Dwight revealed his HIV negative status and produced 
documentation to, perhaps, prove to me that he was actually HIV negative. Dwight’s image of 
health is undoubtedly shaped by his HIV status and materialized through the document stating it. 
When I asked if he was nervous when he took this HIV test, Dwight said that he was and 
explained:  
 I used behind a girl, a beautiful girl, drop dead gorgeous. You would never think that she 
 was infected but she wasn’t. She’s loaded with money. She works on Wall Street. Those 
 are the people I’ve dealt with. Very picky. I’m very picky. I’m telling you the truth. I’m 
 not going to lie to you.  
Even though Dwight shared a needle, which could be construed as an irresponsible act, he 
presents himself as responsible in that he shared with a wealthy, beautiful girl. Dwight’s 
emphasis on HIV status and this instance of syringe sharing demonstrates how his construction 
of healthiness includes both the risk of HIV infection and his own syringe use. 
 Across these three interviewees—Dorian, Yusuf and Dwight—infectious disease is a 
prime concern rising above any other ailments they were concerned about or experiencing. For 
these men harm reduction public health interventions address their foremost health concerns and 
the practices promoted by its interventions can be utilized by this group to address their health 
concerns as they see them.  
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Another focus of harm reduction interventions among drug users is the prevention of 
drug overdose. While overdose was mentioned by several people who inject drugs during their 
interviews, only one, Ashley, a 22-year-old biracial homeless women, mentioned it first as her 
primary health concern. When I asked Ashley what her health concerns are, she responded: 
Just like dying. Overdosing. Everybody I know is dying--three people in the last month. 
They just can't get right out of some place after a year and go back to doing a whole 
bundle. People go to sleep and they don't wake up. I'm just scared. I don't really sleep. I'm 
scared.  
When Ashley refers to people getting out of “some place,” she is referring to a drug treatment 
program. One of the most dangerous times for people who frequently use opiates is right after 
release from a drug treatment program. Following days or months of abstinence, one’s tolerance 
for opiates decreases. If a person decides to use, he or she may misjudge dosage and take too 
much, leading to an overdose. Ashley expressed her great fear of this risk of opiate use as her 
main health concern. The harm reduction movement has focused great effort on educating drug 
users about overdose prevention, and Ashley’s main health concern aligns with this educational 
program. 
As found in the research on harm reduction interventions mentioned above, it could be 
that these interventions have successfully coached some drug users in the framing of their own 
health concerns around infectious disease or overdose. While mere interviews cannot show if 
harm reduction interventions have taught Dorian, Yusuf, Dwight, and Ashley how to prioritize 
their health concerns, it is presumable that this sustained, wide-reaching biopolitical campaign 
has served to shape self-understandings of health for some drug users and given them the tools 
for presenting themselves as responsible citizens.   
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 Ethical subjects. Beyond producing a notion of health, the use of harm reduction 
discourse within risk narratives allowed the interviewees to present themselves as ethical 
subjects of the governing provided by harm reduction public health interventions. Interviewees 
presented themselves as upstanding subjects of harm reduction by affirming their strong 
resistance to sharing syringes and by reporting the use of proper injection techniques. For some, 
this meant producing an ethical subjectivity by reference to the ways they maintained their 
health. Marco, a 30-year-old Puerto Rican handyman, furnishes an example of the connection of 
harm reduction practices to the maintenance of health, and in turn, their connection to a 
normative judgment. While discussing his surprise at not “having anything,” meaning HIV or 
hepatitis C, after being tested upon his entry into the prison system, he stated: “I never shot up 
with nobody. I never shared needles or intercourse when it comes down to sex… In those ways 
I’ve been good.” Marco attributes being “good” to following two central proscriptions of harm 
reduction educational interventions—sharing needles and unprotected sex. It is interesting to 
note that Marco was surprised the he didn’t “have anything” despite obeying harm reduction 
proscriptions. This is a testament to the fear instilled in drug users by harm reduction teachings. 
 Some of the interviewees also presented themselves as ethical subjects of harm reduction 
by discussing their refusal to give others their used syringes. During a conversation about 
avoiding abscesses from injection, Rebecca, a 34-year-old Latina, stated: 
I am like very cautious and stuff. I am. People will be asking me, “Do you have a 
syringe?  Can I use…? No.” Even though I’ve used it already and I’m going to throw it 
away, I still don’t feel comfortable. God forbid something happens. I’m going to feel like 
crap.  
Through this statement, Rebecca explains the level of caution she uses with respect to syringe 
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sharing. The caution she takes extends outward to others, over whose safety she takes caution. 
While in the end, it appears that Rebecca is exercising this degree of caution because she does 
not want to “feel like crap,” she is also making a claim about her personal ethics. Making this 
ethical claim is only possible through the use of harm reduction discourse on the sharing of 
syringes. 
 Victor, a 41-year-old Latino security guard with a lengthy history of incarceration, 
explains his personal ethics using harm reduction discourse on needle sharing. Interestingly, 
Victor’s interview was the other interview that took place in a location unrelated to harm 
reduction. During a discussion of the meaning of harm reduction, Victor proclaims: “I don't 
share needles. Never. No, never. If I want to use something, I go and buy it.” I asked if he 
purchases his needles from a pharmacy and he replies: “Yeah, I buy it. That's how I get 
everything. Everything is clean. I will never share nothing with nobody. Never. Never did. I 
won't do that.” Victor’s emphatic reply and his clear statement of unwillingness to share needles 
is evidence of the personal ethic he has developed around syringe use. He seems to have a rule 
about needle sharing that he upholds with emphatic strength. Victor is clear in presenting himself 
as having strong personal ethics with regard to syringe use, ethics that are able to be spoken 
because of harm reduction discourse.  
Another way an ethical self was crafted was through the discussion of injection 
techniques. Harm reduction interventions spend considerable time and resources advocating for 
certain injection practices, such as always using clean needles, cleaning the injection site, and 
being precise when finding a vein, among many other practices. Alicia, a 48-year-old Latina, 
presents an example of the link between ethical subjecthood and proper injection technique. 
When asked if it’s possible to inject drugs in a healthy way, she replies: “Well yeah, properly. 
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Like me I do it just when I need it.” I asked her to clarify what she means by properly and she 
replies: “Using proper new needles, disinfecting the area, cleaning it out and taking your time.” 
Alicia insists upon the propriety of certain injection techniques, namely those that are taught 
through harm reduction educational interventions. By including that she injects “properly,” 
Alicia makes a claim about herself as an injector. She is able to present herself as an ethical 
injector through the use of harm reduction discourse. Harm reduction enables ethical 
subjectivity, and does this through its claims to protect public and personal health. 
 Other risks. When asked about their main health concerns, several interviewees 
mentioned risks to their health that were unrelated to HIV/AIDS, hepatitis C, and overdose, and 
furthermore, were not directly linked by the interviewees to drug use. The framing of health 
concerns as risks unrelated to HIV/AIDS, hepatitis C, or overdose merit mention here because 
they reveal the use of risk in conceptualizing health. By discussing their health in terms of risk, 
the interviewees constructed responsible selves through demonstrating that they were monitoring 
health risks. The assessment of health through the lens of risk, as mentioned before, has become 
a way to govern individuals by requiring them to actively participate in processes of on-going 
self-care. Low-income people who inject drugs have not been exempt from this societal shift in 
the assessment of health. To give a sampling of the types of risks mentioned by these 
interviewees, I will describe the risk narratives voiced by several of the interviewees when I 
asked: “What are your main health concerns these days?”    
Two interviewees mentioned genetic risk. Linda, a 56-year-old Latina who is stably 
employed as a waitress said: “My main health concern is I'm always worried because cancer is 
such a high risk in my family.” Linda went on to explain that she would like to be scanned for 
cancer and was trying to figure out where to get this done. Brian, a 47-year-old white homeless 
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man said: “I would question my heart, because my dad died of heart complications. I have two 
brothers who died of heart complications.” Unlike Linda, Brian did not mention taking any steps 
to monitor this risk, though articulating his main health concern through the language of risk is 
telling. 
 Other interviewees expressed concern for the health risks posed by smoking cigarettes. 
Helen, a 40-year-old white woman, mentioned this concern along with another one: “My main 
health concerns are smoking and what’s going on now with me because I’ve been smoking for so 
many years and the weight.” She went on to say: “I’ve noticed I’m wheezing. I’m a little short of 
breath.” Helen showed that she was monitoring her health. Also concerned about smoking, 
Angela, a 29-year-old white woman, stated: “My main health concerns? I want to quit smoking. I 
have asthma too. What I think about the most health-wise, what I think about the most is that you 
are killing yourself. I think about really quitting smoking…” At several points in the interview 
Angela conveyed frustration at herself for not participating in prescribed self-care practices. At 
one point she proclaimed: “I feel like I know how to stay healthy and why don’t I do it? You 
know what I mean? I don’t know how to say it. I can hear the words but…” Angela is aware of 
the responsibility she should exercise in taking care of her health but she feels unable to align her 
behavior with her thoughts. Perhaps, if she could say it in a certain way, she might truly “hear” 
the necessity of self-care and take action. Angela felt stuck in an internal struggle: “That’s why 
it’s frustrating because I know that I should be doing this when I’m doing this. It’s been a battle, 
a struggle in my head between myself.” She does one thing, even though she knows she should 
be doing another. Angela feels the call to responsibilization within herself as a struggle between 
maintaining her present behavior (e.g., smoking) and acting in accordance with the ideology of 
health (Metzl 2010). 
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 When discussing her health concerns Helen also mentioned her weight. She articulated a 
concern for how it presently made her feel, as well as for the future health issues it could cause: 
“I don’t have any health issues yet. I’ve only had it [the extra weight] on me for a couple of 
years. It’s just how I feel. It’s unhealthy. It slows you down a little. I don’t know if that’s worse.” 
Helen was uncertain what was worse in terms of her weight--the risk it poses or its present effect. 
As far as who or what is responsible for her weight gain, Helen was divided: “It [her weight] was 
always just regular like that and I guess you can say life changes. I went on methadone and I 
really… a lot of people don’t want to admit it but it slows your metabolism, and you’re trying to 
substitute food for the drug, and it’s a catch 22.” Despite the measured blame that is due 
methadone treatment, Helen recognized that she substituted food for her drug of choice—heroin. 
By articulating her concern over weight, Helen produced a responsible self who is self-
monitoring in the context of a treatment for heroin use that may itself pose a risk for the health 
problems associated with obesity. 
 Eric, a 53-year-old white man, who was homeless at the time of our interview, was also 
concerned about his weight and simply stated: “weight” when I asked: “What are your main 
health concerns?” Not finishing his sentences but still conveying a point, he explained: “Weight 
is a very… I’m thinking of going and having my stomach…” I asked if he wanted to say stapled 
and he replied affirmatively. Later in the interview, Eric revealed that he had been speaking with 
his primary care physician about this surgery. Eric wanted to take action about his weight: “I’m 
300 pounds plus. That is not healthy for a man of my age. No, something has got to be done 
about this weight.” Eric explained that at least part of the responsibility for his obesity lie with 
the practices of organizations that address hunger: “I have to eat in soup kitchens where they 
serve just a lot of starch to fill you up. The main issue there is hunger. Okay, what they do is they 
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feed you a plate of spaghetti with mashed potatoes and bread.” Despite Eric’s limited ability to 
determine the food he will eat, he takes responsibility for addressing the outcome of eating the 
starchy foods available at soup kitchens by pursuing bariatric surgery. As with the other 
interviewees who put forth risk narratives, Eric produces himself as a responsible subject by 
expressing concern over his health risks, demonstrating that he is monitoring his health, and 
considering ways to address risk. 
Narratives of Illness 
 Many of the health concerns expressed by interviewees were not articulated in terms of 
risk but rather had to do with chronic illnesses. While telling the stories of their illnesses, 
interviewees did not often make mention of their drug use, and the chronic conditions they dealt 
with did not appear linked to drug use. Through telling these stories, the interviewees showed the 
efforts they made to address their conditions or in some instances expressed worry over their 
inability to address their conditions. These individuals took responsibility for their chronic 
illnesses despite living in socially and economically marginal positions that made caring for 
illness quite difficult.  
In terms of evidence-based, risk-reduction techniques, harm reduction has shown much 
success as a public health intervention in stemming the spread of HIV, but if my interviews are 
any example, health is still poor among low-income drug injectors. Besides health problems the 
drug users I interviewed also experienced housing instability, which in some instances worsened 
or created health problems. This section will examine three illness narratives that vividly reveal 
the link between poverty and health and further, show that the interviewees maintained personal 
responsibility over their health despite extremely difficult circumstances. Offering space in this 
chapter for the illness narratives of the interviewees and their intersection with socially 
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structured disadvantage reveals that individual-level interventions may be inadequate to address 
the health concerns of socially marginal populations. 
Dan, a 22-year-old white homeless man, unraveled an incredible story of survival as our 
interview progressed that not only reveals the negative health impacts of poverty but also how 
our health care system can work to create them. In explaining how he came to reside in New 
York City, he is originally from Long Island, Dan also described how he became homeless;   
Well, I was living with my girlfriend, and I had three jobs. I had custody of my 
brother. She had a kid too, and we ended up breaking up, and everything 
was in her name. So I was living out of my truck for a little while. I was 
working. I was doing fine. I was taking care of my brother. Somebody stole my truck. 
Yeah, so I lost all my jobs and just became homeless, and it was just pretty much 
downhill from there. Yeah, I lost custody of my brother. I mean my aunt has him. He’s 
okay, but I just kind of ended up out here [in New York City]. It’s actually a lot easier to 
hustle out here. It’s a lot easier to be homeless out here than it is on Long Island. 
 At the time of our interview Dan had been living in a shelter in Brooklyn for about a 
month. Prior to that, he was living on the street. He described this experience:  
 Yeah.  The winter was… Thank God it’s getting warmer because there was a lot of nights 
where I just woke up thanking God that I woke up. There were a lot of nights I was 
drenched. Yeah, yeah. It didn’t kill me, so it made me stronger. That’s the way you’ve 
got to take it.  
Dan showed a remarkably positive attitude throughout the interview, only revealing any amount 
of upset when discussing his health. Before getting to this, it is important to point out that the 
harm reduction center where this interview took place played something of a role in Dan’s life. 
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He explained: “I thought it was a place for homeless people because everybody that I knew came 
here, and I’m like, ‘Oh, why is everybody coming here?’  And I started volunteering, and I’ve 
used needles, so it worked out… It’s like a hangout.” The syringe exchange services of this harm 
reduction center occupy a minor position in Dan’s characterization of his introduction to this so-
called hang-out. It “worked out” for him to become a participant and volunteer because he injects 
drugs. However, Dan didn’t identify the harm reduction center as a place that addresses his 
injection drug use but rather, as a place for homeless people like him to hang out. Dan’s 
prioritized needs have more do to with his homelessness than his injection drug use. However, it 
is his injection drug use that allowed him to gain entrance to this harm reduction center, which he 
seems to use for purposes of hanging out with his social network and to pass time volunteering. 
 During our interview, it was clear that diabetes shaped Dan’s life, as well as how he 
understood his health. He had previously found employment in the food service industry and 
described this work environment as helpful for addressing his diabetes. In describing his interest 
in food service, Dan remarked: “I’m a diabetic. So I’ve got to eat every hour and a half to keep… 
So it was just easier that way.” When I asked, as I did with every interviewee, what his main 
health concerns were, Dan said: “My main health concerns? Pretty much just my diabetes.” 
Notably, he did not mention the health risks associated with injection drug use though going 
through his drug use history revealed weekly injection of heroin, as well as the use of crack and 
prescription painkillers. When I asked him how he managed his diabetes while living on the 
street a story of desperation and frustration with Medicaid sanction and hospital bureaucratic 
rules emerged. He described it: 
Well, it was difficult in the beginning because I didn’t have as much hustles and able to 
make as much money.  So I wasn’t doing so good in the beginning, and my Medicaid got 
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cut off because I accidentally set up a case out here [in NYC] while I had a case in Long 
Island. They cut it off for six months. I almost died like four or five times. I was in the 
hospital every week because I didn’t have my insulin. I can’t go three days without my 
Lantus11. I take two different types, and I can’t. I just – I get sick beyond all means. I got 
no energy because what the insulin does is it literally makes energy in your body, so if 
you don’t have insulin, you don’t have energy. So I couldn’t even make money if I tried. 
I was a wreck. 
Kelly: Because you didn’t have Medicaid, they wouldn’t give you insulin? 
Dan: So I would have to go into the hospital in DKA, diabetic ketoacidosis. That’s when my 
sugar goes completely too high. I black out. I can just die, and that’s pretty much the only 
way they would take me is if I was in DKA. And I’d have to do three days, and I’d be out 
for four days, three days. I mean, I…  my medical bills are ridiculous right now. I mean, 
if I get a regular job, I don’t know what the hell I’m going to do, but they’re just going to 
take all my money. It’s just the snowball that just… 
Kelly: I just can’t believe they wouldn’t give you insulin to take with you. 
Dan: I know. I’m like, “Just give me one pen, one Lantus, and I won’t have to come.” “No, no. 
We can’t do that.” I’m like, “That’s just crazy.” I was about to go under the counter and 
just take it. 
Poverty, Medicaid sanctions and hospital policy worked against Dan in acquiring the medication 
he needed to treat his diabetes. To receive his medication, Dan was compelled to push his 
diabetes to acute levels and seek treatment in the emergency room where he was not allowed to 
take medication with him. Faced with this dire situation, Dan’s primary focus is rightly placed on 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
11	  Lantus is a long-acting insulin that is taken once a day as a form of diabetes treatment.  It 
comes in the form of a pen that uses a small, thin needle to inject the medication. 
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his diabetes though he did show some minor concern for contracting HIV. When asked his usual 
reasons for visiting the doctor, which he does about two times a month now that he has health 
insurance, he replied: “My sugar.” Then, he continued: “To make sure everything is in check, to 
make sure my A1C’s12 good.  Just general…  I take HIV tests like every three months, other 
tests…” Though Dan was concerned about contracting HIV and has himself tested while at the 
doctor, his diabetes is the motivating force for making the doctor’s visit. Dan gets an HIV test 
because as he explained: “Everybody should do it. Just you never know. You never know if 
you’re going to find a hundred dollar bill. You don’t know if you’re going to find out you have 
AIDS.” Though he admitted to doing “a couple stupid things,” meaning things that increased his 
risk for contracting HIV, Dan presented HIV tests as something good that everyone should do, 
rather than a test he should get because he’s taken some risks. Visiting the doctor for his diabetes 
offers access to HIV testing rather than the other way around. Dan’s prioritized need is treatment 
for his diabetes, which could be addressed through consistent access to health insurance.  
 John, a 56-year-old Puerto Rican homeless man, presents an illness narrative that also 
links health to poverty. Additionally, John’s narrative reveals the worry and anxiety felt when 
one is unable to take personal responsibility for their health even though their circumstances 
make it near impossible. Though residing in transitional housing at the time of our interview, 
John was homeless and living on the street the year prior. After losing his job of 12 years in the 
maintenance department of an apartment complex, John began living on the streets. He attributed 
the year he lived on the streets directly to the loss of his job. Now that he is off the streets and 
working part-time as a peer educator at the harm reduction center where the interview took place, 
he’s been able to focus on his myriad health concerns. When I asked him what his main health 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
12	  The A1C test measures average blood glucose control for the past 2 to 3 months. 
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concerns are these days, he replied: “My health is my main concern right now. I do have health 
issues… You know, I was homeless. I didn’t have no insurance. I had nothing.” John listed his 
health concerns as “an aneurysm, kidney stones, COPD [chronic obstructive pulmonary disease] 
and asthma and hypertension.” At various points while discussing his health, John showed 
concern for the effects of being homeless and having no insurance on the health conditions he 
knew he had. He explained:  
I had hypertension for a very long time. That I knew. So you know when I was homeless 
I knew that I had hypertension. The thing was that all the time I was walking around I 
didn't have insurance. I used to say, “How am I going to get medication?” and I knew my 
blood pressure was high because I could feel it.  
Eventually, John was able to see a doctor through a homeless outreach program run by a local 
hospital, and he expressed deep gratitude for this connection to health care. As John explained, 
he is now dealing with the health consequences of a couple years spent without insurance and 
therefore, without medication. John said: 
You see, that was probably why I had the aneurysm because I was walking around for a 
couple of years without no medication. So the fact that I was walking around and my 
pressure was sky high probably caused the aneurysm to happen. And like I said all the time 
I knew that I had high blood pressure but I had no way to take care of it and the fact that 
now, you know, when I found Dr. Marquez and I'm getting meds now it's almost like, you 
know, I'm getting the meds but because of the waiting time of going a couple of years 
without meds caused the aneurysm to happen. You know, so then I used to worry about it a 
lot. “Oh my god, what am I going to do? I can't get meds. I can't do this.” I didn't know that 
I had the aneurysm. All I knew was I had high blood pressure. I didn't know I had COPD 
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and I knew I had a slight case of asthma because everybody used to tell me, “you breathe 
really heavy,” but now I don't, I don't feel like… I mean, I know I'm not real healthy. Like I 
said the things that I need to be taking care of right now are being taken in. I'm seeing the 
doctor that I need to see. 
In an explanatory mode, John described how two years without health insurance contributed to 
why he isn’t “real healthy” at present. John’s injection drug use did not figure into his 
explanation of his health. It seems that he has other overwhelming concerns. John’s current 
health conditions stem from his social marginality living on the streets and outside of our health 
care system. Job loss and temporary work is common in our current faltering economy, where 
some of the most vulnerable workers, the working poor, face insecure employment and a 
declining number of options for work. John was hit particularly hard by his loss of employment, 
which left him living on the streets. Unable to plug into any social safety nets, John’s health 
conditions worsened and he was left permanently affected by ailments that could have been 
ameliorated if he had access to health care and stable housing. 
Joshua, a 27-year-old white man, who was temporarily and precariously housed in a 
“three-quarter house”13 at the time of our interview, explained his difficulty in procuring care for 
multiple psychiatric conditions. Joshua came from a middle-class family on the west coast and 
had a bachelor’s degree. He found his way to New York City through an internship at a non-
profit that offered a living stipend, but that internship ended a year prior. Joshua had been 
unemployed ever since. He explained: 
I had a bunch of savings when I moved to New York. Then, the contract ended at the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
13	  Joshua explained that a “three-quarter house” is similar to a half-way house but with less 
structure. Three-quarter houses offer semi-structured living for people with substance use 
problems in exchange for full access to residents’ monthly public assistance allowances. 
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internship that I was at so I figured I would take a couple months to relax and start 
applying for jobs, and get a job very quickly afterwards, but I was still shooting heroin. I 
hadn’t got the methadone yet. By the time I got on methadone, and stabilized on that, the 
money had run out, and I was having a difficult time finding a job.   
Still intermittently shooting heroin while on methadone, Joshua explained that he had been in the 
shelter system “on a couple of occasions for no longer than like a month or two” but found the 
three-quarter house “a lot more comfortable.” 
 When I began to ask Joshua about his health, he immediately voiced his desire to address 
his multiple psychiatric conditions saying: “I definitely need to see a psychiatrist… I am 
diagnosed with ADD, depression, anxiety, and panic attacks.” He continued: 
I'm having a very difficult time finding a psychiatrist. One reason is because Medicaid is 
basically partially privatized. So we have these HMOs, and when you’re signing up for it, 
they really don’t tell you what the pros and cons of an HMO was. So I just took the first 
one, Affinity. It started with an A. They’re at the top of the list. I didn’t know at that time. 
If I had known what I know now, I would have picked one of several other ones that are 
better. But my particular HMO, I call them. I try to get a provider directory. I can't talk to 
a human being on the phone.  
Not receiving information on the qualities of the various HMOs he was offered as a Medicaid 
recipient, Joshua quickly chose his insurer and later realized that he had chosen poorly. Now he 
is faced with the unfortunate consequence that he cannot gain access to a provider directory in 
order to locate a psychiatrist covered by his insurer. He explained the outcome of this struggle: 
“So I’ve been having a very hard time getting psychiatric help… So I need medication, and so 
I’m forced to get at least anti-anxiety medication illicitly as a result of this.”  
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 Joshua also cited the time commitment required to maintain and use publicly provided 
assistance, such as cash benefits or psychiatric care at a clinic, as prohibitive of seeking care. He 
explained: 
Then a lot of the psychiatry services that are provided are clinics, and I have so much 
stuff to do regarding HRA14. Any time I have an appointment for HRA, it’s a whole day. 
So these clinics--it’s a whole day. It’s very difficult to have a full-time job on welfare. 
You need time to navigate your welfare. So I haven’t been able to get the help that I need.   
Though Joshua does not have a full-time job on the books, he makes the point that maintaining 
an open case with HRA requires a time commitment that would undoubtedly interfere with full-
time work. Even without a full-time job, Joshua is overwhelmed with all of the demands made 
upon him by HRA (“I have so much stuff to do regarding HRA”). Going to a clinic that provides 
psychiatric services would take an entire day and Joshua does not have that kind of time. 
 When I asked Joshua about his main health concern, he reiterated his desire for 
psychiatric care and added that his untreated mental illnesses needed to be stabilized for him to 
move forward. He stated:  
My main health concerns are, like I said, getting adequate psychiatric care, getting 
stabilized on medications, like anti-depressants and anti-anxiety stuff. Then, also ADD, I 
think would be helpful. I thought I grew out of it. So for me to really re-enter the 
workforce, I think I really need the psychiatric stuff to be stabilized through medication, 
and also counseling.   
 Joshua’s narrative of illness illustrates the effects of dysfunction within the bureaucratic 
organization of public assistance programming for the poor. Unable to speak to a human when he 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
14	  HRA, which stands for Human Resources Administration, is the organization that administers 
public assistance in New York City. 
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phones his health insurance company, Joshua cannot access psychiatric care, and thus his 
illnesses go untreated, or at least minimally treated through the illicit procurement of anti-anxiety 
medication. As he takes personal responsibility for his illnesses, he puts himself at risk for arrest. 
In fact, Joshua seems exasperated by the amount of responsibility he is required to assume in 
order to access the most minimal of services. The amount of time to keep his public assistance 
case open is onerous to Joshua who is already busy with other unspecified15 activities to stay 
financially afloat. Unable to access treatment for his mental illnesses, Joshua feels unfit for 
entering the workforce. He mentioned at one point that he went to the emergency room two 
times in the last year for panic attacks (“I have gone to the E.R. twice this year for panic 
attacks”). Living in conditions of economic marginality has meant for Joshua that his mental 
illness is minimally treated, leaving him unfit for employment, and thus keeping him in poverty 
and mental distress. 
CONCLUSION 
Through discussions of health with economically marginalized people who inject drugs, 
it was clear that despite their status as risky subjects, these individuals did not often prioritize the 
concerns focused upon by harm reduction interventions—HIV/AIDS, hepatitis C, and overdose. 
Rather, people talked about common chronic ailments such as diabetes, asthma, and pain. The 
structural roots of the circumstances that led to their illnesses are related to inequality, and the 
inadequacies of our social welfare and health care systems. Often conditions of poverty and 
homelessness made access to health care services and specifically attaining health care insurance 
difficult if not impossible.  
What was also clear from the interviews was that the interviewees constructed themselves 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
15	  Joshua chose not to speak about the work he does to make the money he needs above and 
beyond his public assistance allotment, which is garnished by his three-quarter house. 
	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   	   	  
	   	   	   	  
183 
as responsible individuals by discussing how they monitored and addressed their health risks and 
the conditions from which they currently suffered. Speaking about health in terms of risk reveals 
evidence of neoliberal governmentality wherein individuals are enjoined to self-monitor. 
Responsibility is shifted to the individual even when his or her living circumstances and access 
to resources make it difficult to address health concerns. As the illness narratives demonstrate, 
personal responsibility is also exercised among those who speak about their health in terms of 
current illnesses. However, for those interviewees already suffering from an illness (i.e., not just 
at risk for an illness) exercising personal responsibility proved to be inadequate to the task of 
managing illness. Despite multiple visits to the emergency room, Dan was unable to gain regular 
access to his diabetes medication. John monitored his health while homeless but was unable to 
access health care for two years. And Joshua tried in vain to contact his health insurance 
company to obtain a provider directory. These illness narratives can begin a process of 
questioning the ethics of the ideology of personal responsibility. 
 Since the forty individuals I interviewed were all actively injecting drugs, they could fall 
under the care of the harm reduction movement and most of them did, though as I discussed, this 
movement mainly addresses health in terms of its relation to unsafe drug use practices. However, 
looking back upon the roots of the harm reduction movement to the Junkiebond, reveals that a 
broader sensibility with regard to the concerns of drug users is possible. Several researchers have 
noted the limitations on the parameters of care posed by harm reduction interventions and in 
doing so, issue an implicit and sometimes explicit call for more expansive care practices.  
 In her ethnography of addiction in New Mexico, Angela Garcia (2010) situates the limits 
of harm reduction in a critique of, “the twin processes of devolution and privatization [that] have 
shifted responsibility for health care from the public to the more intimate domains of family and 
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community…” (p. 193). Garcia sees overdose prevention training and needle exchange as 
exemplifying this shift. She asserts they limit, “… even as they extend—residents’ capacity to 
care for the addicted” (Garcia 2010: 192). Garcia (2010) concludes, “…  these strategies, while 
important, are not inclusive forms of care; rather, they are the bare minimum” (p. 193). Perhaps 
not invested in the expansion of harm reduction, Garcia notices how it provides a stop-gap 
measure that allows the state to provide the bare minimum of services.   
 Syringe exchange outreach workers themselves have noted the limits of harm reduction 
services, though they do not necessarily articulate the connection to state devolution of services. 
Nonetheless, the workers experience these limits firsthand and provide a knowledgeable critique. 
In qualitative interviews with syringe exchange outreach workers in Ontario, Canada, Strike, 
O’Grady, Myers, and Millson (2004) found among their respondents a common sentiment that 
harm reduction services were inadequate to the needs of the drug users encountered on the 
streets. One outreach worker described the harm reduction services they provided as, “… a band-
aid reaction to what’s really happening out on the streets…” and further, “… the risks for HIV go 
well beyond, and our little intervention is important but let’s be a little bit serious…” (Strike, 
O’Grady, Myers, and Millson 2004: 212). In describing the outreach workers’ criticism, Strike et 
al. (2004) write, “According to the workers, HIV prevention efforts cannot be confined to 
interventions directed only at injecting and sexual behaviors because a complex constellation of 
disadvantages (e.g., mental illness, poverty, homelessness, frequent incarceration, violent 
victimization, disease, lack of social support and limited job skills), if left unattended, 
undermines their efforts” (p. 213). Frontline harm reduction workers are well-positioned to 
identify this failing of harm reduction and to understand on an intimate level the range of 
disadvantages that make people who inject drugs vulnerable to the risks associated with the 
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transmission of infectious disease. 
 Highlighting the range of needs, drug use-related or not, among participants at a harm 
reduction center in the Bronx borough of New York City, McLean (2012) shows in her 
ethnography that these participants repurpose the harm reduction center to meet needs that 
emerge more from poverty than injection drug use. Her examination of the “off-label” or 
unofficial uses of a harm reduction center reveals that attendees use the center for nutrition, 
temporary daytime shelter, and transportation fare. Her findings can be used to argue “… for a 
(re)expanded mission for harm reduction in the United States” (2012: 301). She suggests that this 
(re)expanded mission could include measures that address housing, hunger, and employment 
among drug users living in a society that, “harshly punishes and stigmatizes certain types of drug 
users” (McLean 2012: 301). The fact that drug users repurpose harm reduction centers to meet 
needs unaddressed by the official mandate of harm reduction reveals the limits of a strictly 
public health intervention that focuses mainly on needle use and its consequences. 
 If harm reduction is taken to be solely a public health intervention into the injection 
practices of people who inject drugs, then it has mostly succeeded in disseminating its messages 
to the drug users I interviewed here. Some have even internalized certain harm reduction 
messages and use them to understand themselves as ethical subjects. However, if harm 
reduction’s goal is to reduce harm, as its moniker implies, then its success is limited. The 
injection drug use practices targeted for intervention have largely changed since the early days of 
the AIDS crisis resulting in a decrease in HIV transmission (Des Jarlais et al. 1996; Gibson, 
Flynn, and Perales 2001).  Thus, harm reduction public health interventions have reduced the 
harmful impact of HIV/AIDS among people who inject drugs. However, examining the 
narratives of risk and illness among the forty drug users I interviewed, reveals that this group has 
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many other health issues besides HIV/AIDS and hepatitis C that cause them harm. Presently, the 
narrow public health mandate of harm reduction externalizes these health-related-issues to other 
service providers, as well as the individual drug user leaving him or her to self-manage often in a 
position of extreme vulnerability. This is not to say that harm reduction in the mode of health 
promotion should expand its intervention into the lives of drug users, intervening in new places 
and on new levels of intensity. Rather, harm reduction as a social movement must focus on a 
more structural level to reduce the harm experienced by low-income people who inject drugs. 
This should involve efforts to mitigate the harm perpetuated through the ideology of personal 
responsibility. This ideology is evident in the obstacles to accessing health care put in place by 
the politics that guide bureaucratic programs of public assistance.  
 Social marginalization manifested through poverty, homelessness, and the stigmatization 
of drug use detaches people from necessary resources and support, furthering the damage of 
physical and mental health problems, as evidenced by the experiences of Dan, John, and Joshua. 
Harm reduction’s public health mission has met a fraction of the needs of the people who inject 
drugs in this study, missing in large part issues of homelessness and poverty that increase one’s 
vulnerability to risk. Its tendency to individualize risk and responsibilize structurally 
disadvantaged people renders it incapable of targeting the causes of poor health, which are 
always social and usually class-based.  
 Harm reduction’s earlier iteration in the Netherlands reminds us that the movement does 
not have to remain focused on technical safety precautions. However, reverting back to the 
tenants of the Junkiebond may be impossible given the political and moral climate of the U.S. 
Presently, syringe exchange is not supported by the federal government, and thus no federal 
funds can be used to support it. This should not preclude the harm reduction movement from 
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expanding in other directions. The narratives of the interviewees in this chapter call for social 
change that will ameliorate the socially structured effects of poverty, rather than technical 
solutions to niche problems. An inclusive re-formulation of what is meant by harm that does not 
focus solely on the prevention of certain diseases and recognizes the harmful effects of 
unemployment and unstable housing, for example, could be the beginning step toward building 
networks of care that also work for social change. These networks would involve a bonding of 
movements that are concerned with socially and economically marginalized communities and 
could include organizations and movements that focus on employment, nutrition, and housing 
among other areas. The findings of this chapter point to the need for a movement that provides 
care, broadly construed and easily accessible, to those most negatively affected by inequality and 
the neoliberal emphasis on personal blame, rather than narrowly-focused movements that parcel 
out only certain types of care. These networks of care should be paired with an effort to 
interrogate the ethics of situating a cultural and institutional emphasis on personal responsibility 
in a social environment structured to produce inequality. 
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Chapter 6 
Conclusion: Care and Power 
 
Kelly: Let’s talk about health because that’s what this research is about. 
Tara: I have hep C. 
Kelly: You have hep C. 
  Tara, a 51-year-old Latina, was quick to respond to my prompt, even though I had not 
asked her a direct question yet. Assuming a public health identity, Tara immediately confessed 
her position with regard to a common infectious disease associated with injection drug use. 
However, as she began to explain her hepatitis C infection in more detail, it became clear that 
she actually did not have hepatitis C. She explained: 
But I never took the medicine for it. I see my primary doctor all the time, and he told me 
that I do not show no symptoms, and I never took the medicine. And he said there’s 
people that are just like that. They have an immune that kills the bacteria. We don’t know 
what it is because we’re not in there. We don’t know what’s going on, but it cleaned it. 
You still have it, but it’s like you drank the medicine. 
After a few more questions I ascertained that she tested positive for the antibodies to the hepatitis 
C virus, but her body had fought off the initial infection. She was, in fact, negative for hepatitis 
C. Why had she so quickly told me she was positive for an infection that she didn’t actually 
have? Further into our interview she detailed struggles with a heart infection associated with 
injection drug use, and asthma. Why hadn’t she mentioned the conditions she actually had first? 
 In part, this dissertation sought to answer this question by understanding the articulation 
of certain health concerns as the power-effects of public health governmentality. This 
governmentality has roots in the early days of the HIV/AIDS epidemic when people who inject 
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drugs were identified as a risk-group. Its trajectory was sustained by the harm reduction 
movement’s educational and material interventions. When beginning this project I thought I 
might find that many drug users understood their health through discourses supplied by harm 
reduction. I also wondered if health care practitioners would mobilize harm reduction discourse 
when discussing drug-using patients’ health. I did find this, but I also found so much more. I 
found that health care practitioners also thought in terms of disease when considering their 
patients’ well-being, and people who inject drugs were often more concerned with chronic 
ailments unassociated with injection drug use. This meant that health was not solely or even 
primarily defined in terms of risk, as has been suggested by current social theorizations of the 
meaning of health (e.g., Dumit 2012; Petersen and Lupton 1996). 
 The idea that drug use or addiction is a disease has persisted at the level of ideology for 
about two hundred years and at the level of science for almost one hundred years. The health 
care practitioners I interviewed evidenced this history in their conceptualizations of drug use. For 
example, Elaine, a medical doctor at an inpatient treatment program, said: “What I really learned 
over the years within this field is that I really see it much as a brain disease, you know, than as a 
strictly behavioral issue.”	   New trajectories of research in neuroscience in the 1990s positioned 
the disease of addiction within the brain. Nearly all of the health care practitioners understood 
their patients’ drug use as a disease, and several of them provided a way to treat this disease in 
the form of buprenorphine. Placing drug use under the category of disease positions it as a matter 
of health that must be treated (Zola [1972] 2013).  
 None of the people who inject drugs spoke about their drug use in terms of disease, 
though some referred to themselves as addicts. The diseases they did mention, such as diabetes, 
hypertension, and asthma, were usually articulated as their primary health concerns and were 
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unrelated to their drug use. For example, Kyle, a 23-year-old homeless white man, had been in 
and out of the hospital immediately prior to our interview for a condition he thought might be 
acid reflux. When I asked him what his main health concern was, he said: 
Well um I’m dealing with, I have acid re… I think it’s acid reflux or something related to 
acid reflux. I had blood work done so I guess there’s no ulcer or something like that. I 
guess it’s just acid reflux. I was hospitalized a few times in like one week. I had run out 
of my medication [for acid reflux], and I wasn’t eating, and I was getting dehydrated as a 
result of all of it. So it kind of all just boiled down to me, you know, which is why I 
ended up getting hospitalized but, you know, I got medication. I got hydrated through IV. 
Now I have medication. 
In discussing his primary health concern Kyle reveals two things important to the 
conceptualization of health among people who inject drugs. First, he articulated a health concern 
that was not tied to his drug use, and thus the harm reduction center where our interview took 
place was not equipped to address his concern. Second, he expressed personal responsibility for 
inducing a bought of reflux. Kyle is homeless and rotates sleeping at a friend’s house, an internet 
café, on the subway, and on a bench or the sidewalk. In all of this he was managing to adhere to 
his medical treatment “morning and night,” but then he ran out of his medication. Kyle takes 
personal responsibility for his health while living in conditions of extreme poverty. 
That the drug-using interviewees discussed their health in terms of chronic illnesses from 
which they were currently suffering, bears witness to the stratified effects of biomedicalization. 
For the upper and middle classes the benefits of advances in technoscience, risk surveillance, and 
medical enhancement--key components of the biomedicalization process--are present and 
accessible, but for economically marginalized communities, these advances may be inaccessible. 
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Clarke et al. (2010) state that the unequal distribution of the benefits of biomedicalization “may 
exacerbate rather than ameliorate social inequalities along many different dimensions” (p. 29). 
Part of the biomedicalization process features an increased energy put into self-monitoring health 
risks, which can mean that health is defined through reference to risk (Dumit 2012). While some 
drug injecting interviewees did conceptualize their health in terms of risk, many were beyond 
risk. They were already suffering from a disease. Being economically marginalized and socially 
marginalized for their drug use, it is likely these individuals did not have access to new medical 
technologies for treating illness, as well as risk. 
However, these drug users did have access to knowledge and materials that addressed 
their risk for HIV/AIDS, though many of them did not discuss their health in terms of this risk. 
In chapter three I detail the acts of governmentality which comprise the management of drug-
using bodies during the early years of the AIDS epidemic. These acts built a subject position—
the injection drug user—that had everything to do with risk. By discursively manufacturing a 
boundary around people who inject drugs, surveilling them through ethnographic research, 
differentiating their so-called culture, and working to free them from (some) legal restrictions, 
public health researchers created a particular subject position through governing it. In Foucault’s 
(1982) theorization of the subject there is a double meaning--subject to someone else by control 
and dependence, and subject to one’s own identity by a conscience or self-knowledge. The 
duality of this meaning becomes clearest when people who inject drugs, recognize themselves as 
injectors and begin to advocate for their health through efforts to legalize syringe exchange. 
Realizing a neoliberal subjectivity, people who inject drugs begin to self-govern. Understanding 
the “injection drug user” as a position created through governmentality offers the opportunity to 
see how power constructs subjects, which in turn, offers us the opportunity to question any 
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beliefs about the real-ness of this risk category. Realizing that the “injection drug user” is an 
effect of power, highlights Foucault’s (1982) encouragement to “refuse what we are” as a means 
to subvert power, whether disciplinary or pastoral. 
In chapter four, the power infused in two frameworks for understanding and intervening 
upon drug use is explored through viewing enactments of the discourse of harm reduction and 
that of the disease model of addiction by health care practitioners. Health care practitioners 
enacted harm reduction through educating their patients about safer injection practices, such as 
using sterile water to mix their drugs, and by refusing to discharge patients who were actively 
using opiates. The disease model of addiction was mobilized by them to understand the lack of 
agency their patients had with regard to taking drugs, and to de-stigmatize drug use when 
speaking to their colleagues. Looking more deeply at a significant philosophical clash between 
these two models, the attribution (or rejection) of authority over oneself, reveals that it is through 
the lack of will imputed by the disease model of addiction that health care practitioners can 
express their commitment to harm reduction ideals of destigmatization. That is, by denying that 
drug users have control over their drug use, one can release them from negative social judgment. 
However, the discourse of harm reduction depends on drug users being able and willing to 
exercise control over the ways they use their drugs. By using both models to understand and 
respond to their patients’ drug use, the health care practitioners contingently impute and negate 
the will. The implication of this apparent contradiction is that drug users are managed by two 
types of power in biomedical settings—disciplinary and pastoral. The negation of will present in 
ascriptions of disease implies disciplinary power to produce a new type of subject out of a docile 
body. The application of harm reduction ideas implies a pastoral power, wherein subjects self-
govern through personal risk management and other self-care practices. Furthermore, 
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understanding health care institutions as manifestations of disciplinary power has implications 
for the deployment of pastoral power in the form of harm reduction education. Pastoral power 
may take on a new, more urgent form when engaged in the context of a disciplinary institution. 
 Chapter five considers the power present in articulations of health concerns by people 
who use drugs and the implications for the harm reduction movement. As mentioned, most of 
these individuals expressed their health concerns by reference to chronic illnesses often 
associated with poverty. Others spoke about their health in terms of risk with some referencing 
illnesses which are the foci of the harm reduction movement. Using risk narratives to describe 
one’s health concerns resonates with the neoliberal logic of personal responsibility whereby 
individuals self-monitor in hopes of preventing illness. Under neoliberalism, social and 
economic costs are defrayed by shifting responsibility for health maintenance to the individual 
level. For example, individuals are responsible for securing and maintaining health insurance that 
will meet their health care needs. The presence of risk narratives that reference HIV/AIDS, 
hepatitis C, or overdose, reveals the existence of harm reduction governmentality. This type of 
power enjoins people who inject drugs to keep themselves healthy through the use of certain 
drug use practices. Again, responsibility is placed on the individual. Personal responsibility was 
also apparent in narratives of illness when individuals discussed the efforts they made or felt they 
should be making to take care of themselves, despite living in extreme poverty. By asking people 
who inject drugs to outline their main health concerns, it became clear that the focus of the harm 
reduction movement was not broad enough to encompass many of the health issues I heard. 
Efforts to provide clean needles and education on how to inject safely were necessary but not 
enough.  
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SIGNIFICANCE 
 This research is broadly situated in the literatures on health and governmentality, though 
in a unique way, by looking at both biomedicine and public health. This combination is most 
visible in chapter four when analyzing the medical response of health care practitioners to 
patients who occupy a public health risk category. Though there is some literature which 
discusses harm reduction in health care settings (Rachlis et al. 2009; Strike et al. 2014), it is 
mostly concerned with advocating for the infusion of harm reduction philosophy and practice 
into the space of health care. My study of harm reduction and health care offers an analysis of 
contradictions and power implications. The incorporation of public health education into 
biomedical practices of care is revelatory of the form health care is taking in the 21st century. 
This is connected to current re-conceptualizations of health that align it more closely to 
calculations of risk (Castel 1991; Dumit 2012). Previously conceived as disciplinary settings 
(Foucault 1979, 2007b), health care institutions are now inclusive of pastoral power evidenced 
by a concern for risk. The contingency of ascriptions of will that occurs when biomedicine and 
public health combine is significant for health care practitioners who provide care for patients 
actively using drugs. It may help them understand the contradictions implicit in their practices of 
care and frameworks of understanding. I believe this has implications for a more respectful 
relationship between doctor and patient. 
 Understanding the “injection drug user” as a figure created through public health 
governmentality has been suggested previously (Campbell and Shaw 2008), though an 
examination of how this occurs within research literature is new. While it is well-known that 
public health is a practice of governmentality (Petersen 1997; Petersen and Lupton 1996), 
examining a particular instance of this governmentality sheds light on specific acts of governing, 
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and may have implications for understanding the chronology of this practice of power. The 
existence of the “injection drug user” offers an example of how power is productive of identity. 
The struggle for legal syringe exchange provides an example of how this identity is inhabited 
and begins a process of self-advocacy and self-governance. Historicizing this risk category offers 
a much-needed critical intervention for a trajectory of research that began in the 1980s and aims 
to understand and describe the behaviors of people who inject drugs. 
 This research also sits within literature that criticizes harm reduction as a governing 
practice that focuses too narrowly on infectious disease (Fischer et al. 2004; McLean 2011; 
O’Malley 1999). Chapter five bolsters this argument by examining narratives of illness and risk 
among people who inject drugs. Asking people who inject drugs to define their health concerns 
opens a space for understanding the success and failure of public health governmentality. The 
finding that the services offered by harm reduction centers may not align with the self-described 
health concerns of their constituents means that this research is also quite significant for people 
who inject drugs. Adding my critical voice to those who have already expressed concern over 
harm reduction’s narrow mandate, may bolster a movement toward expansion that could result in 
a broader range of care available to active drug users. As my research shows, low-income people 
who inject drugs take personal responsibility for preventing and addressing illness. By expanding 
its focus to other forms of ill-health, the harm reduction movement could mitigate the distress 
caused by social systems, functioning under the logics of neoliberalism, that limit access to 
resources for low-income people who become sick. 
 This research can be broadly construed as sitting within the sub-field of medical 
sociology. By soliciting the lay knowledge of people who inject drugs, I was able to see how 
illness and risk narratives reveal processes that lead to health inequalities. I also saw that risk 
	  
	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	   	   	  
	   	   	   	  
196 
narratives reveal the power effects of governmentality by showing that people present 
themselves as personally responsible for monitoring their health risks. By seeking lay 
perspectives on health among a socially and economically marginal group of people, I was able 
to show evidence of harm reduction governmentality. But, I also showed times where the effects 
of this governmentality were overshadowed by embodied concern for present suffering. My 
research linked two analytic frameworks—one, methodological and the other, theoretical. 
Listening for and documenting illness narratives offers a method for representing lived 
experience and the ways people make sense of it. Governmentality offers a theoretical 
framework for understanding the play of power in the way individuals articulated their 
narratives. This link adds another layer to the interpretation of illness narratives in medical 
sociology. 
LIMITATIONS AND FUTURE RESEARCH 
 Of course, my analysis was not without its limits. As with any study based on interviews, 
I did not have access to direct observation of social processes. I relied on what my interviewees 
told me. However, this allowed me to narrow my focus to discourse and to think about how 
power is involved in the ways people describe themselves and their experiences. I took what my 
interviewees told me as representative of their thoughts and feelings. There was no way to 
account for the impact of the interview setting and my perceived social location on what I heard 
from the interviewees. That the majority of the interviews with people who inject drugs took 
place at harm reduction centers, could account for the framing of health concerns around 
HIV/AIDS, hepatitis C, and overdose that I heard.  
 My analysis of the effects of harm reduction governmentality among the interviewees 
could have been aided by participant-observation at the harm reduction centers where I 
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conducted the interviews. This would have allowed me to see when and how people are taught 
harm reduction ideas and practices. In turn, this could have revealed the interventions and other 
educational practices that shape and form perceptions of health. Conducting participant-
observation by hanging out with my interviewees outside of the harm reduction center may have 
offered more access to the ways perceptions of health are governed. The challenge for future 
research on the health of people who inject drugs is to determine productive sites for participant-
observation. Unfortunately, as I discovered in the formation of my research plan, the barriers to 
accessing health care settings are strong. 
 My analysis of the disease model of addiction and its implications for the erasure of will 
in chapter four could also be bolstered by further research. It is well-known that people who are 
dealing with addiction often voice a lack of will with regard to their consumption of drugs. 
While the disease model of addiction may ascribe a lack of will to addicts, individuals addicted 
to substances experience this loss of will on an embodied level. This means that, perhaps, 
addiction researchers and clinicians are not ascribing a lack of will, but rather responding to 
embodied knowledge. In this way, the science of addiction is not actively working to secure the 
negation of drug user will. Future research on this topic could benefit from in-depth interviews 
with individuals addicted to substances that include questions about their experience with 
addiction, and how clinicians have spoken to them about addiction. These interviews might 
reveal if and how they experience a lack of control, and if this idea of lack of control has ever 
been foisted upon them. 
 Another area that could benefit from further research concerns the type of “will,” or lack 
thereof, attributed to the disease model of addiction, and the type of “will” facilitated by harm 
reduction governmentality. Understanding these two attributions of will as distinct mean that the 
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contradiction alluded to in chapter four is not a “true” contradiction. The disease model of 
addiction refers to a lack of will over taking drugs. Harm reduction practices elicit the will of the 
drug user in taking care of his or her health. The will to take care of one’s health is different than 
the will to avoid using drugs. This is made clear in chapter five when I discuss the efforts my 
interviewees take to address their health. Though there may not be a “true” contradiction 
occurring within health care practitioners’ mobilizations of the disease model of addiction 
alongside harm reduction education and practice, both the attribution and denial of will are co-
present, but nested within contingent circumstances. Health care practitioners contingently evoke 
and deny the will of their drug using patients. To delve further into this matter, research 
interviews that ask direct questions about this “contingency of the will” could be carried out with 
health care practitioners, as well as their patients. These interviews could offer a depiction of the 
experience (or non-experience) of contingent contradiction in health care interactions.  
FINAL THOUGHTS 
 As I carried out the research and the writing of this dissertation project, evidence of a 
rising heroin epidemic began appearing in the media (e.g., McDonald 2013; Seelye 2014; Sontag 
2014). People who had been addicted to prescription opioid painkillers were now switching to 
heroin because it was available and cheaper, and many were injecting. When interviewing the 
health care practitioners, I heard from a few of the physician-researchers that injection was on 
the decline, at least in New York City. This felt like a criticism when I heard it, though the 
physicians were able to back-up their statements by reference to research and their day-to-day 
experience with drug-using patients. When I heard media speculation that injection use of heroin 
may be increasing in prevalence, it helped me to re-affirm that my research is relevant. By 
following media depictions of this new heroin epidemic, I learned that much of the heroin use is 
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happening in rural areas. This is of concern since harm reduction centers are not often found in 
small towns. Narrow mandate aside, these centers can be a haven of resources and support for 
drug users who face harsh stigmatization elsewhere. 
 Though harm reduction may be a force of governmentality, I do not want to discount its 
pragmatic usefulness for those who need to address their immediate, injection-related risks. 
Harm reduction centers, through their drop-in areas, also offer a respite from the grim 
circumstances poor injectors often face due to stigmatization, but also due to a lack of resources, 
such as food and shelter. The criticism of harm reduction my research offers should not be read 
as advocating for an elimination of the services and material resources offered by harm reduction 
centers. It should be read as an effort to provoke reflection on how care for people who inject 
drugs can broaden and through this, allay some of the hardship experienced when low-income 
individuals are forced to expend a great deal of personal responsibility to get the bare minimum 
of care. It should also be read as an attempt to understand the diffuse channels of power that flow 
through the care offered by harm reduction services. 
 When thinking about the new rural injectors on which the media reported, I was 
concerned about the health care practitioners they might encounter when in need of care. Outside 
of New York City, in rural areas, health care practitioners may not be predisposed to providing 
non-judgmental, compassionate care for people who use drugs. This is, of course, speculation. 
However, knowing that smaller towns often do not have active collectivities of harm 
reductionists, it seems likely that health care practitioners in these areas might have less exposure 
to this philosophy. Though I also position health care practitioners as mediators of 
govermentality, as well as disciplinary power, through their uses of the disease model of 
addiction and harm reduction education and practices, the individuals I interviewed displayed 
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incredibly empathetic attitudes towards their drug-using patients. Power functions through care, 
even if the care is delivered with compassion. Still, I like to hope that some of the new rural 
injectors encounter health care practitioners who know about and use harm reduction philosophy. 
And, I’d rather see them use the disease model of addiction than moralistic understandings of 
drug use, though morals certainly have guided the formation of the disease model. 
 This dissertation shows that through care individuals are governed in certain ways. They 
are acknowledged as certain types of subjects. Power works through getting us interested in 
taking care of ourselves by recognizing our health in terms of risk. It also works within the very 
act of providing care, such as in drug treatment programs that treat the disease of addiction. It is 
compelling to wonder what this care will look like as neurobiological definitions of addiction 
gain nuance through further research in neuroscience. Also, what could harm reduction care look 
like if the movement were to expand its focus to include the non-drug-use-related illnesses I 
heard from my interviewees? What kind of drug-using subject will this care produce? As access 
to health care increases in the United States, what will the self-care practices of people 
previously without health care look like? The certainty is that power will continue to flow 
through these acts of care. The challenge is to recognize this power that makes itself invisible. 
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Appendix. Professional Profiles of Researchers Interviewed for Chapter Three 
 
 
Samuel Friedman   
 Sam Friedman started conducting research on people who inject drugs (then referred to as 
“intravenous drug abusers” or “intravenous drug users”) in 1983 when he was hired as a data 
analyst and project director by Don Des Jarlais for the first NIDA-funded project in the New 
York City area. Sam is now affiliated with the National Development and Research Institutes in 
New York City where he is the director of the Institute for Infectious Disease Research. When 
asked to give a brief history of his professional work as it relates to people who use drugs and 
HIV/AIDS he humorously said, “Sure, I came, I saw, I suffered.” Elaborating further he 
described early work on self-organizing among people who use drugs, racism as it relates to HIV 
among those who inject and other people, using the metropolitan area level of analysis to show 
the effects of policy on the dynamics of the epidemic and along with Des Jarlais the association 
between syringe exchange and HIV infection. Notably, Sam’s research has theorized the 
responses (or non-responses) to AIDS of some minority community leaders when according to 
Sam, “… they did everything they could to hide their heads for a number of years and oppose 
syringe exchange.” Through his research he also showed that metropolitan-level policies such as 
those prohibiting the sale of  syringes over the counter were associated with more HIV infection. 
And with Des Jarlais he showed that syringe exchange prevents infection. Though he did not 
mention it, Sam has also conducted influential research on the social networks of people who use 
drugs and HIV and STI transmission risk. Sam has collaborated with numerous other researchers 
and mentioned them throughout our interview. One such person he collaborated with in the early 
days of the AIDS epidemic was an ethnographer named Ric Curtis.  
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Ric Curtis  
 Ric Curtis is now Professor of Anthropology at John Jay College of Criminal Justice 
where he continues to focus his research and activist efforts on people who use drugs. Initially 
interested in being a Caribbean scholar with a focus on drugs, Ric landed a research position 
prior to the HIV/AIDS epidemic involving the study of drug dealers and users in Greenpoint, 
Brooklyn. In 1989 Ric began working for Sam Friedman on an evaluation of an attempt by a 
local organization to organize people who use drugs into a union. This was when Ric was 
initially exposed to people who inject drugs whereas before he had only heard about drug 
injection but not witnessed it or visited shooting galleries. Ric went on to achieve his position at 
John Jay College and along the way conducted research on such topics as street-level drug 
markets, social and risk networks of people who use drugs and HIV infection, drug eras in 
Williamsburg, Brooklyn, and crime and drug use among women. Ric often uses ethnographic 
methods in conducting his research but recently has been involved in technically-advanced 
analyses of social networks. Ric is also on the board of directors of two HIV/AIDS prevention, 
community-based organizations and syringe exchanges.  
Sherry Deren  
Sherry Deren who is currently a Senior Research Scientist at New York University’s 
College of Nursing and the director of the NIH-funded Center for Drug Use and HIV Research, 
began researching people who use drugs in the 1970s before the widespread appearance of 
AIDS. Sherry conducted this work as part of a state bureau that in the 1970s was referred to as 
the Drug Abuse Control Commission. It is now known as OASAS, Office of Alcoholism and 
Substance Abuse Services. Trained as a social psychologist and holding a Ph.D., Sherry took part 
in research that investigated the personality characteristics of people who use drugs. She also 
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was involved with evaluations of drug treatment programs including methadone programs which 
at the time served mainly people who injected heroin. In 1987 and 1988 when NIDA recognized 
that injection drug use was a major risk factor for HIV transmission, Sherry applied for a grant 
from NIDA and received it. One of her early studies focused on people who inject drugs and 
their sex partners and was based in Harlem. She then went on to research people who inject 
drugs and those who smoke crack in the 1980s when crack use was recognized as a risk for HIV 
in terms of sexual behavior. She was also involved in comparison research of Puerto Ricans who 
inject drugs in the United States and those in Puerto Rico, which revealed the effects of the 
availability of health care services and syringe exchange on the incidence of HIV infection. In 
1997 Sherry applied for and received a NIDA grant to create a center to support drug use and 
HIV researchers in carrying out their research and implementing interventions based on findings. 
This grant has been continually refunded and Sherry serves as the director of this center known 
as CDUHR, Center for Drug Use and HIV Research.  
Brian Edlin  
Brian Edlin comes at this area of research from the angle of medicine as he was trained as 
an internist with a specialty in infectious disease. In 1989 Brian joined the Epidemic Intelligence 
Service at the CDC and began to conduct work related to drug use and AIDS. From 1997 to 2002 
he directed the Urban Health Study at the University of California, San Francisco, which is the 
longest running longitudinal study of people who inject drugs in the world. In 2002, under 
Brian’s recommendation, the NIH rescinded the restriction against treating people who use drugs 
for hepatitis C in its new guidelines and began to recommend hepatitis C prevention, testing and 
treatment programs for people who inject drugs and incarcerated persons. In 2005 Brian began 
conducting research on hepatitis C among people who inject drugs in New York City, which 
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included research on the provision of hepatitis C treatment to people who use drugs. Brian is a 
longstanding advocate for research on hepatitis C particularly among people who use drugs.  
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S E R V I C E   T O   T H E   P R O F E S S I O N 
Scholarly Activity Award committee member, Sociologists’ AIDS Network (summer 2014) 
 
Manuscript Reviewer, The International Journal of Drug Policy (on-going) 
 
Sociology Editor, Maxwell Review (2007-2008) 
 
 
C O N S U L T I N G   E X P E R I E N C E 
Composed grant report on peer-delivered syringe exchange, Chemical Dependency Institute, Beth 
Israel Medical Center (Spring 2013) 
 
Subject Matter Expert for Pearson sociology textbooks, Ohlinger Publishing Services (Fall 2012 to 
present) 
 
Research Study Liaison to Onondaga County Department of Correction for “Acute Hepatitis C Virus 
Infection in Injecting Drug Users” study, Principal Investigator: Dr. Brian Edlin, SUNY Downstate 
Medical Center (2008-2009) 
 
 
S E R V I C E   T O   T H E   D E P A R T M E N T   A N D   C A M P U S 
Graduate Student Representative, University Senate (2010-2011) 
 
President and Co-Creator, Sociology Graduate Student Assemblage (Fall 2010) 
 
Member of Symposium Planning Group, Sociology Department (Fall 2010) 
 
Departmental Workshop and Panel Co-Organizer, Sociology Department (2009-2010) 
 
Sociology Department Representative, Graduate Student Organization (2008-2011) 
 
 
P R O F E S S I O N A L   A S S O C I A T I O N 
American Sociological Association (on-going) 
 
Society for the Study of Social Problems (on-going) 
 
Eastern Sociological Society (on-going) 
 
Sociologists’ AIDS Network (on-going) 
 
 
L A N G U A G E   A N D   T E C H N I C A L   S K I L L S 
Written and verbal proficiency in Spanish 
 
Data Analysis: HyperResearch, Dedoose 
